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Abstract
Receptor tyrosine kinases (RTKs) form a medically important class of membrane
proteins whose malfunction as signalling entities has been reported as the cause of a
large number of diseases. The structure and dynamics of the transmembrane domain
(TM) of these receptors is central to their role in cellular signalling. However, this
structure–function relationship is poorly understood. This is largely due to the
problems associated with the production of these proteins for analyses in vitro and
the fact that they are hydrophobic and require membrane mimetics to solubilise
them, which in turn often means loss of structural integrity.
This study aimed at using solution- and solid- state NMR to probe the structure and
interactions of two biologically important RTK-TMs for which no high resolution
structures exist. For the oncogenic Neu receptor tyrosine kinase transmembrane
domain, it was sought to understand which amino acids are involved in stabilis-
ing the helical dimer. Synthetic peptides were reconstituted into liposomes and
then analysed using solid-state NMR. The platelet-derived growth factor   receptor
transmembrane domain was another RTK-TM whose structure and interactions with
E5 protein were studied using solution-state NMR. A detailed protocol for the ex-
pression, purification and reconstitution of PDGF R-TM into membrane mimetics
was devised in order to perform the stated NMR analyses.
xv
Chapter 1
Introduction
1.1 Membrane Proteins
Any living cell houses a host of constituents which are compartmentalised using
a barrier known as the plasma membrane. Furthermore, organelles within a cell
partition certain cellular machinery using membranes. These biological membranes
are made up of a variety of phospholipids (mostly replaced by glycolipids in algae and
plant chloroplasts) which self-associate to form a bilayer. Embedded within these
bilayers, amongst other biological molecules (e.g cholesterol), are a class of proteins
known as membrane proteins. These proteins are involved in almost all aspects of
cellular function, from relaying information from the external environment to the
cell, to tra cking material in and out of the cell. As such, their malfunction usually
has serious consequences and they have been implicated in a broad range of diseases
such as cancer, inflammatory and neurological diseases.
Genomic studies over the last couple of decades have revealed that membrane pro-
teins constitute as much as a third of eukaryotic proteins (Baker, 2010) and inves-
tigating their structure and function has never been more important. Even though
membrane protein structure determination has moved forward leaps and bounds
within the last decade due to novel techniques in X-ray crystallography, NMR spec-
troscopy, and more recently, cryo-electron microscpy, they still represent less than
3% of the structural entries in the Protein Data Bank (PDB) (Berman et al., 2000).
This is in stark contrast with their pharmacological importance given that around
60% of the current approved drug targets are membrane proteins (Yıldırım et al.,
1
CHAPTER 1. INTRODUCTION
2007).
Membrane proteins have traditionally presented themselves as very challenging sys-
tems to study for structural biologists. This is primarily because they natively reside
within the hydrophobic environment of the lipid bilayer and their analysis requires a
membrane-mimicking environment. This is usually achieved by studying the protein
in vitro in the presence of detergents and/or lipids, which exponentially increases the
obstacles that need to be overcome for successful high-resolution structural analysis
(Warschawski et al., 2011). Furthermore, membrane proteins are present natively
in the membrane only at very low concentrations while very often milligram quan-
tities are required for structural analyses. This problem is usually overcome by
overexpressing the protein of interest recombinantly in heterologous host organisms.
Although Escherichia coli has been extensively employed for this purpose, other bac-
terial hosts (e.g. Lactococcus lactis), yeast expression systems (e.g. Picha pastoris
and Saccharomyces cerevisiae), insect and mammalian systems are also routinely
used. Extensive and systematic screening of expression systems often needs to be
performed to obtain a membrane protein in su cient quantities while maintaining
structural integrity.
1.2 Receptor Tyrosine Kinases (RTKs)
RTKs are cell-surface phosphotransferase enzymes that specifically phosphorylate
the tyrosine amino acid using ATP and create ADP and a phosphotyrosine in the
protein. This allows protein substrates to bind to docking sites in the kinase do-
main and hence allow RTKs to mediate transmembrane transduction of extracellular
signals to the cytoplasm for the downstream control of various cellular processes in-
cluding cell-proliferation, di↵erentiation, metabolism and motility (Blume-Jensen
and Hunter, 2001; Ullrich and Schlessinger, 1990).
The overall topology of RTKs is highly conserved with a ligand-binding region in the
extracellular domain, a single transmembrane helix, and a cytoplasmic region which
includes a regulatory juxtamembrane domain and a catalytic kinase domain (Lem-
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mon and Schlessinger, 2010) (Figure 1.1). The ligands for RTKs include di↵usible
peptides or small proteins such as growth factors, cytokines, hormones, neurotrophic
factors, and other extracellular signalling molecules (Li and Hristova, 2010).
The traditional model for the mechanism of RTK activation involves ligand binding
to the extracellular domain which induces dimerisation with an adjacent receptor,
which in turn causes the kinase domain to become active. The activated receptor
then autophosphorylates on multiple intracellular tyrosine sites. The phosphorylated
tyrosines can then bind to specific substrates. These may be enzymes or molecules
that can bind to enzymes elsewhere. The products generated from this process
may yet bind elsewhere and thus continuing the signalling cascade (Lemmon and
Schlessinger, 2010). This is illustrated in Figure 1.1.
Figure 1.1: Schematic for ligand-induced activation of RTKs. Adapted from
(Zhang et al., 2006).
An alternative model for receptor activation which has been garnering increasing ev-
idence is that of rotation-coupled activation. Here, the receptors exist as preformed
dimers and ligand binding induces a rotation of the transmembrane domain such
that the kinase domain is conferred a conformational rearrangement to an active,
asymmetric state. Rotation of the transmembrane helices and variations against the
tilt angle are also more energetically feasible than lateral association of the monomer
receptors in the lipid bilayer, as proposed by the ligand-induced activation model.
Additionally, the rotation-coupled activation model can also explain bidirectional
3
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signal transduction, where cytoplasmic factor(s) may induce transmembrane rota-
tions in reverse direction to those of ‘outside-in’ signalling (Maruyama, 2015).
Mutations in RTKs and other biological processes which result in aberrant intracel-
lular signalling have been implicated in a wide variety of diseases such as cancers,
diabetes, inflammation, severe bone disorders and angiogenesis. Their increasing
medical significance has provided an impetus for the development of drugs which
block or attenuate RTK activity (Lemmon and Schlessinger, 2010). As such, inves-
tigations of the structure–function relationship of RTKs has become more impor-
tant than ever. This is particularly true for the transmembrane domains of these
receptors, which have been particularly challenging for high-resolution structure de-
termination methods, with only two high-resolution structures of transmembrane
domain dimers available (Bocharov et al., 2008b,a). This study will investigate the
structural properties of two RTKs: Neu and PDGF R.
1.2.1 Neu RTK
The ErbB family of RTKs have been shown to play vital roles in cardiac, neurological
and endocrine systems (Bublil and Yarden, 2007). The activation mechanism of
this family is of considerable medical interest because mutations and deletions that
result in aberrant signalling have been identified in a number of human tumours
(Lemmon and Schlessinger, 2010; Holbro et al., 2003). The constitutive activity
of mutant forms of ErbB2/Her2 receptor in particular have been implicated in a
very aggressive form of breast cancer which forms about 30% of all human breast
cancers, and in many other cancers such as ovarian, stomach, bladder, salivary, and
lung carcinomas (Tan and Yu, 2007). The involvement of ErbB2/Her2 in various
cellular processes is shown in Figure 1.2.
The rat homologue of this receptor, Neu, has been shown to undergo full oncogenic
transformation following a V664E mutation in the transmembrane domain. Studies
conducted on the Neu RTK have provided evidence that specific interactions between
transmembrane helices can mediate dimerisation and receptor activation (Hynes and
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Figure 1.2: The involvement of various Neu kinase domain tyrosines in cell sig-
nalling processes. Examples of substrates that bind to specific tyrosines are given
in ovals.
Stern, 1994; Bell et al., 2000; Smith et al., 2002a) and hence it provides a valuable
paradigm for investigating the mechanistic details of RTK transmembrane domains
in signal transduction.
1.2.2 Platelet derived growth factor receptor-  (PDGF ) RTK
Platelet derived growth factors (PDGFs) are a family of four cystine-knot-type
growth factors (PDGF-A, -B, -C and -D) which have important roles in regulating
cell proliferation, di↵erentiation, growth and development (Williams, 1989). There
are two forms of receptors for PDGFs: PDGF↵R and PDGF R. Both of them be-
long to the class III subfamily of RTKs, and others in the family are the stem cell
growth factor receptor (Kit), macrophage colony-stimulating factor (M-CSF) recep-
tor, and FMS-like tyrosine kinase 3 (Schlessinger, 2000). All of these receptors have
very important physiological roles; PDGF R in particular is an essential regulator
of early hematopoiesis and blood vessel formation (Andrae et al., 2008) through
chemotactic and mitogenic signalling (see Figure 1.3). Malfunction of the receptor
has been linked to diseases such as inflammation, pulmonary fibrosis and restenosis,
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atherosclerosis and many types of cancer.
Figure 1.3: The involvement of various PDGF R kinase domain tyrosines in cell
signalling processes. Examples of substrates that bind to specific tyrosines are given
in ovals.
Structural studies have shown that PDGF R transmembrane (TM) domains have
the propensity to dimerise on their own (Oates et al., 2010; Muhle-Goll et al., 2012).
The smallest known oncoprotein, E5 from bovine papillomavirus type-1, is known
to induce ligand-independent activation of the receptor. This interaction will be
discussed in detail in section 4.1 and involves the E5 homodimer forming a complex
with PDGF R-TM slowing down receptor internalisation. This in turn generates
a sustained proliferative signal resulting in tumorigenic transformation (Nilson and
DiMaio, 1993).
1.3 Membrane Mimetics
Biological membranes are essential in separating the constituents of a cell or organelle
from their external environment. However, the transfer of information, nutrients
and other biological molecules through these membranes is key in order to retain
proper biological function. As such, membranes are a complex heterogeneous barrier
6
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made up of not only lipids but also a variety of other biomolecules such as proteins,
carbohydrates and cholesterol.
Membrane proteins need to be extracted from their natural environment and re-
constituted in artificial milieus for the structural analysis by X-ray crystallography
or NMR. The choice of membrane mimetics should, in general, satisfy two criteria:
first, it should replicate the native environment of the protein as closely as possible
as protein–lipid interactions may play a key role is structure and function; second,
it should be compatible with downstream applications and also allow data acquisi-
tion of the highest quality. The search for membrane mimetics that conserve the
native structure and function remains a prime challenge for structural biologists.
This section will discuss some of the most commonly used membrane mimetics with
a particular focus on their application to NMR spectroscopy.
1.3.1 Detergent micelles
Detergents are the most commonly used membrane mimetics to characterise mem-
brane proteins in an aqueous medium (Kang and Li, 2011). These are amphiphilic
molecules with a hydrophilic ‘head’ and a hydrophobic ‘tail’. Above a certain con-
centration, known as the critical micellar concentration (CMC), detergent monomers
self-associate to form micelles where the hydrophilic head is solvent-exposed and the
hydrophobic tails are in contact with each other (Figure 1.4).
Figure 1.4: Representation of an assembly of detergent molecules to form a micelle.
The polar head groups face outwards towards the solvent whereas the acyl chains
cluster together due to their hydrophobicity.
Detergents are an invaluable tool in a wide array of biochemical and biophysical
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techniques, including X-ray crystallography and solution-state NMR spectroscopy.
Their significance in the latter is underscored by the fact that a large majority of
membrane protein structures obtained to date have been in detergents. This is
primarily because detergent micelles are much smaller (⇠30–50A˚) and hence tumble
faster on the NMR timescale which allows the acquisition of high-resolution NMR
spectra (Warschawski et al., 2011). The challenge when screening detergents for
NMR analyses is to find a detergent which confers to the protein a high degree of
conformational stability, does not impose curvature stress which would greatly alter
protein structural integrity and gives the protein–detergent complex the ability to
withstand lengthy periods of data collection, often at elevated temperatures.
Despite the advantages that detergent micelles bring in solubilising membrane pro-
teins for structural studies, a preferential system would be where the environment
more closely resembles the lipid bilayer that the membrane protein is embedded in
in vivo. Although recreating the complexity of native membranes is not possible
in vitro, the addition of lipids to the micelle (forming what is known as a ‘mixed
micelle’) has proven very useful in analysing membrane proteins using solution-state
NMR. For example, a recent study investigating Yop1p protein found that helical
propensity was increased at the edges of the TM domain and also more homoge-
neous signals were observed in general (Brady et al., 2015). Another example is
when studying mammalian retinal opsin protein it was found that it is generally
very unstable in detergents alone; however, stable opsin was obtained when purified
in a mixture of lipids and detergents (Reeves et al., 1999).
1.3.2 Liposomes
Lipid vesicles, or liposomes, are formed when lipids organise themselves as bilayers in
an aqueous environment (Figure 1.5). As they are made up of phospholipid bilayers,
they very closely resemble native conditions. Although lipids spontaneously tend to
form non-homogeneous multilamellar vesicles, a homogeneous size distribution can
often be obtained through extrusion. Additionally, properties of the membrane such
as fluidity, length and head group charge can be manipulated to further resemble
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native conditions. Membrane proteins are usually inserted into the liposomes using
a detergent-mediated pathway as detergents are convenient for the initial solubili-
sation, isolation and purification of the protein. There are a variety of methods to
subsequently insert the protein in to liposomes but they generally involve dialysis
or incubation with detergent-adsorbing beads (Seddon et al., 2004).
Figure 1.5: A diagrammatic illustration of a liposome. Lipid molecules arrange
themselves in a bilayer with the headgroups facing towards the solvent. A hetero-
geneous mixture of lipids and other biomolecules such as cholesterol can be used to
make liposomes which mimic more native-like conditions. Adapted from (Monteiro
et al., 2014).
Liposomes are excellent mimetics for membrane bilayers but their large size precludes
them from analysis through solution-state NMR. However, it is this same property
which makes them amenable for solid-state NMR analysis. Static NMR spectra of
liposomes generally su↵er from very poor resolution but crucial information involving
protein–lipid interaction can be obtained through 31P NMR and/or 2H NMR when
using deuterated lipids (Ali et al., 2001).
Significant improvements in resolution of solid-state NMR spectra can be achieved
by spinning the sample at the magic angle. Magic angle spinning solid-state NMR
(MAS ssNMR) on liposomes has frequently been the technique of choice for a number
of structural investigations over the last decade and has provided unprecedented
9
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insights into membrane protein structure, for example, the Influenza M2 channel in
DLPC or DMPC liposomes (Cady et al., 2010) and protegrin in POPC liposomes
(Mani et al., 2006).
As mentioned earlier, although liposomes are excellent membrane mimetics, they
do not completely capture the complexity of a native biological membrane. The
e↵ect of lipid composition on membrane protein structure has been gaining increas-
ing importance recently (Lee, 2004; Dowhan and Bogdanov, 2011). The commercial
availability of a heterogeneous mixture of lipid extracts from E. coli and yeast etc.
has greatly aided several membrane protein studies (Rice et al., 2014; Brady et al.,
2015). Furthermore, recent advances in solid-state NMR methodology, such as the
development of Dynamic Nuclear Polarisation (DNP), have been exploited to demon-
strate the feasibility of studying overexpressed membrane proteins in native E. coli
membranes (Fu et al., 2011; Renault et al., 2012; Ward et al., 2015).
1.3.3 Bicelles
Bicelles (bilayered micelles) are formed when, at the correct concentration and
temperature, certain detergents such as DHPC or CHAPS are mixed with lipids
such that they assemble into a bilayered discoidal structure (Sanders and Prosser,
1998) (Figure 1.6). Bicelles have prove to be a valuable tool for studying integral
membrane proteins using solution-state NMR. As they represent an intermediate
morphology between micelles and liposomes, they maintain the attractive feature
of providing a bilayer environment while being monodisperse and small enough to
be suitable for solution-state NMR analysis. Bicelles have been instrumental in
performing structural studies on membrane proteins (Lau et al., 2008; Bocharov
et al., 2007, 2008a).
Depending on downstream use, bicelles can be prepared in two di↵erent sizes. Small
isotropic bicelles which tumble rapidly in solution are suitable for solution-state
NMR. Larger bicelles can also be magnetically aligned with the magnetic field and
can be used for studying orientation and crossing angles of membrane proteins em-
10
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Figure 1.6: Representation of a bicelle. Short chain detergent molecules (red) form
a rim around the long chain lipid molecules (blue).
bedded within bicelles (Sanders and Prosser, 1998). Not only can aligned bicelles
be used in the solution state, but solid-state NMR can also be used to investigate
protein structure in aligned bicelles. An example is when a combination of solution-
and solid-state NMR was used to characterise local and global dynamics of the
chemokine receptor CXCR1 (Park et al., 2006).
Bicelles have also proven to be useful in other arenas of structural biology. The
helical tilt of phospholamban, a regulatory single-pass transmembrane protein, and
its segmental mobility were investigated by electron paramagnetic resonance (EPR)
spectroscopy in oriented bicelles (Ghimire et al., 2012). X-ray crystallography has
also employed bicelles to successfully solve several membrane protein structures (Fa-
ham and Bowie, 2002; Rasmussen et al., 2007; Payandeh et al., 2011) and as such
the arrival of bicelles has had far-reaching implications in structural biology.
1.3.4 Nanodiscs and SMALPS
Nanometric lipid bilayers, or nanodiscs, form a planar phospholipid bilayer like bi-
celles but instead of detergents, the lipids are encompassed by a dimer of a lipopro-
tein known as membrane sca↵old protein (MSP) (Figure 1.7) . During the last
10 years, a large number of solution-state NMR studies have been performed on
membrane proteins embedded in nanodiscs and a number of high-resolution spectra
have been obtained (Tzitzilonis et al., 2013; Shenkarev et al., 2013; Yokogawa et al.,
2012). The first membrane protein structure solved using nanodiscs was that of
OmpX which highlighted the potential of these mimetics (Hagn et al., 2013). One
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major advantage of using nanodiscs is that various MSPs can be engineered to define
the size of the nanodisc. This allows membrane proteins to be reconstituted in a
more controlled manner and factors such as the oligomeric state can be manipulated
(Ritchie et al., 2009). This benefit was exploited in the study of EGF receptor ty-
rosine kinase where they showed RTK kinase activity was significantly stabilised in
nanodiscs (Mi et al., 2008).
Figure 1.7: Illustration of a nanodisc structure. The two membrane sca↵old pro-
teins (coloured orange and blue) for a ring-like cassette which encompasses the lipid
bilayer. Adapted from (Bayburt and Sligar, 2010).
Nanodiscs have also been used in solid-state NMR studies in two di↵erent ways.
One approach is to use large nanodiscs, also known as macrodiscs, which can be
precipitated with polyethylene glycol (PEG) or lyophilisation and then packed into
an MAS rotor (Li et al., 2006; Mo¨rs et al., 2013). Since nanodics are monodisperse,
membrane proteins obtained in this fashion are expected to be more homogeneous
and hence provide narrower NMR linewidths. More recently, nanodsics have been
packed into MAS rotors by through centrifugal sedimentation (Ding et al., 2015).
This avoids issues with precipitation and lyophilisation which may negatively a↵ect
protein structure and function.
There are several synthetic polymers which have shown significant promise in mem-
brane protein structural analyses. One such polymer is styrene maleic acid lipid
particle (SMALP). SMALPs are made up of alternating styrene (hydrophobic) and
maleic acid (hydrophilic) groups; this property allows them to insert into a bio-
logical membrane and extract discs of the lipid bilayer. Unlike amphipols, bicelles
and nanodiscs, SMALPs can bypass detergent extraction and subsequent reconsti-
tution making it a very powerful method for in vivo membrane protein analysis.
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Although several studies have been used to analyse membrane proteins using this
method (Knowles et al., 2009; Jamshad et al., 2011; Postis et al., 2015), a thorough
characterisation is still lacking and some studies have shown these SMALPs can sig-
nificantly alter the physical properties of the membrane (Orwick et al., 2012).
1.3.5 Amphipols
Amphipols are short amphipathic polymers that can solubilise integral membrane
proteins (Tribet et al., 1996). For certain membrane proteins, amphipols are favoured
over conventional detergent micelles because of their ability to increase stability of
the embedded membrane protein while exhibiting good refolding properties (Elter
et al., 2014). Amphipols possess great potential for solution-state NMR studies
owing to the fact that upon solubilisation of membrane proteins, very few poly-
mer molecules remain disassociated with the amphipol–protein complex overcoming
problems associated with viscosity increase at high concentrations (Seddon et al.,
2004). Having said that, problems to do with polymer aggregation and deleterious ef-
fects of the amphipol sca↵old on protein function have been reported (Picard et al.,
2006). Like bicelles, amphipols have also been used to determine high resolution
structures through X-ray crystallography (Polovinkin et al., 2014).
1.4 NMR as a tool for the elucidation of membrane pro-
tein structures and interactions
The advent of novel sample preparation techniques coupled with developments in
NMR methodologies, both in solution and solid state, have made an increasing
number of membrane proteins amenable to comprehensive structural studies. NMR
structures of integral membrane proteins constitute 10–15% of overall structures
(Nietlispach and Gautier, 2011). This proportion has the potential to increase as
limiting aspects continue to be overcome with the employment of techniques such
as the use of lanthanide-induced pseudo contact shifts in solution-state NMR (Crick
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et al., 2015), and the use of detergent microcrystals in solid-state NMR (Shahid
et al., 2012a).
NMR spectroscopy is uniquely placed in the field of structural biology in that it
is able to report on protein dynamics at atomic resolution over a wide range of
timescales. The importance of studying protein dynamics is underscored by the
fact that a host of biological processes such as enzymatic activities, protein fold-
ing, and cellular signalling rely on time-dependent fluctuations in conformation. A
recent study, which illustrates the power of NMR spectroscopy in studying these dy-
namics, reports a direct observation of hierarchy of protein and solvent motions in
the protein conformational energy landscape (Lewandowski et al., 2015). Solution-
and solid-state NMR methods have frequently been used to study protein dynamics
in membrane mimetics as well. For example, 15N relaxation measurements have
been used to study relative motions between helices of polytopic membrane proteins
(Hwang et al., 2004; Villinger et al., 2010). In this vein, NMR spectroscopy is an ex-
cellent method which can be used in conjunction with other high-resolution methods
which can only provide a static picture of membrane protein structure.
Membrane mimetics used to determine the high-resolution structure of proteins em-
bedded in a bilayer have been highlighted in the previous section. However, most of
the full length structures that have been obtained are of integral membrane proteins
and structures of single-pass membrane proteins are rare as conditions required for
a stable structural fold are extremely di cult to obtain, as has been pointed out
previously (Yamamoto et al., 2015). This study focuses on the transmembrane (TM)
domains of RTKs, and while no high-resolution structure of a full length RTK ex-
ists, only two high resolution structures have been obtained of RTK-TM dimers and
both were obtained through the use of solution-state NMR spectroscopy (Bocharov
et al., 2008b,a). New sample preparation methods specifically designed to study
these TM domains (Bugge et al., 2015), as well as novel NMR methodologies can be
combined to give an unprecedented insight into the structure and function of these
RTKs.
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1.5 NMR Theory
1.5.1 Spin
Spin, or spin angular momentum, is a quantum mechanical property which is intrin-
sic to all nuclei that do not contain an even number of protons and neutrons. Spin
is characterised by a spin quantum number (I) which can either be an integer or
half integer. If the spins in an atom are paired (e.g. in 12C and 16O), then they will
cancel each other out (I = 0) rendering the nucleus NMR-inactive.
All other spins produce a magnetic dipole moment (µ) related to the spin quantum
number through the equation:
µ =  ~
p
I(I + 1)
where ~ = Planck0s constant2⇡ .
The constant of proportionality ( ) is known as the gyromagnetic ratio and is unique
to each nuclear isotope. When the nuclear spins are placed in an external magnetic
field (B0), they will reorient themselves either with or against the magnetic field.
Protein NMR spectroscopy is primarily concerned with three NMR active nuclei:
1H, 13C and 15N. All of these have a spin quantum number of 12 , i.e. I =
1
2 , and
as such split into two energy levels when placed in a magnetic field, one parallel
and and one anti-parallel (Figure 1.8). The distribution of these nuclear spin energy
levels is governed by the Boltzmann distribution from which it is possible to deduce
that at thermal equilibrium, the two energy levels are nearly equally populated.
Nevertheless, the very small excess in the lower energy state which is of consequential
importance as it is this net magnetisation (M0) which can be measured, albeit the
low di↵erence in population levels renders NMR a method with inherently weak
sensitivity.
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Figure 1.8: Alignment of spins in a magnetic field. When spins are placed in a
magnetic field (B0), they are no longer isotropically distributed and align themselves
either with or against the field. There is a small excess of parallel spins resulting in
a net magnetisation (M0).
1.5.2 Larmor precession
When a nucleus with spin angular momentum is placed in a magnetic field (B0)
applied along the z -axis, the magnetic moment will precess along this axis as shown
in Figure 1.9. The rate of precession is known as the Larmor frequency (!0) and its
dependence on the gyromagnetic ratio ( ) and the magnetic field (B0) is defined by
the following equation:
! =   B0
where negative sign denotes the direction of motion of the magnetic moment about
the static field.
In an actual sample being analysed, there will be an extremely large number of
nuclear spins all precessing about the z -axis. The net bulk magnetisation (M0)
arises from an ensemble of nuclei of the same kind precessing with the same angular
frequency (Larmor Frequency) in a magnetic field.
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Figure 1.9: Spin precession about a magnetic field (B0) along the z -axis. Net mag-
netisation (M0) will be parallel to the magnetic field as a result of excess population
of spins in the lower energy level.
1.5.3 Radiofrequency (RF) pulse
In order to detect nuclear magnetic resonance in a spectrometer, the magnetic mo-
ment must be perturbed away from the z -axis. This is done by applying electro-
magnetic radiation, i.e. RF pulse, perpendicular to the magnetic field at the Larmor
frequency. When applied for a su cient amount of time, this rotates the magneti-
sation from the z -axis to the xy-plane as shown in Figure 1.10. This pulse is called
a ⇡2 -excitation pulse. The precession of the magnetisation in the xy-plane can now
be detected by a receiver coil through electromagnetic induction.
1.5.4 Free induction decay (FID)
Once the RF pulse is switched o↵, the bulk magnetisation then returns to thermal
equilibrium parallel to the z -axis (Figure 1.11). This phenomenon depends on the
longitudinal relaxation (T1) and the transverse relaxation (T2). T1 describes the
return to thermal equilibrium as a result of the interaction of spins with the sur-
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Figure 1.10: Rotation of bulk magnetisation by RF pulses.When RF pulses are
applied along the x -axis, the bulk magnetisation (M0) rotates and is transferred to
the xy-plane. The precession in this plane induces an electric current which is then
detected.
rounding lattice while T2 is a result of the interactions between spins. As a result of
these two relaxation rates, the detected signal decays over time (i.e. the amplitude
reduces) (Figure 1.11). This is known as free induction decay and is a measure of
decay rate as a function of time.
The FID contains contributions from all the di↵erent target nuclei in the sample. In
order to obtain an NMR spectrum, Fourier transformation needs to be performed
on the time dependent FID to yield a frequency domain spectrum.
1.5.5 Chemical Shift
The magnetic field experienced by each nucleus in a particular sample is di↵erent and
results in each nucleus to precess at a distinct frequency resulting in separation of
signals in an NMR spectrum. This is because each nucleus in the sample produces
a local magnetic field which opposes the external field. This local magnetic field
is determined by the local electronic environment. It is due to this that nuclei
of the same type in di↵erent chemical environments experience slightly di↵erent
local magnetic fields and therefore have di↵erent frequencies of precession. The
chemical shift can be defined as the di↵erence between a frequency of interest and a
reference frequency of a chosen standard. Hence, nuclei in a particular sample can
18
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Figure 1.11: Free induction decay.
be di↵erentiated from each other by virtue of their chemical shift.
In order to remove the reliance of the chemical shifts on the magnetic field strength,
the chemical shifts are converted from Hz to ppm using the following equation:
 ppm =
!0 !ref
!ref
⇥ 106
where !ref is the Larmor frequency of the chosen standard e.g. tetramethylsilane
(TMS) or 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS). This results in a scaled
spectrum that is independent of the external magnetic field (B0) and can be used
for comparative purposes.
1.5.6 Two dimensional (2D) NMR spectroscopy
Although nuclei in di↵erent chemical environments will provide distinct chemical
shifts, sometimes in the case of large and/or complex molecules such as proteins
there may be a crowding or overlapping of signals which can make the resulting
spectrum complicated or even impossible to interpret. For this reason, multidimen-
sional experiments are performed to successfully assign chemical shifts.
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Several homonuclear and heteronuclear 2D experiments exist in solution- and solid-
state NMR. However, the general scheme involves exciting all nuclei simultaneously
creating a magnetisation in the xy-plane. This magnetisation is then allowed to
evolve for a given amount of time (t1). Next, during a mixing time (tmix), magneti-
sation is allowed to transfer between nuclei using a combination of pulses. Finally,
during the detection period, FID signal from the sample is recorded. A set of dif-
ferent FIDs is recorded by varying (t1). A 2D NMR spectrum can then be obtained
through Fourier transformation of the data. A simplified schematic of this is shown
in Figure 1.12.
Figure 1.12: A simplified schematic of how a 2D spectrum is obtained from a series
of 1D data. When there is a correlation between certain peaks in the 1D spectra,
arising from magnetisation transfer, they will show up on the 2D spectrum (blue
peaks in 2D spectrum). When there is no such correlation, there will not be any
corresponding peak in the 2D spectrum (pink peaks in 1D spectra).
One of the most important and useful 2D experiments in biomolecular solution-
state NMR is the HSQC experiment, which will be further explained in section 6.2.
Similarly, a commonly used 2D experiment in protein solid-state NMR, and one that
this study has frequently employed, is the DARR experiment explained further in
section 1.6.4.
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1.5.7 Three dimensional (3D) NMR for protein backbone assign-
ment
Two dimensional experiments can also be extended to a third dimension. In protein
NMR, backbone assignment is usually accomplished using a set of triple resonance
experiments. In order to do so, a 1H–15N HSQC correlation spectrum is extended
into a third 13C dimension as illustrated in Figure 1.13. Signal overlap in the HSQC
can hence be resolved and 13C shifts can help sequentially link the backbone, in
addition to helping identify amino acid type. For instance, serine, threonine and
alanine have characteristic 13C  chemical shifts which makes them easily identifiable.
On the other hand, glycine has no 13C  chemical shift.
Figure 1.13: A simplified schematic of how a 2D spectrum is extended to a 3D
spectrum. In this example, an HSQC experiment (green) is extended vertically
using carbon as an additional dimension. The resulting 3D data set can be analysed
using ‘strip plots’ where an entire carbon dimension is shown at a single 15N and 1H
chemical shift. This enables us to look at carbon chemical at shifts at known values
of 15N and 1H chemical shifts, H(i) and N(i) in the given illustration.
Most triple resonance experiments involved in backbone assignment are named ac-
cording to the atoms involved in the transfer, and the sequence in which they are
involved. For example, the CBCACONH experiment (Grzesiek and Bax, 1992), cor-
relates the backbone amide hydrogen and nitrogen atoms of a given residue (i) with
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the C↵ and C  of the preceding residue (i   1), as illustrated diagrammatically in
Figure 1.14(a). The magnetisation is transferred via the carboxyl group but this is
not observed in the spectrum as the chemical shift is not evolved on the COs. In
the resulting data set, two carbon peaks are observed at the same 1H and 15N shifts
as each peak in the HSQC.
Triple resonance experiments for backbone assignment are always performed in pairs
for sequential linking of amino acids. This is necessary in order to unambiguously
identify (i) and (i  1) residues. The complementary pair for the CBCACONH ex-
periment is the CBCANH experiment (Wittekind and Mueller, 1993). As shown in
Figure 1.14(a), CBCANH correlates the amide hydrogen and nitrogen in the back-
bone of given residue (i) with the C↵ and C  of that residue as well as the C↵ and
C  of the preceding residue. This results in four carbon peaks for given peak at a
particular 15N and 1H chemical shifts in the HSQC. However, due to the fact that sig-
nals arising from C  are opposite in phase, they will appear as negative peaks. This
property allows peaks from each of the residues, (i) and (i 1), to be di↵erentiated af-
ter overlaying it with the CBCACONH spectrum. Theoretically, complete backbone
assignment is possible using this pair of experiments alone. However, overlapping of
peaks and the inherently low sensitivity of these experiments (see Table 6.2) means
that further triple resonance experiments need to be performed.
The HNCA/HNCOCA and HNCO/HNCACO pairs of experiments are frequently
employed to aid in backbone assignment (Bax and Ikura, 1991; Clubb et al., 1992;
Kay et al., 1990). These experiments are much more sensitive and can resolve sev-
eral ambiguities encountered with the CBCACONH/CBCANH pair. Furthermore,
these experiments can be performed with a better resolution in the 13C dimension
due to the fact that the sweep width is smaller due to a smaller chemical shift
range (compared with the CBCACONH/CBCANH pair) and are extremely useful
in forming amino acid links. Figures 1.14(b) & (c) show the magnetisation trans-
fer pathways for the HNCA/HNCOCA and HNCO/HNCACO pairs of experiments
respectively.
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Figure 1.14: Correlations for triple resonance experiments. (a) During CBCACONH, the residue (i) is correlated with C↵ and C  of the
preceding residue (i 1) whereas in CBCANH the residue (i) is correlated with C↵ and C  of the same residue as well as the previous residue;
(b) HNCA correlates the residue (i) with the C↵ of the same residue as well as the previous residue (i  1) whereas HNCOCA correlates the
residue (i) with C↵ of the previous residue (i  1); (c) HNCO correlates residue (i) with the CO of the preceding residue whereas HNCACO
provides the same correlation in addition correlating it the CO of the current residue.23
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1.6 Solid-State NMR Theory
The chemical shift of a nucleus changes with respect to its orientation in a magnetic
field. This orientation dependence is known as anisotropy.
1.6.1 Anisotropic interactions
While anisotropic interactions are averaged out in solution-state NMR due to molec-
ular tumbling, solid samples possess restricted molecular motion and the full e↵ect of
orientation-dependent interactions is still present in solid-state NMR. As molecules
are oriented in possible directions with respect to the external magnetic field, su-
perposition of all possible chemical shifts is observed for each nucleus giving rise to
broad peaks.
Two of the most important anisotropic interactions in solid-state NMR are chemical
shift anisotropy (CSA) and dipolar coupling. Figure 1.15 shows how the CSA of
a 13CO nucleus with respect to a static magnetic field (B0) a↵ects the resonance
frequency. The resultant spectrum shows a sum over distribution of orientations of
the nucleus with respect to the magnetic field.
Figure 1.15: Dependence of resonance frequency upon orientation of 13CO due to
chemical shift anisotropy. Adapted from (Gauglitz and Moore, 2014).
Similarly, dipolar coupling, which arises as a result of the nuclear interaction between
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two separate spins, is also a cause for line broadening. It is dependent on the
orientation of the vector connecting the two nuclear spins.
Although both of the aforementioned anisotropic interactions significantly hinder
resolution of distinct sites, they still contain valuable structural and dynamic in-
formation about the protein. NMR spectroscopists have developed a number of
ingenious approaches to access this information. One such approach is to mimic
the averaging e↵ect in solution-state NMR due to tumbling using a technique called
magic angle spinning (MAS).
1.6.2 Magic angle spinning (MAS) NMR
First introduced by E.R. Andrew and I.J. Lowe (Andrew et al., 1959), magic angle
spinning is a routinely used technique in solid-state NMR to mimic isotropic tum-
bling in the solution state by the mechanical rotation oft he sample. The reason
why magic angle spinning is successful is that anisotropic interactions such as CSA
and dipolar coupling have the same orientational dependence:
1
2(3cos
2✓   1)
where ✓ denotes the angle between anisotropic interaction vector (CSA or dipolar
coupling) and the magnetic field B0. Thus, for all vectors where ✓ = 54.7  the
anisotropic component of the relevant interaction is zero.
When a sample is placed in a magnetic field and spun at high frequency about an axis
54.7  to the magnetic field, it simulates isotropic tumbling. This can be understood
by considering a component of the interaction vector parallel to the magic angle and
perpendicular to the magic angle. All vectors parallel to the rotation axis will be
zero on average as they are at the magic angle. And all vectors perpendicular to the
rotation axis will be zero on average due to high frequency spinning.
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1.6.3 Cross polarisation (CP)
Cross polarisation (CP) is a central theme in solid-state NMR and involves transfer-
ring magnetic polarisation from an abundant nucleus with a high gyromagnetic ratio
(usually 1H) to a nucleus with a low gyromagnetic ratio such as 13C. The primary
consequence of this is an enhancement in sensitivity. CP is achieved by RF irra-
diating simultaneously both resonance frequencies such that the transition energy
for both nuclei is the same. This is also known as the Hartmann-Hahn matching
condition.
CP usually provides a much higher signal to noise ratio than direct excitation, and
allows a faster repetition rate for the experiments (it now depends on the T1 of 1H).
However, since it requires high-power irradiation, it could have deleterious e↵ects
on the sample or probe and these must be monitored closely.
1.6.4 Dipolar assisted rotational recoupling (DARR) experiment
Dipolar Assisted Rotational Recoupling (DARR) (Takegoshi et al., 2001) is one
of the most popular 13C–13C correlation experiments in solid-state NMR and the
method of choice to observe such correlations in this study. While MAS successfully
averages out anisotropic interactions that could lead to spectra which are unresolv-
able, it also deprives us of a wealth of structural information regarding orientation
and inter-nuclear distances. In light of this, several RF pulse sequences have been
developed to selectively reintroduce desired interactions. DARR is one such mech-
anism which is designed to recouple homonuclear dipolar couplings under MAS.
DARR has been, and continues to be, applied to a number of membrane protein sys-
tems to observe short- and long-range through space 13C–13C correlations (Shahid
et al., 2012b; Das et al., 2013; Yamamoto et al., 2015). Figure 1.16 shows the pulse
sequence for the DARR experiment while the magnetisation transfer between nuclei
during the DARR regime is illustrated in Figure 1.17.
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Figure 1.16: Pulse sequence for Dipolar assisted rotational recoupling (DARR)
experiment. The 1H magnetisation is first transferred to the xy-plane through a
⇡
2 -pulse before applying a ramped CP pulse to transfer polarisation to
13C. 1H is
decoupled during the t1 evolution after which 13C magnetisation is placed on the
z -axis using a ⇡2 -pulse. A lower power DARR pulse on the
1H channel equal to
that of the MAS spinning speed is also applied. A final ⇡2 -pulse is applied on the
13C before recording the FID, during which time a high power decoupling pulse is
applied on the 1H channel.
Figure 1.17: Magnetisation transfer in a protein during a DARR experiment. Nu-
clei circled in pink indicate those atoms observed in the experiment and those circled
in blue indicate those atoms through which magnetisation flows in a protein chain.
Residues (i) and (i   1) are used to illustrate this. Black arrows show magnetisa-
tion transfer and grey arrows indicate magnetisation that is normally only observed
through longer mixing times (image taken from http://www.protein-nmr.org.uk/
spectra_ssnmr.html).
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1.7 Aims and Objectives
As has been highlighted in section 1.2, the malfunction of RTKs has been linked
to a plethora of diseases. The transmembrane domain, albeit a short span in the
sequence of these RTKs, is of critical importance as a single mutation can lead to the
constitutive activation of a receptor. This study aimed at using solution- and solid-
state NMR to probe the structure and interactions of two biologically important
RTK-TMs for which no high resolution structures exist.
The first RTK-TM to be studied was oncogenic Neu. Structural insights into what
amino acid motifs stabilise the activated dimer of oncogenic Neu were sought by
selectively labelling amino acids that have been proposed to lie at the dimer inter-
face. After reconstituting them into ‘native-like’ lipid bilayers, through-space NMR
(DARR) correlation experiments were performed to identify which amino acids lie
close in space in the dimeric interface of Neu.
An alternative approach was chosen to study PDGF R-TM. The protein was iso-
topically labelled so as to be able to assign the protein backbone. Once this was
done, E5 was titrated into the sample to obtain not only direct evidence of bind-
ing, but to also deduce exactly which amino acids are involved in stabilising the
PDGF R-TM/E5 complex. In doing so, a detailed set of protocols for the cloning,
expression, purification and reconstitution of PDGF R-TM were developed.
Successful development of these methods and their application to RTKs will provide
critical information about their behaviour in various diseases and aid the develop-
ment of rationally-designed drugs. In pursuit of this long term objective of struc-
tural biology, this study focuses on the transmembrane domains of oncogenic Neu
and PDGF R.
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Materials and Methods
2.1 Suppliers of Chemicals and Reagents
All chemicals and reagents used in this study were of an appropriate purity grade
(e.g. analytical or molecular biology) and were acquired from the following suppliers
unless otherwise specified:
• Fisher Scientific UK Ltd.; Loughborough, UK
• Promega Corporation; Madison, Wisconsin, USA
• Sigma-Aldrich Company Ltd.; Dorset, UK
• New England Biolabs (UK) Ltd.; Hitchin, Hertfordshire, UK
• Perkin Elmer; Waltham, Massachusetts, USA
• A↵ymetrix (formerly Anatrace); Santa Clara, California, USA
• GE Healthcare; Little Chalfont, Buckinghamshire, UK
• Avanti Polar Lipids; Alabaster, Alabama, USA
• VWR International Ltd.; Lutterworth, UK
• Roche; Basel, Switzerland
• Life Technologies Ltd.; Paisley, UK
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2.2 Plasmids
The pET151/D-TOPO plasmid was purchased directly from Life Technologies UK.
The pDEST17-MISTIC plasmid was kindly provided by authors of (Bernaudat et al.,
2011b) at the Institut de Biologie Structurale Jean-Pierre Ebel, CEA, Grenoble,
France. Previously generated plasmids used in this study and the plasmids generated
in this study are illustrated in Table 2.1 and Table 2.2 respectively.
Plasmid Details Reference
pET30a-
PDGFR20
pET30a vector ligated with PDGF R
transmembrane domain and 20 residues on
either side beteeen BamH1 and Xho1
restriction sites
(Oates et al.,
2010)
pET30a-
PDGFR30
pET30a vector ligated with PDGF R
transmembrane domain and 30 residues on
either side beteeen BamH1 and Xho1
restriction sites
(Oates et al.,
2010)
pET30a-
PDGFR40
pET30a vector ligated with PDGF R
transmembrane domain and 40 residues on
either side beteeen BamH1 and Xho1
restriction sites
(Oates et al.,
2010)
pET151/D-
TOPO
An expression vector to be used for directional
TOPO cloning with a hexahistidine tag and
TEV-specific proteolysis site
(Shuman, 1994)
pDEST17-
MISTIC
A Gateway cloning vector with the
MISTIC-tag added
(Bernaudat et al.,
2011b)
pET21a-
GFP-TEV
A vector for the expression of GFP-TEV
protease with a His-tag
(Wu et al., 2009)
pRK793-
TEV
A vector for the expression of MBP-TEV
protease with a His-tag
(Kapust et al.,
2001)
Table 2.1: Previously generated plasmids used in this study
Plasmid Template Features
pET151-
PDGFR20
pET151/D-
TOPO
Gene of PDGF R-TM plus 20 residues either side in-
serted in the TOPO cloning site
pDEST17-
MISTIC-
PDGFR
pDEST17-
MISTIC
Gene of PDGF R-TM plus 20 residues either side in-
serted between PspXI and SalI restriction sites
Table 2.2: Plasmids generated in this study
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2.3 DNA Manipulation and Cloning Techniques
2.3.1 Primers
Primers were designed against the relevant gene target to allow the cloning of PCR
products in frame with any C-terminal tags. Restriction sites or overhang sequences
for TOPO-cloning were also incorporated, as appropriate. All primers were pur-
chased from Sigma-Aldrich, UK.
Name Sequence 5’ to 3’ Tm ( C)
topoforward GTGGAACTCCATGGGTGGAGATTCGCAGG 80
toporeverse CTATTAACCGTCAGAGCTCACAGACTCAATGA 71.7
pdgfrforward TAAGCACATATGATGTCGTACTACCATCACCATC
ACCATCAC
75.5
pdgfrreverse TCCGATGCTCGAGGCTATTAACCGTCAGAGCTC
ACAGACTCAAT
80.9
Table 2.3: Primers used in this study, Tm represents the melting temperature
2.3.2 Preparation and storage of plasmid DNA
Plasmid DNA was isolated using GeneJET MiniPrep kit (Thermo Fisher Scientifc,
UK) as per manufacturer’s protocol. The DNA was recovered in 50 µL dH2O and
stored at -20  C.
2.3.3 Polymerase chain reaction (PCR)
The amplification of the PDGF R-TM gene was performed on ice with 5 µL of
5⇥ Phusion HF bu↵er, 1 µL 10 mM dNTP mix, 2.5 µM of each primer, 1 µL
template DNA (0.5 ng), 0.5 µL of Phusion DNA Polymerase (1 units/50 µL) and
dH2O to a final volume of 50 µL.
After gently mixing the reaction, all liquid was collected at the bottom of the PCR
tube through a quick spin in a microcentrifuge. The tubes were then transferred
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from ice to a Biometra T3 thermocycler and a PCR was initiated according to the
conditions illustrated in Table 2.4.
Step Temperature ( C) Time (s)
Initial Denaturation 98 30
25-35 Cycles 98 10
Tannealing 30
72 20 per kb
Final Extension 72 600
Hold 4
Table 2.4: Thermal cycling scheme for a typical PCR, Tannealing was 3–5  C below
the Tm of the relevant primers
2.3.4 Agarose gel electrophoresis
Agarose gels were prepared by dissolving 1–2% high-melting point agarose (Sigma-
Aldrich) in 50 mL of 1⇥ Tris-acetate-EDTA (TAE) bu↵er in a 250 mL conical flask
and heating in a microwave oven until dissolved (⇠2 minutes). The solution was
subsequently cooled and 5 µL of Biotium GelRed Nucleic Acid Stain (10,000⇥ in
water) was added and gently shaken to mix evenly. This was immediately poured
into a gel cast and left to solidify. DNA samples were prepared by adding 1 µL
of 6⇥DNA loading dye (Fermentas) per 5 µL of DNA sample. The samples were
then loaded on to a gel which had been submerged in a gel tank containing 1⇥ TAE
bu↵er. In order to quantify the size of the DNA samples, a lane with 10 µL of
FastRulerTMMiddle Range DNA ladder was added. Electrophoresis was performed
at 150 V for 30 minutes or more, as required. The DNA was visualised using
BioDoc-Itr Imaging System equipped with a camera to take photographs of the
gels with the DNA illuminated.
2.3.5 Purification of DNA from PCR and restriction digests
Purification of the DNA samples from polymerases and endonucleases after PCR
and restriction digests was performed through adsorption to a silica matrix using
QIAquick PCR Purification Kit (QIAGEN). In cases where gel extraction was re-
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quired, the QIAquick Gel Extraction Kit (QIAGEN) was used which also achieves
purification through the adsorption of DNA on a silica matrix. Both kits were used
as per manufacturer’s instruction and DNA was eluted in 30 µL of water.
2.3.6 Restriction endonuclease digestion of DNA
Restriction digests were carried out in an appropriate bu↵er system using restriction
enzymes (NEB, UK) as per the manufacturer’s instructions. Typically, reactions
were incubated for 2–3 hours at a temperature of 37  C. DNA was subsequently
purified as detailed in section 2.3.5.
2.3.7 Ligation of chimeric DNA fragments
After gel extraction and/or purification, the linearised vector strands and insert DNA
fragments were ligated using T4 DNA Polymerase (NEB, UK) as per manufacturer’s
protocol. This was typically done for 2 hours at room temperature or overnight at
4  C at a vector to insert ratio of 1 : 3.
In particularly troublesome ligation reactions, calf-intestinal alkaline phosphatase
(CIP) (NEB, UK) was used, as per manufacturer’s instructions, to dephosphorylate
the 5’-ends of linearised vector DNA to prevent recircularisation.
The ligation mixture was then used to directly transform the relevant strain of E.
coli as per the description in section 2.5.3. Colonies were picked at random using a
sterile pipette tip and cultured overnight at 37  C in 10 mL of LB in the presence
of appropriate antibiotics. The plasmid DNA was then extracted (section 2.3.5)
and digested using restriction enzymes (section 2.3.5). It was then analysed on an
agarose gel (section 2.3.4) to establish the presence of an insert at the appropriate
molecular weight.
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2.3.8 Colony PCR
In order to a rm the presence of insert DNA in the plasmid constructs, a colony
PCR was performed. This was done by picking a random selection of 30 colonies and
resuspending each of the them in 50 µL of PCR mixture described in section 2.3.3.
The PCR was run according to the relevant thermal profile and the reactions were
subsequently run on agarose gels. Where there was evidence of the insert being
present, the colony was grown overnight in rich media after which the plasmid was
extracted and sent for sequencing.
2.3.9 Concentration of DNA fragments
The concentration of DNA fragments was measured using Thermo Scientific Nan-
oDrop Lite spectrophotometer.
2.3.10 DNA sequencing of plasmid constructs
For all cloned genes, it was important to ensure that
– start and stop codons were present,
– there were no PCR errors in the form of point mutations etc.,
– the gene along with any tags or restriction sites that were added was correctly
oriented and in frame.
In order to do so, 20 µL of ⇠100 ng/µL of DNA was sent for sequencing to GATC
Biotech Ltd., UK. All sequencing experiments were performed using a T7 primer. Se-
quencing results were manually checked using Serial Cloner 2.6 for Mac OS X.
2.4 Escherichia coli Strains
The E. coli strains used in this study are illustrated in Table 2.5.
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Strain Genotype Reference
DH5↵
F   80lacZ M15  (lacZYA - argF)
U169 recA1 endA1 hsdR17 (rk-,mk+)
phoA supE44  -thi -1 gyrA96 relA1
(Hanahan, 1983)
TOP10
F mcrA  (mrr -hsdRMS-mcrBC)
 80lacZ M15  lacX74 recA1 ara 139
 (ara-leu)7697 galU galK rpsL (StrR)
endA1 nupG
(Grant et al.,
1990)
BL21(DE3)
fhuA2 [lon] ompT gal (  DE3) [dcm]  
hsdS   DE3 =   sBamHIo   EcoRI-B
int:: (lacI:: PlacUV5:: T7 gene1) i21  
nin5
(Studier and
Mo↵att, 1986)
BL21(DE3)pLysS
F  ompT hsdSB (rB- mB-) gal dcm
(DE3) pLysS Cmr
(Mo↵att and
Studier, 1987)
C41(DE3)
F  ompT hsdSB (rB- mB-) gal dcm
(DE3)
(Miroux and
Walker, 1996a)
C43(DE3)
F  ompT hsdSB (rB- mB-) gal dcm
(DE3)
(Miroux and
Walker, 1996a)
BL21-CodonPlus
(DE3)-RIPL
F  ompT hsdSB (rB- mB-) dcm+ Tetr
gal   (DE3) endA Hte [argU proL Camr]
[argU ileY leuW Strep/Specr]
(Jerpseth et al.,
1998)
RosettaTM(DE3)
pLysS
F  ompT hsdSB (rB- mB-) gal dcm
(DE3) pLysSRARE (CamR)
(Jerpseth et al.,
1998)
ccdB SurvivalTM
F mcrA  (mrr-hsdRMS-mcrBC)
 80lacZ M15  lacX74 recA1 ara 139
 (ara-leu)7697 galU galK rpsL (StrR)
endA1 nupG fhuA::IS2
(Bernard and
Couturier, 1992;
Bernard et al.,
1993)
Table 2.5: Bacterial strains used in this study
2.5 Growth and Maintenance of E. coli
2.5.1 Growth Media
Lysogeny broth (LB)
Lysogeny Broth (Bertani, 2004) is a rich growth medium and is composed of 10 g/L
bacto-tryptone, 5 g/L yeast extract, 10 g/L sodium chloride. It is commonly used
for the aerobic growth of E. coli in liquid media. LB was prepared in deionised
water (dH2O) and autoclaved prior to use.
In order to make LB agar plates, 15 g of bacto-agar was added to 1 L of media and
autoclaved. This solution was then cooled to ⇠50  C and poured onto sterile petri
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dishes after the addition of appropriate antibiotics. These were then sealed using
para n film and stored at 4  C.
Super optimal broth with catabolites (SOC) medium
This was originally proposed by Hanahan and coworkers (Hanahan, 1983) and is
composed of 20 g/L tryptone, 0.5 g/L NaCl, 5 g/L yeast extract, 0.2 g/L KCl, 3.6
g/L glucose and 1 g/L MgCl2. This nutrient-rich medium was used for outgrowths
after bacterial transformation as it is known to result in higher transformation e -
ciency. SOC medium was prepared in dH2O and autoclaved prior to use.
M9 minimal medium
5⇥ M9 salts were prepared by dissolving 64 g Na2HPO4.7H2O, 15 g KH2PO4 and
2.5 g NaCl in dH2O and autoclaving. Subsequently, 1 L of the medium was prepared
by adding 100 µL of 1 M CaCl2, 2 mL of 1 M MgSO2, 1 mL of 15 mg/mL FeCl3 and
10 mL of 100⇥ BME vitamins (Sigma) in ⇠500 mL of dH2O. 1 mg of NH4Cl (or
15N-NH4Cl) and 4 mg of glucose (or 13C-glucose or 13C-1-glucose) were then added
and completely dissolved. Finally, appropriate antibiotics were added and the pH
was adjusted to 7.4 before topping up to 1 L with dH2O.
Antibiotics were added to all media, where necessary, to concentrations in Table 2.6.
Antibiotic Concentration µg/mL
Ampicillin 100
Kanamycin 50
Chloremphenicol 35
Carbenecillin 100
Table 2.6: Antibiotic concentrations
Handling of the aforementioned media was done within a sterile field created by a
Bunsen burner flame until the medium was sealed.
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2.5.2 Preparation of competent E. coli cells
To generate chemically competent E. coli cells, 10 mL of LB was inoculated with
the relevant strain of E. coli cells and incubated overnight at 37  C with shaking at
180 rpm. Subsequently, 2.5 mL of this culture was added to 250 mL of fresh LB and
grown under the same conditions until an optical density at a wavelength of 600 nm
(OD600) of 0.4–0.6 was reached. The cells were then pelleted by centrifugation at
3000 ⇥ g and resuspended in 10 mL of 50 mM CaCl2. After leaving this suspension
on ice for 5 minutes, the centrifugation was repeated and the cells were once again
resuspended in 100 mL of 100 mM CaCl2 plus 15% v/v glycerol. This was then
incubated on ice for ⇠1 hour before being snap frozen in liquid nitrogen to be stored
as 100 µL aliquots at -80  C. All solutions were filter-sterilised prior to use.
2.5.3 Bacterial transformations
Competent cells, whether provided by a commercial supplier or prepared in the
laboratory as described in section 2.3.5, were first thawed on ice. A 1–2 µL aliquot of
DNA was added to 50 µL of competent cells and mixed gently followed by incubation
on ice for 30 minutes. Cells were then heat-shocked at 42  C for 45 seconds and
then placed on ice for 2–3 minutes. Following this, 1 mL of pre-warmed LB or
SOC medium was added to the cells and the suspension was incubated at 37  C
with shaking at 180 rpm for 1 hour. The cells were then pelleted by centrifugation
at 3000 g for 5 minutes. A total of 850 µL of clear LB was removed from the
supernatant and the pelleted cells were resuspended in the remaining 200 µL. This
was then plated on LB-agar plates containing the necessary antibiotic selection for
the transformed plasmid. Plates were incubated at 37  C overnight.
2.5.4 Preparation of glycerol stocks
Plasmid constructs which demonstrated long-term stability in bacterial cells were
stored after transformation as glycerol stocks. These were made by inoculating 5 mL
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of LB supplemented with the appropriate antibiotic(s) with a single E. coli colony
following a fresh transformation. The cells were grown at 37  C with shaking at
180 rpm to mid-log phase and then mixed with sterile 50% v/v glycerol in a 1 : 1
ratio in a Corning cryo-vial. This was then frozen in liquid N2 and stored in a -80  C
refrigerator until required.
2.6 PDGF R-TM Expression and Purification
2.6.1 Expression of platelet-derived growth factor receptor-  trans-
membrane domain (PDGF R-TM)
PDGF R-TM was heterologously expressed with 20, 30 or 40 residues of the receptor
on either side. These peptides were expressed in various E. coli strains (Table 2.5)
with pET expression systems using IPTG induction. Their expression was optimised
in rich and minimal media so as to obtain high enough yields for biophysical analyses.
Competent cells of the relevant strains were transformed with an expression plasmid
containing the PDGF R-TM gene and plated on LB agar plates with appropriate
antibiotics.
Overexpression of the target gene was carried out either in a rich (LB) or minimal
(M9) medium. However, in all cases, after fresh transformation of the cells (sec-
tion 2.5.3), a colony was picked at random and grown overnight in 10 mL of LB at
37  C with shaking at 180 rpm in the presence of appropriate antibiotics. This pre-
culture was then added to 1 L of fresh LB containing the same antibiotics. When the
pET151/D-TOPO vector was being used, the pre-culture was centrifuged and then
resuspended in 1 L of LB. The cells were then incubated in a 5 L conical flask under
the same conditions until and OD600 of 0.6 was reached. The expression protocol
di↵ered henceforth depending on the expression medium.
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Expression in LB
In order to induce expression, isopropyl  -D-1-thiogalactopyranoside (IPTG) was
added to the culture to a final concentration of 1 mM. This metabolite initiates
the transcription of the lac operon hence triggering production of the protein of
interest. The cells were harvested after an additional 4–5 hours of incubation using
SORVALLr RC 6 Plus centrifuge at 3000 g for 10 minutes. They were washed with
Tris-HCl bu↵er (pH 7.5) and stored at -80  C until required.
Expression in M9 minimal medium
Following a protocol for the production of very high yields of recombinant proteins
(Sivashanmugam et al., 2009), just prior to induction, the cells were harvested and
washed with 1⇥ M9 salts to remove any residual LB. The pellet was then resus-
pended in a smaller volume of M9 minimal media (section 2.5.1) using fraction (1/2,
1/3, 1/4 or 1/8) of the initial volume. The cells were then left to equilibrate in
M9 media (37  C with shaking at 180 rpm) for an hour before being induced by
1 mM IPTG and left to overexpress for 4–5 hours. They were harvested, washed
and stored in the same way as described above.
Aliquots were taken pre-induction and post-expression for SDS-PAGE (section 2.8.1)
and Western Blot analysis (section 2.8.4) for all PDGF R-TM expressions.
2.6.2 Purification of PDGF R-TM for solid-state NMR
The cells from 1 L of culture were thawed on ice and then resuspended in 20 mL
of lysis bu↵er (50 mM Tris-HCl, pH 7.5, 150 mM NaCl). Additionally, 20 µL of
10 mg/mL DNAse I was added along with MgCl2 to a final concentration of 5 mM.
Lysozyme was also added to a final concentration of 1 mg/mL. This was left to
incubate on ice for 30 minutes. The cells were then lysed either using a probe
sonication (30 second pulses with 30 second gaps for 10 minutes) or using a Constant
Cell Disruption System (10 mL ⇥ 2). The inclusion bodies along with cell debris
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were then pelleted using a SORVALLr RC 6 Plus centrifuge with an SS-34 rotor for
90 minutes at 47,000 ⇥ g. The pellet was then washed with 5 mL lysis bu↵er and
then centrifuged for an additional 20 minutes. The supernatant was then stored at
4  C and the pellet was dissolved in 20 mL solubilisation bu↵er (100 mM NaCl, 50
mM NaH2PO4, 6 M GnHCl (or 8 M urea), pH 8.0) while rotating on a end-over-end
mixer at 4  C overnight.
After the inclusion bodies were solubilised, the mixture was centrifuged again at
47,000 ⇥ g for 30 minutes. The insoluble material was stored and the supernatant
was passed through a 4.5 µm filter. The purification procedure was then continued
with immobilised metal ion a nity chromatography (IMAC) (see section 2.6.4 for
more details). The solution was poured in a Bio-Rad Econo-Columnr chromatog-
raphy column and mixed with ⇠4 mL of IMAC Sepharose High Performance resin
(GE Healthcare) charged with Ni2+ ions and left to rotate on an end-over-end mixer
for ⇠1 hour. The resin should only bind His-tagged proteins due to the presence of
charged metal groups on the beads. The suspension was then left to settle and the
flow-through was collected. The resin was then washed with 20 mL of wash bu↵er
(20 mM HEPES, 150 mM NaCl, 5% glycerol, 1 mM n-decyl- -D-maltopyranoside
(or 1% Triton X-100), 20 mM imidazole, pH 8.0). The presence of detergent also
ensured on-column refolding of the PDGF R-TM peptide, whereas glycerol was
used to stabilise the protein by reducing hydrophobic interactions. The protein was
then eluted from the column by washing the beads with 2.5 mL elution bu↵er (20
mM HEPES, 150 mM NaCl, 5% glycerol, 1 mM n-decyl- -D-maltopyranoside (or
1% Triton X-100), 330 mM imidazole, pH 8.0). This was repeated twice to en-
sure all the protein had eluted o↵ the column. The solution was then immediately
passed through a PD10 desalting column (GE Healthcare) to remove imidazole, as
per manufacturer’s instructions.
All bu↵ers used in the purification process were either filter-sterilised or autoclaved,
as appropriate. Aliquots were taken for SDS-PAGE (section 2.8.1) and Western Blot
analysis (section 2.8.4) for each step in the purification.
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2.6.3 Purification of PDGF R-TM for solution-state NMR
The cells from 1 L of culture were thawed on ice and then resuspended in 20 mL lysis
bu↵er (50 mM Tris-HCl, pH 7.5, 150 mM NaCl). This was followed by an addition of
2 mL of Novagen BugBusterTMProtein Extraction Reagent and this left to incubate
at room temperature for about an hour with gentle shaking. The cells were then
lysed using a Constant Cell Disruption System (10 mL ⇥ 2). The inclusion bodies
along with cell debris were then pelleted using a SORVALLr RC 6 Plus centrifuge
with an SS-34 rotor for 45 minutes at 47,000 ⇥ g. The supernatant was then stored
at 4  C and the pellet was dissolved in 20 mL solubilisation bu↵er (100 mM NaCl,
20 mM Tris-HCl, 6 M GnHCl (or 8 M urea), pH 8.0) while rotating on a end-over-end
mixer at 4  C overnight.
After the inclusion bodies were solubilised, the mixture was centrifuged again at
47,000 ⇥ g for 30 minutes. The insoluble material was stored and the supernatant
was passed through a 0.45 µm filter. The purification procedure was then continued
with IMAC (2.6.4). The solution was poured in a Bio-Rad Econo-Columnr chro-
matography column and mixed with ⇠4 mL of IMAC Sepharose High Performance
resin (GE Healthcare, UK) charged with Ni2+ ions and left to rotate on an end-over-
end mixer for ⇠1 hour. The suspension was then left to settle and the flow-through
was collected. The resin was then washed with 20 mL of wash bu↵er (100 mM NaCl,
20 mM Tris-HCl, 6 M GnHCl (or 8 M urea), 10 mM imidazole, pH 8.0). The protein
was then eluted from the column by washing the beads with 2.5 mL elution bu↵er
(100 mM NaCl, 20 mM Tris-HCl, 6 M GnHCl (or 8 M urea), 10 mM imidazole, pH
8.0). The solution obtained was then pooled and dialysed in a dialysis tubing with
3.5 kDa cut-o↵ against 4 L of water for 24 hours switching to fresh water at regular
intervals. Once all the protein had precipitated out, it was pelleted and freeze-dried
to obtain a protein powder.
It was found that it is advantageous to further purify this peptide using reverse-
phase high performance liquid chromatography (HPLC). To that end, approximately
2 mg of this protein powder was dissolved in 200 µL of trifluoroacetic acid (TFA)
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and 200 µL of 2,2,2-trifluoroethanol (TFE) and the suspension was sonicated until
complete dissolution of the powder was observed. 400 µL of isopropanol was then
added followed by the gradual addition of ⇠1 mL of a solution containing HPLC-
grade water and isopropanol in a 3 : 7 ratio. This mixture was then loaded on to
a semi-preparative Jupiter C4 5 µm (300 A˚, 250 ⇥ 10.0 mm) reverse-phase HPLC
column (Phenomenex, Macclesfield, Cheshire, UK) connected to a purpose built
two-pump HPLC system (Jasco UK, Great Dunmow, Essex, UK). The column was
equilibrated with 70% Bu↵er A and 30% Bu↵er B (see below for compositions).
While maintaining a constant flow rate of 1.5 mL/minute, the protein was purified
using a two-component gradient illustrated in Table 2.7. The two HPLC bu↵ers
were the same as those used by (Claridge and Schnell, 2012):
• Bu↵er A: 5% isopropanol, 95% water, 0.1% trifluoroacetic acid
• Bu↵er B: 57% isopropanol, 38% acetonitrile, 0.1% trifluoroacetic acid
Time (minutes) Bu↵er A (%) Bu↵er B (%)
0 70 30
10 70 30
20 0 100
30 0 100
40 70 30
50 70 30
Table 2.7: HPLC gradient for the purification of PDGF R-TM
The presence and purity of PDGF R-TM in a particular fraction was confirmed
through mass spectrometry (section 2.8.5). All the fractions containing the peptide
were then pooled and freeze-dried to obtain PDGF R-TM in powder form. This
was then stored at 4  C until required.
2.6.4 Immobilised-metal a nity chromatography (IMAC)
IMAC was first introduced and shown as a feasible technique for protein separation
by Porath and coworkers (Porath et al., 1976). It exploits the fact that transi-
tion metal ions (such as Ni2+ and Co2+) have an a nity for histidine and cysteine
residues in solution. This technique was further improved upon the introduction of
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nitrilotriacetic acid (NTA) as an extremely e↵ective chelating ligand (Hochuli et al.,
1987).
In this study, all the constructs used to express PDGFR-TM domains and TEV
protease encoded for an N-terminal hexahistidine tag to allow IMAC purification
(sections 2.6.3 & 2.7.2). The protein was resolved following a gravity-flow protocol
with an IMAC Sepharose High Performance resin (GE Healthcare, UK) packed in a
Bio-Rad Econo-Columnr chromatography column. The resin was first washed with
dH2O and if the resin was previously used, it was stripped with 5 column volumes of
stripping bu↵er bu↵er (20 mM Tris-HCl, 50 mM EDTA, 200 mM NaCl, pH 7.4). It
was then washed with 10 column volumes of dH2O. The column was then charged
with 2 column volumes of NiCl2 solution and washed again with 10 column volumes
of dH2O and stored in 20% ethanol until required.
2.6.5 Plasmid stability test
It is advisable to check the fraction of cells that still carry the plasmid just prior to
induction. This can be used to maximise protein yield by optimising variables in the
protein expression protocol such as induction OD600, bacterial cell line and choice
of antibiotics. This involves preparing four di↵erent plates (see Table 2.8).
Plate Cells that grow
LB All viable cells
LB + antibiotic Cells that still carry the plasmid
LB + IPTG (1 mM)
Cells that have lost the plasmid or mutants that have
lost the ability to express the target gene
LB + antibiotic +
IPTG (1 mM)
Mutants that retain the plasmid but have lost the
ability to express the target gene
Table 2.8: Plasmid stability test
An aliquot of cell culture is taken immediately before induction. A serial dilution of
this is performed including a 105 and a 106 dilution. Cells from the 105 dilution are
plated on the LB + IPTG plate and on the LB + IPTG + antibiotic plate. Cells
from the 106 dilution are plated on the LB plate and on the LB + antibiotic plate.
These are incubated overnight at 37  C.
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Cells do not grow on the IPTG plates if they are carrying a protein production
plasmid because they have dedicated all their resources to the production of the
recombinant protein instead of cell proliferation. With unstable target plasmids,
the fraction of cells that have lost the plasmid will be reflected by an increase in
colonies on the LB + IPTG plate and a decrease on the LB + antibiotic plate.
2.7 Tobacco etch virus (TEV) protease expression and
purification
The construct for MBP-tagged TEV protease was transformed into BL21-CodonPlus
(DE3)-RIPL cells whereas the GFP-tagged TEV protease was transformed into
RosettaTM(DE3) pLysS as described in section 2.5.3. The protocol adopted for the
expression and purification of maltose binding protein (MBP)- or green fluorescent
protein (GFP)-tagged TEV protease were the same.
2.7.1 Expression
A 10 mL starter culture grown overnight at 37  Ccontaining appropriate antibiotics
was inoculated from glycerol stocks (see section 2.5.4) using a sterile loop. This
starter culture was then poured into 1 L of LB and grown at 37  C with shaking at
180 rpm in the presence of appropriate antibiotics until an OD600 of 0.6 was reached.
The cells were then induced using 0.1 mM IPTG and incubated for 24 hours at 15  C
with shaking at 180 rpm. The cells were then harvested using SORVALLr RC 6
Plus centrifuge at 3000 ⇥ g for 10 minutes. They were washed with Tris-HCl bu↵er
(pH 7.5) and stored at -80  C until required.
2.7.2 Purification
The cells from 1 L of culture were thawed on ice and then resuspended in 20 mL lysis
bu↵er (50 mM Tris-HCl, pH 7.5, 150 mM NaCl). This was followed by an addition of
2 mL of Novagen BugBusterTMProtein Extraction Reagent and this left to incubate
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at room temperature for about an hour with gentle shaking. The cells were then
lysed using a Constant Cell Disruption System (10 mL ⇥ 2). This suspension was
then centrifuged using a SORVALLr RC 6 Plus centrifuge with an SS-34 rotor for
45 minutes at 47,000 ⇥ g. The pellet was discarded and the supernatant was passed
through a 0.45 µm filter. The purification procedure was then continued with IMAC.
The following bu↵ers were used in the subsequent purification process:
Bu↵er A: 50 mM Tris-HCl, 150 mM NaCl, 20 mM imidazole, pH 8.0
Bu↵er B: 50 mM Tris-HCl, 150 mM NaCl, 40 mM imidazole, pH 8.0
Bu↵er C: 50 mM Tris-HCl, 150 mM NaCl, 300 mM imidazole, pH 8.0
The sample was loaded onto a Ni-NTA column pre-equilibrated with Bu↵er A. It
was then washed with Bu↵er B with at least 5 column volumes. The protein was
then eluted o↵ the column with Bu↵er C and immediately passed through a PD10
column to obtain TEV in 50mM Tris-HCl, 150 mM NaCl, pH 8.0. This was either
used immediately or stored in 50% glycerol at -80  C till required.
2.8 Protein Analysis and Detection
2.8.1 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis
(SDS-PAGE)
At various steps of the expression and purification of proteins, it was important
to ascertain presence and relative amount of the protein of interest in the sample.
To this end, the separation of proteins was carried out using either a Tris-glycine
bu↵er system (Laemmli et al., 1970) or using a commercially available NuPAGEr
Bis-Tris-HCl bu↵ered system (Life Technologies, UK).
Tris-glycine gels
Typically 1.0 mm gels were prepared with a separating gel (40% of ULTRA PURE
ProtoGelr (30% (w/v) acrylamide to 0.8% (w/v) bis-acrylamide); 375 mM Tris-HCl
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pH 8.8; 0.1% SDS; 0.02% APS; 0.06% TEMED) and a stacking gel (13.5% ULTRA
PURE ProtoGelr; 125 mM Tris-HCl pH 6.8; 0.1% SDS; 0.6% APS; 0.06% TEMED).
A plastic comb was added to form the wells and the gels were left in a casting block
for about 0.5 hours. The samples were prepared by mixing them with 2⇥ NuPAGEr
sample loading bu↵er in a 1 : 1 ratio. They were then denatured on a heating block
at 60  C for 10 minutes. Electrophoresis was carried out at room temperature with
a uniform running bu↵er (25 mM Tris, 250 mM glycine, 0.1% (v/v) SDS, pH 8.3).
A BioRad Mini-PROTEANr Tetra Cell was used to run the samples for 1 hour at
180 V.
NuPAGEr Bis-Tris gels
The NuPAGEr 12% Bis-Tris precast gels were washed with dH2O and docked into
an XCell Sure LockTMmini-cell electrophoresis system. The samples were prepared
by mixing them with 2⇥ NuPAGEr sample loading bu↵er in a 1 : 1 ratio. They
were then denatured on a heating block at 60  C for 10 minutes and loaded onto
the gels. After being submerged in NuPAGEr 1⇥ MES running bu↵er, the samples
were allowed to run down the gels at 125 mA and 200 V for 40 minutes.
All gels were loaded with either ColorPlusTMPrestained Protein Marker, Broad
Range (7–175kDa) or Sigma-Aldrichr Colour Marker Ultra-Low Range (1.06–26.6 kDa)
for molecular weight quantification of proteins.
2.8.2 Coomassie staining
Coomassie dye binds to proteins primarily through basic amino acids (mainly argi-
nine, lysine and histidine) under the acidic conditions of the solution (Neuho↵ et al.,
1988).
After the resolution of proteins by SDS-PAGE (2.8.1), the gels were placed in fixer
solution (50% (v/v) ethanol, 10% (v/v) acetic acid). They were then visualised
by leaving them overnight in ⇠30 mL of coomassie stain solution (0.025% (w/v)
coomassie blue R-250, 10% (v/v) acetic acid) with gentle shaking. The gels were
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then destained using a solution containing 20% (v/v) methanol and 7% (v/v) acetic
acid for approximately 4–6 hours. They were stored in dH2O.
2.8.3 Silver staining
In instances where the peptide/protein was of low molecular weight or if the con-
centration was too low to achieve adequate protein visualisation through coomassie
staining, silver staining was used. This method relies on the binding of silver ions
to the amino acid side chains, mostly the sulfhydril and carboxyl groups (Switzer
et al., 1979; Merril et al., 1981; Merril and Pratt, 1986) followed by reduction to free
metallic silver (Rabilloud, 1990).
Prior to silver staining a gel, they were coomassie stained to reduce background
discolouration. Subsequently, the gel was placed in fixer solution (50% acetone,
1.25% TCA, 0.015% formaldehyde) for 15 minutes. The gel was then washed with
dH2O (3⇥ quick wash, 1⇥ 5 minute wash, 3⇥ quick wash). The gel was then soaked
in 50% acetone for 5 minutes followed by another 5 minute incubation in 0.0167%
(w/v) sodium thiosulfate solution. The gel was again quickly washed three times
with dH2O before being placed in stain solution (0.267% (w/v) silver nitrate, 0.37%
(v/v) formaldehyde) for 8 minutes. The gel was again washed with dH2O twice
before being placed in developer solution (0.2 mM sodium carbonate, 0.004% (w/v)
sodium thiosulfate, 0.015% formaldehyde) until protein bands appeared (typically
10–20 seconds). The gel was then quickly placed in a quencher (1% acetic acid) to
stop the developing process. The gel was then washed with dH2O and subsequently
stored in it too.
2.8.4 Immunoblotting (western blotting)
To unambiguously ascertain the presence of protein and to assess the cleavage of
His-tag from a particular protein, it was often necessary to analyse the separation
of proteins using western blots. This method was first developed by (Towbin et al.,
1979) and involves transferring the protein bands on a gel onto a nitrocellulose
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membrane and subsequently using antibodies to specifically visualise certain protein
or peptides.
Following SDS-PAGE (section 2.8.1), the electrophoresed proteins along with the
relevant pre-stained protein ladder were blotted onto a nitrocellulose blotting mem-
brane with 0.45 µm pore size (GE Healthcare, UK) using an XCell IITMBlot Module
(Life Technologies, UK) as per manufacturer’s instructions. This involved equilibrat-
ing the gel in transfer bu↵er (100 mM Tris, 80 mM glycine, 20% methanol) before
placing it on top of the nitrocellulose membrane. The transfer was then carried out
in the blotting module at 35 V for 1 hour as per manufacturer’s instructions.
After the transfer the membrane was blocked in 20 mL of TBST (50 mM Tris,
150 mM NaCl, 0.1% Tween 20, pH 7.6) + 10% (w/v) milk powder by gently rocking
for 1 hour at room temperature. The milk was then removed and the membrane
was placed in 20 mL of TBST + 10% milk powder + (1 : 3000) Sigma-Alrichr
monoclonal anti-polyhistidine (mouse IgG2a isotype) antibody for 1 hour. In order
to identify C-terminal His-tags, mouse histidine (C-term) tag monoclonal antibody
was used (Life Technologies, UK). It was then washed twice with TBST with gentle
rocking for 5 minutes. The wash bu↵er was then removed and TBST + 10% milk
powder + (1 : 5000) anti-mouse IgG (whole molecule) alkaline phosphatase antibody
(produced in goat) was used to incubate the membrane for another hour. The
secondary antibody was then discarded and the membrane was washed with TBST
three times for 15 minutes each. It was then left to wash for an additional 30 minutes
to minimise the background in the blot. The TBST was then discarded and 3 mL
of of Novexr AP Chromogenic Substrate (BCIP/NBT) was poured over the blot.
Bands typically appeared after ⇠30 seconds following which the membrane was
washed with TBST for 5 minutes. The membrane was then left to dry before being
imaged.
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Dot blots
In order to determine whether a particular His-tagged protein has been expressed
or is present in a solution, a convenient quick check is to perform a dot blot. This
involves taking 2 µL of the relevant sample and spotting the nitrocellulose membrane
with it using a narrow-mouth pipette tip. The membrane is then allowed to dry and
the blot is developed as described earlier in this section.
2.8.5 Mass spectrometry
Mass spectrometry is an analytical technique that can be used to measure the mass-
to-charge ratio of various charged entities within a sample. It can be used to pro-
vide information about various physical and chemical properties of a compound.
These properties include masses of particles, the elemental composition of a sample
or molecule, and the chemical structures of molecules, such as peptides and other
chemical compounds.
Post-HPLC analysis
In this study, mass spectrometry was used after HPLC to see which fractions con-
tained the desired peptide (of which the mass is known) and the relative amounts
present in each fraction. All such characterisation was carried out on a Bruker
micrOTOF. This uses an electrospray ionisation source (ESI) which allows small
quantities of the peptide in solution to be taken straight from the HPLC fractions.
The sample passes through a nebuliser, is dried to remove solvent and then ionised.
Approximately 10 µL of a particular fraction was injected into the spectrometer while
spectra were recorded in positive ion mode, measuring between 500 and 3000 m/z
(mass/charge) for an average of 1.5 minutes. The spectra collected over this time
were averaged and deconvoluted using DataAnalysis v.3.3 by Bruker Daltonics, UK.
This deconvoluted spectrum showed the mass of the main singly charged species in
the sample. The fractions were then sorted by purity and pooled before either being
lyophilised for storage, or reconstituted in membrane mimetics.
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Post-SDS-PAGE analysis
Coomassie stained gel pieces were sent to the Warwick Proteomics Facility (Uni-
versity of Warwick), where they underwent tryptic digestion as per manufacturers
protocol on the MassPrep robotic protein handling system. The extracted pep-
tides from each band were processed through a nanoLC-ESI-MS/MS using the
NanoAcquity/Ultima Global instrumentation using a 30 minute LC gradient. All
MS and MS/MS data were corrected for mass drift using reference data collected
from the [Glu1]-Fibrinopeptide B (human - F3261 Sigma) sampled each minute
of data collection. The data were used to interrogate the E. coli BL21 database
(http://www.ebi.ac.uk/integr8) using the full-length protein sequence using Pro-
teinLynx Global Server v 2.5.1.
2.8.6 Protein quantification
Protein concentration in a particular sample was measured using either bicinchoninic
acid (BCA) assay or measurement of absorbance of light at 280 nm.
BCA assay
This assay was particularly useful when measuring the concentration of proteins in
detergent because it tolerates the presence of typical concentrations of most ionic
and anionic detergents in a sample. This method works on the principle that Cu+2
will be reduced to Cu+ by proteins in an alkaline medium (the biuret reaction). The
colorimetric detection of the cuprous cation is done using a reagent containing BCA.
Each cuprous ion chelates with two BCA molecules and this complex exhibits a deep
purple colour which can be measured at 562 nm as it has a linear absorbance with
increasing concentrations. The assay was carried out using PierceTMBCA Protein
Assay Kit as per the manufacturer’s instructions.
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Absorbance at 280 nm
A 3 mm quartz cuvette with an internal volume of 50 µL was used to measure
the absorbance at 280 nm. This was done using Caryr 50 UV-Vis spectropho-
tometer. The extinction coe cient was computed using the ExPASy ProtParam
tool (http://web.expasy.org/protparam/) (Wilkins et al., 1999) and the protein
concentration was subsequently calculated using the Beer-Lambert law:
A280 = "cl
where,
" = extinction coe cient
A280 = absorbance at 280 nm
c = concentration in mol dm 3
l = path length in cm.
2.9 Peptide Synthesis and Purification
2.9.1 Synthesis of Neu* transmembrane (TM) domain
Four peptides corresponding to the transmembrane domain of the oncogenic Neu*
receptor with the sequence RASWVTFIIATVEGVLLFLILVVVVGILIKRRR were synthesised
using solid-phase chemistry. The N-terminus was acetylated and the C-terminus
was amidated to mimic the peptide bonds found in the parent sequence. Peptides
were synthesised using solid phase 9-fluorenylmethyl carbamate (FMOC) chemistry
(Carpino and Han, 1972) at the Yale University W.M KECK Facility (New Haven,
CT, USA). A single amino acid per peptide was uniformly labelled with 13C and 15N
isotopes. The position of these amino acids is shown in Table 2.9 and the rationale
behind this choice is discussed in section 3.3.
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Peptide name Peptide sequence
DIX13553 acetyl-RASWVTFIIATVEG⇤VLLFLILVVVVGILIKRRR-conh2
DIX13554 acetyl-RASWVTFIIATVEGVLL⇤FLILVVVVGILIKRRR-conh2
DIX13555 acetyl-RASWVTFI⇤IATVEGVLLFLILVVVVGILIKRRR-conh2
DIX13556 acetyl-RASWVTFIIAT⇤VEGVLLFLILVVVVGILIKRRR-conh2
Table 2.9: List of Neu* peptides used in this study. Amino acids which have been
13C- and 15N-labelled are marked with an asterisk (*).
2.9.2 Synthesis of bovine papillomavirus (E5) transmembrane (TM)
domain
The putative transmembrane domain of the oncoprotein E5 was synthesised by In-
sight Biotechnology UK using solid phase 9-fluorenylmethyl carbamate (FMOC)
chemistry (Carpino and Han, 1972). As with the Neu* peptides, the N-terminal was
acetylated and the C-terminal was amidated to mimic the peptide bonds found in
the parent sequence. Additionally, non-native lysines were added on each terminal
to aid solubility. The sequence of the peptide was
acetyl-KKKFLGLVAAMQLLLLLFLLLFFLVYWDHK-conh2.
2.9.3 Purification of synthetic peptides
The manufacturers supplied the peptides as crude reaction products. These could
contain impurities such as deletion products from the synthesis or peptides miss-
ing one or two amino acids. Pure peptides with the molecular weight of interest,
as determined by mass spectrometry (section 2.8.5), were obtained by performing
reverse-phase high-performance liquid chromatography (HPLC).
Samples for injection were prepared by dissolving ⇠5 mg of crude peptide in 200 µL
trifluroacetic acid (TFA), 200 µL 2,2,2-trifluroethanol (TFE), 400 µL isopropanol
(IPA) and then drop-wise adding a 7 : 3 mix of to IPA to a final volume of
2 mL. The sample was then run through a semi-preparative Jupiter C4 5u (300 A˚,
250 ⇥ 10.0 mm) reverse-phase HPLC column (Phenomenex, Macclesfield, Cheshire,
UK) connected to a purpose built two pump HPLC system (Jasco UK, Great Dun-
mow, Essex, UK) at a flow rate of 1.5 mL/min. A gradient constituting dH2O and
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IPA was employed as illustrated in Tables 2.10 & 2.11 for E5 and Neu* respectively.
Mobile phase bu↵ers A and B in the case of E5 are the same as those used in the
purification of PDGF R-TM (section 2.6.3). The column was equilibrated with the
initial conditions beforehand.
Time (minutes) Bu↵er A (%) Bu↵er B (%)
0 70 30
15 70 30
50 0 100
70 0 100
90 70 30
100 70 30
Table 2.10: HPLC gradient for the purification of E5
Time (minutes) Water (%) Isopropanol (%)
0 70 30
15 70 30
25 60 40
50 85 15
55 100 0
60 100 0
65 70 30
Table 2.11: HPLC gradient for the purification of Neu*
The absorbance of the eluate was measured at a wavelength of 280 nm at which
aromatic amino acids within the peptides absorb UV light. Multiple runs of HPLC
were performed until a su cient amount of pure protein was obtained. The presence
and purity of the peptide of interest was determined using mass spectrometry (as
described in section 2.8.5.
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2.10 Protein Reconstitution into Detergent Micelles or
Liposomes for NMR analyses
2.10.1 Reconstitution of Neu* into lipid vesicles for solid-state NMR
analysis
For each sample, the fractions containing the pure peptides from HPLC were col-
lected together separate round bottomed flasks. Their absorbances were measured
and the Beer-Lambert law was used to calculate the concentration of each peptide
(section 2.8.6). Volumes containing 5 mg of each of the peptides were added to
a separate round bottomed flask. To these peptides, 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC) lipids (dissolved in 1 mL of TFE) and cholesterol (dis-
solved in 500 µL of chloroform) were added at a protein : cholesterol : DMPC ratio
of 1 : 2 : 20.
All organic solvents were then evaporated o↵ on a rotary evaporator while water
was simultaneously added. This allowed for the creation of proteoliposomes in an
aqueous environment. The absence of any residual organic solvents was confirmed
using 1H measurements by solution-state NMR. Approximately 5 mL of dH2O was
then added and the mixture was sonicated to break down any large aggregates.
This suspension was then transferred to a 50 mL clear centrifuge tube and freeze-
thawed 10 times to facilitate the creation of unilamellar liposomes. It was then
centrifuged at 4  C and 19,000 rpm (45,000 ⇥ g) for 45 minutes. The supernatant
was removed and 3 mL of 50 mM phosphate bu↵er (pH 7.4) was added. The mixture
was centrifuged again under the same conditions as above.
The resulting pellet was resuspended in ⇠5 mL of 50 mM phosphate bu↵er (pH 7.4)
and transferred to 1.5 mL ultracentrifuge tubes (Beckman Coulter, High Wycombe,
UK). This was followed by ultracentrifugation at 70,000 rpm (267,000 ⇥ g) at 4  C
for 15 minutes in an OptimaTMTLX ultracentrifuge (Beckman Coulter, UK). Any
supernatant was removed with the aid of a filter paper. This step was repeated and
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the sample stored in a fridge at 4  C. Prior to the NMR experiments, this sample
was funnelled into a 3.2 mm or 4 mm Magic Angle Spinning (MAS) rotor through
centrifugation.
2.10.2 Reconstitution of PDGF R-TM into lipid vesicles for solid-
state NMR analysis
After purifying PDGF R-TM (as outlined in section 2.6.2) and obtaining it in a
detergent environment, the N-terminal His-tag was cleaved o↵ using TEV protease.
This was done by adding freshly purified TEV protease to the protein solution
in a 1 : 5 protein to TEV protease ratio. This was left to incubate overnight
at room temperature. The His-tag and the TEV protease were then removed
from solution by passing it through an IMAC column. Either 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine (POPC) or 1,2-dierucoyl-sn-glycero-3-phosphocholine
(DEPC) lipids were then added to the solution such that the final protein to lipid
concentration was 1 : 20. The solution was then vortexed briefly to dissolve the
lipids through the formation of mixed micelles.
The detergent was removed from the solution by adding Bio-BeadsTMSM-2 Resin
(Bio-Rad, UK). These are neutral macroporous polymeric beads and can be used
to remove detergents from solution, even if they have a very low critical micelle
concentration (CMC) and hence Bio-Beads are particularly useful for removal of
detergents such as Triton X-100 and SDS (Rigaud et al., 1998). Bio-Beads work on
the principle that they contain pores which trap detergents, however, large molecules
such as proteins and lipids are not trapped and therefore detergent is selectively
removed.
Prior to detergent removal, the Bio-Beads were washed with ethanol and water as per
manufacturer’s instructions. They were then added to the clear protein/lipid/detergent
mixture and left to rotate on an end-over-end mixer overnight at 4  C. As the de-
tergent is removed, the turbidity of the solution increases. The detergent removal
was monitored with 1H measurements by solution-state NMR. The resulting sus-
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pension is pelleted and proteoliposomes are prepared for solid-state NMR analysis
as described in section 2.10.1.
2.10.3 Reconstitution of PDGF R-TM into detergent micelles for
solution-state NMR analysis
In order to perform solution-state NMR experiments, the protein powder obtained
from the purification of PDGF R-TM (section 2.6.3) was directly dissolved in a
detergent/bu↵er solution. Various detergents and bu↵er conditions were screened
(see section 6.3 for details) and optimal conditions were found at 0.4 mM uncleaved
PDGF R-TM, 100 mM n-dodecylphosphocholine (DPC), 10 mM 1,2-dipalmitoyl-
sn-glycero-3-phosphocholine (DPPC), 20 mM NaCl in 30 mM sodium phosphate
bu↵er with pH 5.8 at 318 K.
2.11 Circular Dichroism
Circular Dichroism (CD) is a useful technique for the characterisation of secondary
structure of proteins. CD measures the di↵erence in absorbance of left- and right-
handed circularly polarised light and it is this di↵erence which is reflected in a CD
spectrum. In order to estimate the secondary structure, this spectrum is compared
to a database of previously obtained spectra for ↵-helical,  -sheet and random coil
proteins (Kelly and Price, 2000; Bulheller et al., 2007).
CD experiments were carried out at room temperature (⇠25  C) using a Jasco J-815
spectropolarimeter (Jasco UK, Great Dunmow, Essex, UK) and 1 mm path-length
quartz cuvettes (Starna; Optiglass Ltd., Hainault, UK) requiring a sample volume
of 200 µL. Spectra were recorded in the far UV region between 190 and 260 nm,
with a data pitch of 0.2 nm, a 1 nm bandwidth, 50 nm/min scanning speed and a
response time of 2 seconds.
CD experiments were performed on samples which contained ⇠0.25 mg/mL of the
peptide in a bu↵er (20 mM sodium phosphate, 20 mM NaCl, pH 7.4). The final
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spectrum was obtained by averaging 32 individual spectra and subtracting a blank
spectrum which is exactly the same as the sample of interest sans peptide. In certain
instances where the high tension [HT] voltage exceeded 600 mV at wavelengths
below 200 nm, the data were truncated to 200 nm as this indicates light scattering
and potentially unreliable results. On occasion, the problem was resolved by slight
lowering the concentration or using a cuvette of di↵erent path length.
2.12 Cross-Linking
The two cross-linkers used in this study were bis(sulfosuccinimidyl)suberate (BS3)
(Thermo Scientific, UK) and gluteraldehyde. All cross-linking reactions were op-
timised and performed as per manufacturer’s instructions. This typically involved
adding 20- to 50-fold molar excess of the cross-linker to the protein solution to a final
concentration of cross-linker at 0.25–5 mM. The reaction mixture was incubated at
room temperature for 30 minutes or on ice for 2 hours. It was then quenched with
1 M Tris-HCl (pH 7.4) such that the final concentration of Tris was 20–50 mM.
The quenching reaction was allowed to continue for 15 minutes before the reaction
mixture was run on gels as described in section 2.8.1.
2.13 Magic Angle Spinning Solid-State Nuclear Mag-
netic Resonance (NMR) Spectroscopy
Solid-state magic angle spinning (MAS) NMR experiments were conducted on 500
MHz Bruker Avance III, 600 MHz Bruker Avance II+ or 850 MHz Bruker Avance
III solid-state NMR spectrometers (Bruker, Karlsruhe, Germany), where MHz indi-
cates 1H Larmor frequency. All spectrometers were equipped with 4 mm and 3.2 mm
MAS probes (Bruker) capable of running in double or triple resonance modes. Sam-
ples were cooled to required temperatures using Bruker BCU Xtreme cooling unit.
Spinning frequency was maintained by a Bruker MAS II controller unit. Chemical
shift referencing was done with respect to the carbonyl peak of natural abundance
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alanine (177.9 ppm) with respect to DSS (Morcombe and Zilm, 2003; Harris et al.,
2008). Samples were prepared as detailed in sections 2.10.1 and 2.10.2. All data
acquisition and initial processing was done using Topspin 2.1. All post-acquisition
processing was done using Topspin 3.0 and further data analysis was done using
either SPARKY (T. D. Goddard and D. G. Kneller, SPARKY 3, University of Cal-
ifornia, San Francisco) or CcpNmr Analysis (Vranken et al., 2005) software for Mac
OS X.
2.13.1 1D 13C NMR experiments
Data were collected with an acquisition time of 40 ms using 4k complex data points
for 64 co-added transients and a spectral window of 397 ppm. Typically, a 1H–13C
cross polarisation (CP) with a contact time of 1 ms was used, along with 100 kHz
SPINAL-64 proton decoupling during acquisition. Data was zero-filled to 65k was
used along with an exponential multiplication (EM) line broadening of 100 Hz.
Unless otherwise stated, spectra were acquired using a 3 s recycle delay and a ⇡2
excitation of 1H and 13C at pulse lengths of 2.5 µs and 4 µs respectively.
2.13.2 2D 13C–13C dipolar-assisted rotational recoupling (DARR)
NMR experiments
All DARR experiments (Takegoshi et al., 2000) were conducted through cross-
polarisation of 13C nuclei using a (50–100%) ramped proton CP pulse of 1 ms
with radio frequency (RF) field strengths of 90 kHz for 1H and 80 kHz for 13C.
SPINAL-64 (Fung et al., 2000) was employed as a method of choice for the requisite
proton decoupling. Experiments were conducted at either short (⇠30 ms) or long
(⇠400 ms) mixing times in order to probe spin interactions over short as well as long
distances in space. Data was collected using 1994 complex data points in F2 and
336 increments in F1. Typically, data were Fourier transformed using EM window
function with line broadening of 150 Hz and a zero-filling of 1k and 4k in F1 and F2
respectively.
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2.14 Solution-State NMR Spectroscopy
All protein NMR experiments were carried out on a 700 MHz Bruker Avance II
solution-state spectrometer (Bruker, Germany) fitted with a cryoprobe (Bruker,
Germany) running in triple resonance mode for 1H/13C/15N experiments. All sam-
ples were analysed in 3 mm NMR tubes (Hilgenberg, Germany) and 1H referencing
was done with respect to water (⇠4.7 ppm) on the DSS scale (Wishart et al., 1995).
All samples contained 10% D2O so that the spectrometer field was locked on to
the resonance position of deuterium during acquisition. All data acquisition and
initial processing was done using Topspin 2.1. All post-acquisition processing was
done using Topspin 3.0 and further data analysis was done using either SPARKY
(T. D. Goddard and D. G. Kneller, SPARKY 3, University of California, San Fran-
cisco) or CcpNmr Analysis (Vranken et al., 2005) software for Mac OS X.
2.14.1 1D 1H NMR experiments
All 1D 1H NMR experiments were collected using the watergate method for the
suppression of 1H signal arising from water (Liu et al., 1998). Spectra were recorded
using 32k complex data points and 32 co-added transients. A recycle delay of 1.5 sec-
onds was used and data was typically acquired by optimising the ⇡2 pulse length for
the excitation of 1H nuclei whilst maintaining a power level of 5.9 dB. The acquisi-
tion time was 1.67 s and the spectral window was set to 20 ppm. Data were Fourier
transformed using a zero-filling of 65k and using the exponential window function
with a line broadening of 1 Hz unless otherwise specified.
2.14.2 2D 1H/15N NMR experiments
Double resonance heteronuclear single quantum coherence (HSQC) experiments
(which correlate the resonances of 1H and 15N nuclei) (Schleucher et al., 1994) were
recorded over a variable range of acquisition parameters so as to achieve the best
possible spectra in the minimum time. Typically data were acquired with 2k com-
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plex data points in F2 and 128 increments in F1 with 32 co-added transients and 16
dummy scans. A spectral width of 14 ppm was used in the 1H dimension and 40 ppm
was used in the 15N dimension. The data were Fourier transformed using a zero-
filling on 4k in F2 and 2k in F1. Processing was done using Gaussian multiplication
(GM) window function with a line broadening of -10 Hz in both dimensions. Ad-
ditionally, a polynomial baselines correction was used in F2 and a linear prediction
was used in F1.
2.14.3 3D 1H/15N/13C NMR experiments
All 3D experiments were performed as detailed in Table 2.12. All spectra were
acquired at 45  C. Processing was done by Fourier transforming using Gaussian
multiplication (GM) window function and using a line broadening of -10 Hz in all
dimensions. Baseline correction was done in F1 and linear prediction was used in
dimensions F2 and F3.
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Experiment Details Reference
HNCO 78, 48 and 2k increments in F1, F2 and F3 respectively with 36 co-added
transients. Spectral widths of 22 ppm, 40 ppm and 14 ppm in F1, F2
and F3 respectively. 16 dummy scans.
(Kay et al., 1990)
HNCACO 92, 48 and 2k increments in F1, F2 and F3 respectively with 36 co-added
transients. Spectral widths of 22 ppm, 40 ppm and 14 ppm in F1, F2
and F3 respectively. 16 dummy scans.
(Clubb et al., 1992)
HNCA 72, 48 and 2k increments in F1, F2 and F3 respectively with 40 co-added
transients. Spectral widths of 32 ppm, 40 ppm and 14 ppm in F1, F2
and F3 respectively. 16 dummy scans.
(Kay et al., 1990)
HNCOCA 80, 52 and 2k increments in F1, F2 and F3 respectively with 46 co-added
transients. Spectral widths of 32 ppm, 40 ppm and 14 ppm in F1, F2
and F3 respectively. 16 dummy scans.
(Bax and Ikura, 1991)
CBCANH 78, 50 and 2k increments in F1, F2 and F3 respectively with 56 co-added
transients. Spectral widths of 75 ppm, 40 ppm and 14 ppm in F1, F2
and F3 respectively. 16 dummy scans.
(Wittekind and Mueller, 1993)
CBCACONH 78, 48 and 2k increments in F1, F2 and F3 respectively with 32 co-added
transients. Spectral widths of 75 ppm, 40 ppm and 14 ppm in F1, F2
and F3 respectively. 16 dummy scans.
(Grzesiek and Bax, 1992)
15N HSQC–TOCSY 86, 54 and 2k increments in F1, F2 and F3 respectively with 42 co-added
transients. Spectral widths of 14 ppm, 40 ppm and 14 ppm in F1, F2
and F3 respectively. 16 dummy scans.
(Marion et al., 1989b)
15N HSQC–NOESY 86, 54 and 2k increments in F1, F2 and F3 respectively with 42 co-added
transients. Spectral widths of 14 ppm, 40 ppm and 14 ppm in F1, F2
and F3 respectively. 16 dummy scans.
(Marion et al., 1989a)
Table 2.12: Triple resonance experiments conducted in this study61
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2.14.4 E5 titrations
To investigate the binding of the oncoprotein E5 to the PDGF R-TM, E5 was
titrated into PDGF R-TM reconstituted into DPC/DPPC micelles at PDGF R-
TM to E5 molar ratios of 1 : 1, 1 : 3, 1 : 5, 1 : 7, 1 : 9 and 1 : 11. E5 was dissolved
and stored in TFE solution post-purification. The amount of E5 required per titra-
tion was dried in a 1.5 mL eppendorf tube forming a thin film. This was resuspended
in PDGF R-TM mixed micelle solution, sonicated till all the E5 dissolved and equi-
librated for ⇠1 hour. The temperature and bu↵er conditions were maintained and
1H–15N HSQC spectra recorded.
2.14.5 Deuterium exchange experiments
In these experiments amide hydrogen exchange is observed by the disappearance
of 1H–15N resonances in an HSQC spectrum after the solvent is exchanged from
H2O to D2O. This is done by lyophilising the sample and then resuspending it
in 200 µL of D2O followed by dissolution of the suspension through sonication.
HSQC spectra are obtained before exchange and after exchange using the same
experimental conditions. Additionally, a set of 5 spectra are obtained at 2 hour
intervals after exchange.
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A Solid-State NMR Analysis of
Oncogenic Neu
3.1 Introduction
As detailed in section 1.2.1, the ErbB2/HER receptor has been implicated in a
very aggressive form of breast cancer which constitutes 30% of all breast cancers
(Mitri et al., 2012). It has a particularly poor prognosis due to its resistance to
conventional therapies and high relapse rates (Slamon et al., 1987). In order to
study this oncogenic transformation, scientists have taken a keen interest in the rat
analogue of this receptor known as Neu. Where ErbB2 in humans is constitutively
active due to the V659E mutation in the TM, the oncogenic Neu mutant (hereafter
referred to as Neu*) is similarly activated due to a TM V664E mutation. Despite
being rigorously and extensively studied, there is no agreement on how a single
mutation within the TM domain of the Neu* receptor a↵ects the structural integrity
of the protein.
Even though previous biophysical studies have yielded useful information on the
structural e↵ect of the point mutation in Neu*, they have largely remained incon-
clusive or contradictory. In this study, we aim to investigate the orientation of the
Neu* TM helices with respect to each other. The insights obtained here will be
particularly interesting as the investigative technique of choice, solid-state NMR
spectroscopy, allows us to look at these dimers in ‘native-like’ lipid bilayers. Fur-
thermore, the addition of cholesterol grants the bilayer a fluidity and heterogeneity
63
CHAPTER 3. A SOLID-STATE NMR ANALYSIS OF ONCOGENIC NEU
which make the results obtained in this section all the more biologically relevant.
This is contrary to solution-state NMR where protein solubilisation is achieved by
embedding the proteins in detergent micelles. This can lead to distortion of mem-
brane protein structure due to the curvature stress induced by the micelles.
Further to addressing the specific problem described in the following section, the
novel protocols that have been developed as part of this study can be used as the
basis of investigating structural properties of a host of membrane proteins.
3.1.1 Previous work
Preliminary investigations of the dimeric structure of Neu* have been conducted in
the Dixon/Brown groups using solid-state NMR previously (Ellis et al., unpublished
data). However, the experimental procedure adopted here is di↵erent in several ways,
of which two are significant:
• At no point during the sample preparation was the peptide freeze-dried so
as to reduce the chances of compromising the structural integrity which may
result from this process (Roy and Gupta, 2004). This has been explained in
section 3.5.
• Simultaneous studies in the Dixon group suggested that the cholesterol con-
centration in 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) bilayers af-
fects the the structural properties of the membrane as a function of tempera-
ture. Importantly, it was found that at subzero temperatures, increasing the
cholesterol concentration reduced bilayer rigidity. This is because addition
of cholesterol results in bilayers in liquid-crystalline (L↵) phase rather than
gel-phase (L ). This was believed to be the cause for the reduction in sig-
nal to noise ratio for GpA peptide signals inserted in a DMPC/cholesterol
bilayer (Patel et al., unpublished data). The cholesterol concentration in this
study was hence reduced from a lipid:cholesterol ratio of 3 : 1 to 10 : 1, which
represents a reduction of about 64%.
64
CHAPTER 3. A SOLID-STATE NMR ANALYSIS OF ONCOGENIC NEU
3.2 Models for the Neu* Dimer
The inter-helical interactions that have been hypothesised to stabilise the Neu*
dimer shall be discussed here. There are two sequence motifs that are thought to
pack at the interface of the helical Neu* TM domain dimer.
The first model (Model A) suggests that the A661XXXG665 motif in the transmem-
brane domain stabilises the dimer, with T657 also lying at the interface. This model
has been supported by 1D REDOR ssNMR experiments and computational mod-
elling (Smith et al., 2002b) and is illustrated in Figure 3.1a.
The second model (Model B), on the other hand, suggests that the I659XXXV663
motif stabilises the dimer with I659 and V663 lying at the dimeric interface. Studies
conducted to support this model include Molecular Dynamics (MD) simulations,
site-specific infrared dichroism (Beevers and Kukol, 2006), FTIR spectroscopy and
mutagenesis studies (Beevers et al., 2010). This model has been structurally illus-
trated in Figure 3.1b.
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(a) Model A: A A661XXXG665 motif sta-
bilises the dimer
(b) Model B: A I659XXXV663 motif sta-
bilises the dimer
Figure 3.1: Models for Neu* TM dimer packing
3.3 Labelling Scheme
3.3.1 Motivation and scientific approach
To verify which of the models outlined in section 3.2 can be corroborated using NMR
correlation experiments, pairs of synthetic peptides were designed to be used together
to test each model. Synthetic peptides are particularly useful in NMR analyses as
their use allows amino acids at very specific positions to be labelled. Peptides can
be mixed together and due to one amino acid per peptide chain, interactions can
be confirmed to be inter-molecular as opposed to intra-molecular. In this case the
amino acids chosen are those which are close to the proposed dimer interface.
In designing each pair of peptides, the following considerations and/or requirements
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were important:
• For each of the helices within a particular model, an amino acid at or very near
the suggested dimeric interface would be uniformly 15N- and 13C-labelled.
• Short inter-helical distances of up to 5A˚ between the pair of labelled amino
acids must be chosen to detect through-space intermolecular magnetisation
transfer.
• Average chemical shifts of each of the resonances of the selected amino acids
must be as di↵erent as possible to its counterpart in the other peptide. This
is to ensure that there are no overlapping peaks in the NMR spectrum. This
becomes all the more important when conducting the experiments at low tem-
peratures where the line-broadening observed due to conformational inhomo-
geneity is introduced by quenching of motions upon freezing.
3.3.2 Design
With the aforementioned considerations in mind, PDB files of each of the models
were used to guide the design of synthetic peptides for solid-state NMR analyses.
This approach avoids the spectral crowding that can occur due to uniformly labelled
samples, especially when experiments are conducted at low temperatures and peaks
tend to be broad. As mentioned earlier, to verify each model, a pair of peptides will
be used together to check for inter-helical magnetisation transfer.
Model A
The first pair of peptides was designed to detect inter-helical magnetisation transfer
across the A661XXXG665 dimeric interface as suggested by Model A. Many short
inter-helical distances between carbon atoms were predicted by this model (see Ta-
ble 3.1) including a distance of 3.90 A˚ between C↵ of G665 and C 2 of L668 and
3.59 A˚ between CO of G665 and C 2 of L668 (Figure 3.2a). In light of this, two
peptides were designed: one with [U –15N, 13C]-G665 as the only isotopically labelled
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amino acid in the sequence and, similarly, the other with [U –15N, 13C]-L668 as the
only isotopically labelled amino acid in the sequence.
Model B
Similarly, short inter-helical distances of 4.35 A˚ between the C 2 of I659 and the C 
of T662 were predicted in Model B. Additionally, 4.18 A˚ between the C 2 of I659
and the C  of T662 was predicted (see Table 3.2 and Figure 3.2b). In this case,
however, an additional motivation behind choosing I659 was the FTIR spectroscopy
and mutagenesis data reported previously (Beevers et al., 2010) which suggested a
strong role of I659 in oligomerisation.
Table 3.1: List of predicted inter-
atomic distance between L668 and
G665. Distances less than 5 A˚ are
highlighted in green.
Leu/Gly CO C↵
CO 6.42 6.65
C↵ 5.93 5.97
C  4.55 4.75
C  4.50 4.51
C 1 5.91 5.95
C 2 3.59 3.90
Table 3.2: List of predicted inter-
atomic distance between I659 and
T662. Distances less than 5 A˚ are
highlighted in green.
Ile/Thr CO C↵ C  C 
CO 7.75 7.75 6.45 6.81
C↵ 7.95 7.74 6.30 6.50
C  7.83 7.33 5.83 5.67
C 1 8.52 7.36 6.33 6.00
C 2 6.42 5.85 4.35 4.18
C  9.38 8.54 7.02 6.38
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(a) Model A: Distances less than 5 A˚ are shown between L668 (magenta) and G665 (green).
(b) Model B: Distances less than 5 A˚ are shown between T662 (magenta) and I659 (green).
Figure 3.2: Predicted inter-atomic distances for Neu* TM dimer packing for each
of the models.
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(a) Isoleucine (b) Threonine
(c) Glycine (d) Leucine
Figure 3.3: Chemical structures of uniformly 15N- and 13C-labelled amino acids.
All labelled nuclei are in red.
The labelling scheme hence adopted is represented in the following peptide se-
quences, where (*) represents a labelled residue:
Model A
Peptide pair to test: acetyl-RASWVTFIIATVEG⇤VLLFLILVVVVGILIKRRR-conh2
acetyl-RASWVTFIIATVEGVLL⇤FLILVVVVGILIKRRR-conh2
Model B
Peptide pair to test: acetyl-RASWVTFI⇤IATVEGVLLFLILVVVVGILIKRRR-conh2
acetyl-RASWVTFIIAT⇤VEGVLLFLILVVVVGILIKRRR-conh2
The labelled amino acids are shown in Figure 3.3, with isotopically labelled nuclei
shown in red. After the peptides were purified, the pair for each model was combined
(to form dimers) and reconstituted into a lipid bilayer for NMR analyses.
3.4 Peptide Purification
Peptides were provided by the manufacturer in a crude form containing truncated
products and protecting groups from the solid-phase synthesis. These were purified
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using reverse-phase HPLC (RP-HPLC) as detailed in section 2.9.3 and then analysed
by mass spectrometry.
3.4.1 High performance liquid chromatography (HPLC)
The crude protein was dissolved and passed through a column containing a porous
solid matrix. Depending on the strength of the interactions that the proteins (mo-
bile phase) have with this solid matrix (stationary phase), they are retained and the
rate at which they pass through the column will vary accordingly, hence separating
di↵erent peptides. A characterising feature of an HPLC column is the length of the
hydrophobic alkyl chains (-CH2-CH2-CH2-CH3) which form the stationary phase
and that interact with the analyte. Commonly used chain lengths are C4, C8, and
C18. C4 is generally used for proteins and C18 is generally used to capture peptides
or small molecules. The eluted solution then passes through a UV-Visible absorp-
tion detector before the fractions are collected. Peptides absorb at wavelengths of
220 nm due to C = O bonds, and if amino acids with aromatic side chains, such as
tryptophan, are present, they also absorb more strongly at wavelengths of 280 nm
due to C = C bonds. This produces a UV-Vis absorption spectrum which can be
used to help identify the fractions containing the desired peptide. The fractions
which correspond to peaks on the chromatogram can then be characterised by mass
spectrometry.
Even though a C4 column was used in this study, which is ideally suited for the pu-
rification of these extremely hydrophobic peptides, they can bind very strongly to the
stationary phase of the column and may prove di cult to elute. Resultantly, clear
baseline separation is lost and the peaks are broad, which often means unresolved
peaks overlap and purification is not possible. This phenomenon can be controlled
by optimising two parameters during peptide purification. Firstly, the gradient of
the organic solvent which is used as the mobile phase can be optimised. Secondly,
the flow rate can be carefully optimised to achieve maximum resolution.
Several runs of purification of Neu* crude peptide were performed on the HPLC
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instrument and the UV absorbance at 280 nm was recorded. A representative chro-
matogram with optimised gradient is shown in Figure 3.4. It was confirmed using
mass spectrometry that the peptide eluted at about 48 minutes at a mobile phase
composition of about 80% isopropanol : 20% water. The peak observed at 15 minutes
is most likely due to by-products from the synthesis of the peptide. Most of these
compounds are more soluble than the peptide and hence elute much earlier. The
other peaks observed which are closer to the Neu* peak are likely due to deletion
products from the synthesis, for example peptides missing one or two amino acids.
After the peak of interest was identified, only fractions containing that peak were
collected. Approximately 10 runs of about 5 mg of crude peptide were required to
obtain enough peptide to fill a 4 mm MAS ssNMR rotor.
Figure 3.4: Neu* peptide was purified by a Jasco HPLC instrument using a
Phenomenex Jupiter C4 column. The chromatogram shows the UV absorbance
at 280 nm (green line) as the percentage of organic (isopropanol) passing through
the column is varied. This gradient is illustrated in blue. The peak at about 48
minutes corresponds to pure Neu* peptide (as indicated).
3.4.2 Electrospray ionisation mass spectrometry (ESI-MS)
Mass spectrometry is an analytical technique that can be used to measure the
mass-to-charge ratio of charged entities within a sample. It can be used to pro-
72
CHAPTER 3. A SOLID-STATE NMR ANALYSIS OF ONCOGENIC NEU
vide information about various physical and chemical properties of a compound.
These properties include masses of particles, the elemental composition of a sample
or molecule, and the chemical structures of molecules, such as peptides and other
chemical compounds.
In this study, mass spectrometry was used after HPLC to identify fractions which
contained the desired peptide (of which the mass is known) and determine the purity.
All such characterisation was carried out on a micrOTOF instrument (Bruker, UK).
This uses an electrospray ionisation source (ESI) which allows small quantities of
the peptide in solution to be taken straight from the HPLC fractions. The sample
passes through a nebuliser, is dried to remove solvent and then ionised.
The mass spectrum of the fraction obtained at 48 minutes for the peptide labelled
at G665 is shown in Figure 3.5. In the mass spectrum obtained, charge states corre-
sponding to +5, +4, +3, +2 and +1 can be observed (top panel). The total mass
of the major species obtained from the deconvoluted spectrum is 3794 Da (bottom
panel), which agrees well with the theoretical mass of 3795 Da for the peptide. A
peak at about 3906 Da can also be observed. This is due to TFA-adducts formed
during the purification process and have been observed previously (Hua and Kobertz,
2013).
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Figure 3.5: Assessment of purified Neu* through ESI-MS. Pooled fractions from
the HPLC purification were checked for the existence of the peptide and it’s purity.
The top panel shows the mass spectrum with multiple charge states of the peptide.
The bottom panel shows a major peak corresponding to the Neu* peptide (3794 Da)
with an additional peak at about 3906 Da which can be attributed to a TFA adduct.
3.5 Reconstitution of Neu* peptides in lipid bilayers
Reconstitution of the Neu* peptide into DMPC/cholesterol liposomes was carried
out by dissolving all three components into organic solvents, combining them to-
gether to thoroughly mix, and gradually adding phosphate bu↵er (pH 6.8) as organic
solvents are removed using a rotary evaporator (see section 2.10.1 for details). This
protocol was adopted in lieu of removing all organic solvents under vacuum to form
a film that is subsequently hydrated so as to prevent the peptide from undergoing
changes which may compromise its structural integrity. Specifically, previous studies
have shown that structural properties such as ↵-helical content of a protein can be
artificially altered through freeze-drying (Roy and Gupta, 2004). Even though the
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molecular basis for this isn’t completely understood, several reasons have been put
forth. As an example, water molecules bind to a protein in a particular order: the
first to interact are charged and polar amino acids, next, around the hydrophobic
clusters. The former stage is particularly important because in the absence of water
molecules, side chains may interact with each other and ‘lock-up’ certain confor-
mations which may prevent the flexibility required for dimer formation (Poole and
Finney, 1983; Falconi et al., 2003).
In order to ensure that all organic solvents were removed from proteoliposomes,
1H spectra were collected to look for characteristic 1H chemical shifts of 2,2,2-
trifluoroethanol (TFE) and isopropanol. Figure 3.6 shows a representative spectrum
in which no solvent peaks are observed. The peaks that can be observed upfield of
4 ppm and the single peak at 8.17 ppm can be attributed to cholesterol and lipids
in the solution. The negative peak at 4.711 ppm is due to WATERGATE water
suppression.
Figure 3.6: 1H NMR spectrum of Neu* proteoliposomes. No peaks which can be
attributed to organic solvents are observed.
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3.6 Circular Dichroism (CD)
To evaluate the secondary structure of the Neu* peptide in DMPC/cholesterol bi-
layers, CD spectra were obtained as per the protocol detailed in section 2.11. CD
measures the di↵erence in absorbance of left- and right-handed circularly polarised
light and it is this di↵erence which is reflected in a CD spectrum.
Figure 3.7: CD spectrum of Neu* in DMPC liposomes recorded between 190–
270 nm at a peptide concentration of 0.1 mg/mL. The characteristic negative peaks
at around 208 nm and 222 nm are indicative of ↵-helical structure of Neu* in DMPC
liposomes.
Samples for analysis were prepared as described in section 2.10.1 and diluted with
50 mM phosphate bu↵er (pH 7.4) to a final protein concentration of ⇠0.1 mg/mL.
The protein : cholesterol : DMPC molar ratio was maintained at 1 : 5 : 15. An
examination of the CD spectrum reveals two minima at 210 nm and 223 nm and a
maximum at about 197 nm, all of which are characteristic of an ↵-helical structure
in membranes (Wallace et al., 2003). These are slightly shifted from values observed
in soluble proteins (nminima at 208 nm and 222 nm whereas a maximum is seen at
76
CHAPTER 3. A SOLID-STATE NMR ANALYSIS OF ONCOGENIC NEU
192 nm). These shifts have been observed previously in the Dixon group and in the
scientific literature (Wallace et al., 2003) for a host of membrane peptides. Several
explanations for this phenomenon have been put forth, including the hypothesis that
detergent micelles or bilayer environments posses a low dielectric constant which
can a↵ect the relative ground and excited states of the electronic transitions of
the backbone of membrane embedded peptides relative to those which are soluble
(Cascio and Wallace, 1995; Chen and Wallace, 1997).
3.7 Solid-state NMR
Samples for analysis were prepared as described in section 2.10.1. Rotors were placed
in appropriate probes for magic angle spinning (MAS).
3.7.1 Probe CP setup
Prior to each measurement of the Neu* samples, a 13C cross-polarisation (CP) spec-
trum was obtained on natural abundance alanine for referencing. Additionally, the
COOH, CH and CH3 peaks provided magic angle, shimming and decoupling controls
respectively. It was ensured that the COOH, CH and CH3 linewidths were less than
30 Hz, 50 Hz and 30 Hz respectively. In order to monitor the health and status of
the probe, the parameters for acquisition of alanine CP were kept constant at 16
scans, 10 kHz MAS, 40 ms acquisition time, 1 ms contact time, 100 kHz TPPM
decoupling, 70–100% ramp for CP (on 1H) and 3 s recycle delay. Figure 3.8 shows
a 13C alanine cross-polarisation spectrum obtained on a 500 MHz spectrometer in a
4 mm rotor.
3.7.2 Temperature
A low-temperature of -15  C was chosen to conduct all MAS ssNMR experiments.
At this temperature, the DMPC lipids are in ‘gel’ phase (Needham and Evans, 1988).
The rationale behind the low temperature was that this would lead to reduction of
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Figure 3.8: 13C alanine cross-polarisation spectrum. The inset shows the chemical
structure of alanine. Each of the carbon peaks are labelled. Spinning sidebands are
labelled with an asterisk (*).
internal motions within the protein (such as side-chain dynamics), which in turn
would improve spectral resolution (Abdine et al., 2010). However, this would also
lead to line-broadening as dipolar couplings and T1 relaxation times are increased
(Hiller et al., 2005; Frericks et al., 2006; Cady et al., 2009). Since only a single
amino acid was labelled per peptide, spectral crowding due to broadening wasn’t a
major concern and the benefits of performing experiments at low temperatures were
capitalised upon. Furthermore, cholesterol can be used to alter the rigidity of the
membrane, and increasing cholesterol concentrations may allow for the experiments
to be conducted at higher temperatures which are more physiologically relevant (Luo
et al., 2009).
Before conducting 2D DARR experiments (explained in section 1.6.4), 1D 1H spectra
were obtained to corroborate that the samples were indeed frozen. Figure 3.9 shows
a comparison of the peptide 1H spectrum at two temperatures. The spectrum at
25  C (pink) shows relatively sharp peaks, but as the temperature is dropped to
-15  C, almost all the peaks broaden considerably (green).
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Figure 3.9: Comparison of the 1H spectra of the sample made to investigate
model A. The spectrum at 25  C (pink) shows relatively sharp peaks but as the
temperature is dropped to -15  C, almost all the peaks broaden considerably (green).
3.7.3 Cross polarisation (CP)
NMR as a technique su↵ers from inherently low sensitivity. This is particularly true
for biologically important nuclei such as 13C and 15N which have a low gyromagnetic
ratio and natural abundance. For this reason a basic pulse-acquire solid-state NMR
experiment, known as the Bloch decay (BD) experiment, yields only a small fraction
of the expected signals (Kolodziejski and Klinowski, 2002). Another contributing
factor to low sensitivity is the fact that spin-lattice relaxation times of dilute spin-12
nuclei tend to be quite long. This means long experimental times because su cient
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delays must be left between consecutive scans. This can be particularly problematic
when several thousand scans are required to get a reasonable signal to noise ratio,
making the acquisition of quality data impractical.
When combined with MAS, spin polarisation from a nucleus with high gyromagnetic
ratio such as 1H can be transferred to nuclei like 13C whose gyromagnetic ratio is
fourfold lower. Cross polarisation (CP) is a frequently exploited technique to achieve
this transfer and relies on Hartmann-Hahn matched radio frequency (RF) pulses (see
section 1.6.3) for details).
Optimisation of CP contact time
For each of the samples, the CP transfer was optimised for the best e ciency. A
crucial parameter is the CP contact time describing the time during which magneti-
sation is transferred from the nucleus with a high gyromagnetic ratio (usually 1H) to
the dilute nucleus (e.g. 13C). The build up of magnetisation for various 13C nuclei in
the biological molecules analysed in this study depends on the extent of the dipolar
coupling to the proton network. The extent of this dipolar coupling depends on the
degree of protonation for each type of carbon and any molecular motions (such as
methyl group rotation) which may contribute to the averaging out of this dipolar
coupling (Kolodziejski and Klinowski, 2002). Protonated carbons, with reduced mo-
bility, have a faster rate of magnetisation build-up while methyl groups with higher
rotational mobility build-up at a slower rate. As a result, di↵erent nuclei will cross
polarise at di↵erent rates. The length of the contact time is chosen such that all
types of carbons of interest have had su cient time to polarise but not so long so as
to loose significant magnetisation. In order to optimise signal to noise, a range of 1D
13C CP MAS spectra of Neu* were recorded at a range of contact times. Figure 3.10
shows a range of contact times tested, a contact time of 0.8 ms is chosen as after
that no improvement in polarisation transfer is observed.
Figures 3.11 & 3.12 show 13C CP spectra of Neu* samples which were made to test
model A and model B respectively. Assignment of all amino acids was performed
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Figure 3.10: Optimisation of contact time for CP. For this particular sample, run
at 850 MHz spectrometer on a U-13C G665/L668 sample. Magnetisation build-up
and polarisation transfer is improved up until a contact time of 0.8 ms after which
it plateaus out.
as described in section 3.8.2. Several additional peaks were also observed which
were attributed to DMPC lipids present at natural abundance. These are identified
using data previously acquired for DMPC liposomes in the absence (Lee and Gri n,
1989) and presence (Patel et al., unpublished data) of 5% cholesterol. The DMPC
resonances typically appear as sharp peaks (0.5-1.6 ppm) due to the fast internal
Brownian motions of the DMPC molecules (Sa↵man and Delbru¨ck, 1975).
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Figure 3.11: 13C CP spectrum of Neu* [U –15N, 13C]-G665/L668 labelled sample
made to investigate model A in DMPC liposomes. Peaks which can be attributed
to [U –15N, 13C]-G665 or [U –15N, 13C]-L668 have been indicated. Secondary species
from G665 are marked in purple and tertiary species are marked in green. Spectrum
recorded on a 600 MHz spectrometer with 10 kHz MAS at -15  C for 256 co-added
transients.
Figure 3.12: 13C CP spectrum of [U –15N, 13C]-T662/I659 Neu* labelled sample
made to investigate model B in DMPC liposomes. Peaks which can be attributed
to [U –15N, 13C]-T662 or [U –15N, 13C]-I659 have been indicated. Spectrum recorded
at 500 MHz with 10 kHz MAS at -15  C for 10,000 co-added transients.
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3.7.4 13C polarisation enhancement using nuclear Overhauser po-
larisation (NOP)
Even though CP has been the technique of choice for polarisation enhancement
for most solid-state NMR experiments for a long time, alternative techniques have
been introduced more recently which o↵er an advantage over CP for certain appli-
cations. One such technique called nuclear Overhauser polarisation (NOP) relies on
the nuclear Overhauser e↵ect (NOE) for polarisation transfer (Takegoshi and Terao,
2002). NOE enhancement occurs for 13C spins in fast-rotating groups such as CH3.
The enhanced polarisation of mobile 13CH3 spins is then successively transferred by
DARR to the other 13C spins, which in turn leads to NOE enhancement of the other
stationary 13C spins. It has been shown that NOP transfer works particularly well
for mobile biological molecules (Katoh et al., 2004).
NOP provides three main advantages over CP. Firstly, it works well with mobile
molecules while CP signal enhancement becomes smaller with short T1⇢ of 1H or
13C. Secondly, the repetition time of acquisition is reduced even when 1H T1 is long.
Thirdly, NOP enables a more quantitative comparison of signal intensities. For these
reasons, and the fact that the peptide is expected to demonstrate at least a certain
degree of mobility, NOP polarisation transfer was also tried on the U-13C G665/L668
Neu* sample using the same experimental conditions as previously.
A comparison of 13C NOP-MAS and CP-MAS spectra for the [U –15N, 13C]-13C-
G665/L668 Neu* sample is shown in Figure 3.13. Even though several sharp peaks
are observed for NOP, including that of L668 C↵, several peaks such as G665 C↵1 and
G665 CO have completely disappeared. This could be because at low temperatures
the narrowing condition for methyl rotation is not met (Katoh et al., 2004). There
is also a broad peak centred around the MAS sideband at about 105 ppm. These
features (or lack thereof) would prove greatly detrimental to the analysis here and
hence it was decided not take this approach forward.
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Figure 3.13: A comparison of 13C NOP-MAS and CP-MAS spectra for [U –15N,
13C]-G665/L668 Neu* sample. 13C NOP-MAS spectrum is in green and 13C CP-MAS
spectrum is in orange. Spectra recorded at 850 MHz spectrometer with 10 kHz MAS
at -15  C.
3.8 Homonuclear 2D Solid-State NMR of Neu*
3.8.1 Pulse sequence
In order to investigate the dimeric structure of Neu* using labelled samples as de-
scribed above, it was imperative that an RF pulse sequence which can provide the
most e cient 13C–13C long-range through-space correlations be selected. Prelimi-
narily, the following pulse sequences were considered:
Proton-driven spin di↵usion (PDSD)
In this pulse sequence, CP is carried out followed by a ⇡2 -pulse which then restores
the carbon magnetisation along the z-axis. Spin di↵usion is then allowed to occur
between carbon atoms for a set amount of time known as the mixing time (tmix). Fi-
nally, another ⇡2 -pulse brings the carbon magnetisation back to the transverse plane
84
CHAPTER 3. A SOLID-STATE NMR ANALYSIS OF ONCOGENIC NEU
and the free induction decay (FID) is recorded under high power proton decoupling
(Szeverenyi et al., 1982; Pines et al., 1973).
Dipolar-assisted rotational resonance (DARR)
This is a modification of PDSD where magnetisation transfer occurs faster. The
pulse sequence is the same as PDSD but during tmix, a weak field on the 1H channel
broadens the carbon lines and facilitates spin di↵usion (Takegoshi et al., 2001) (see
section 1.6.4 for a schematic illustration of the pulse sequence).
Figure 3.14: 1D 13C-13C spectra of Neu* [U –15N, 13C]-G665/L668 labelled sample
using various pulse sequences. Spectrum recorded at 850 MHz with 10 kHz MAS at
-15  C.
Proton-assisted recoupling (PAR)
PAR involves irradiation on both carbon and proton channels and avoids all rotary
resonance and Hartmann-Hahn conditions (Lewandowski et al., 2009).
Figure 3.14 shows 1D projections of all of the above pulse sequences run on a U-13C
G665/L668 Neu* sample. While peaks of significant resolution and intensity are seen
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for both PDSD and DARR in the aliphatic region, the carbonyl region can only
be observed in the DARR spectrum. This is in concordance with the information
in scientific literature and that which has previously been acquired in our group.
Consequently, all subsequent homonuclear 2D experiments were performed using
the DARR experiment.
3.8.2 Resonance assignment
In order to assign resonances in the [U –15N, 13C]-G665/L668 and [U –15N, 13C]-
T662/I659 samples of Neu*, the resonances observed in the spectrum were compared
with published average chemical shift values for glycine, leucine, isoleucine and
threonine found at the Biological Magnetic Resonance Databank (BMRB) (http:
//www.bmrb.wisc.edu/) (Ulrich et al., 2008). All peaks corresponding to side chain
carbons of these 13C-labelled amino acids in both samples of Neu* were successfully
assigned (apart from L668 C 1 &  2 and T662 C↵ & C ) as they matched well with
published values in BMRB. Even though the peaks were broad, the amino acids
were selected to ensure minimal overlap and the ambiguities were observed only in
the cases of T662 C↵ & C  and L668 C 1 & C 2 which couldn’t be resolved and were
labelled collectively as C↵\  and C 1\ 2 respectively. Tables 3.3, 3.4, 3.5 and 3.6 list
the 13C Neu* chemical shifts and the BMRB values for all labelled amino acids used
in this study. It is worth noting that the random-coil chemical shift values given
in the BMRB database are referenced with respect to 4,4-dimethyl-4-silapentane-1-
sulfonic acid (DSS) and the Neu* experimental chemical shifts are referenced with
respect to tetramethylsilane (TMS). Hence 2.0 ppm are subtracted from all entires
in the BMRB before considering them in this study.
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L668 chemical shifts (ppm)
Nucleus Neu* shift BMRB
CO 176.0 175.3
C↵ 56.13 53.95
C  39.65 40.61
C  24.30 24.78
C 1 21.52 22.68
C 2 21.52 22.07
Table 3.3: 13C chemical shift data for L668.
G665 chemical shifts (ppm)
Nucleus Neu* shift BMRB
CO1 172.7 171.9
CO2 169.0 171.9
CO3 171.3 171.9
C↵1 45.76 43.36
C↵2 43.23 43.36
C↵3 50.79 43.36
Table 3.4: 13C chemical shift data for G665. Nuclei in a secondary environment
are highlighted in purple and those in a tertiary environment are highlighted in red.
T662 chemical shifts (ppm)
Nucleus Neu* shift BMRB
CO 174.1 172.6
C↵ 65.60 60.27
C  65.60 67.71
C  19.7 19.56
Table 3.5: 13C chemical shift data for T662.
I659 chemical shifts (ppm)
Nucleus Neu* shift BMRB
CO 175.3 173.93
C↵ 64.21 59.68
C  36.03 36.57
C 1 27.48 25.74
C 2 15.54 15.53
C  12.35 11.4
Table 3.6: 13C chemical shift data for I659.
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3.8.3 Secondary chemical shift analysis
The secondary chemical shift can be described as the deviation of the chemical
shift of a nucleus from the random-coil shift. In particular, C↵, C  and CO nuclei
form a useful probe into the secondary structure of proteins for carbon-detected
ssNMR experiments (Spera and Bax, 1991; Wishart et al., 1991; Wishart and Sykes,
1994b,a). The secondary chemical shift,   iS , can be calculated using the following
equation:
  iS =   
obs
S    rcS
where,
  obsS is the observed chemical shift and
  rcS is the random-coil chemical shift.
In a study of 442 residues whose secondary structure is known with a high degree of
precision, and C↵, C  and CO shifts are also known, it was found that for an ↵-helix
the average C↵ and C  secondary shifts are 3.09 ppm and -0.38 ppm respectively
(Spera and Bax, 1991). In a similar study, the average secondary shift for CO was
found to be 1.7 ppm downfield (Wishart and Sykes, 1994b). These values match well
with the average values for the four labelled amino acids in our study: 3.62 ppm,
-2.92 ppm and 1.09 ppm for C↵, C  and CO respectively. For each individual amino
acid these values are illustrated in Figure 3.15 and the values are consistent with
that of an ↵-helical structure and also in agreement with CD data.
As shall be explained in section 3.8.4, secondary and tertiary species were also
observed for G665. For both of these, the C↵ secondary shifts are consistent with an
↵-helix but the CO shift values are negative and hence are not. The C↵ shift values
are a more reliable indicator of secondary structure than the CO shift values (Wang
and Jardetzky, 2002). At the very least, however, it can be said that the results for
these species are inconclusive in showing a conformational preference.
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Figure 3.15: Secondary chemical shift analysis of all labelled amino acids in Neu*
samples. Positive C↵ and CO shifts and negative C  shifts are consistent with the
↵-helical structure of the peptide.
Figure 3.16: Secondary chemical shift analysis of secondary and tertiary species
of G665.
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3.8.4 2D DARR spectra to investigate model A
After collecting an alanine CP spectrum for referencing/check and optimising CP on
[U –15N, 13C]-G665/L668 sample of Neu* in DMPC/cholesterol liposomes, 2D MAS
ssNMR DARR experiments were performed. This would allow the observation of
any inter- and intra-residue dipolar coupling for the Neu* dimer. As stated in
section 3.3, should model A be representative of the dimeric interface of the Neu*
dimer, it is expected that inter-helical polarisation transfer should be observed in
the form of cross-peaks between [U –15N, 13C]-G665 and [U –15N, 13C]-L668 in the
DARR spectrum.
Long (400 ms) mixing time
A 2D 13C–13C DARR spectrum obtained using a 400 ms mixing time is shown in
Figure 3.17. Several cross peaks on either side of the diagonal were observed. The
strong signals on the diagonal were due to either the labelled amino acids in Neu* or
from natural abundance 13C present in DMPC lipids. Since only one amino acid was
labelled per peptide, and because the labelling of amino acids was done such that
the average chemical shift of each resonance was as di↵erent as possible, peaks were
largely well resolved in both the carbonyl and aliphatic regions. The only exceptions
to this were C 1 and C 2 of [U –15N, 13C]-L668 which were unresolvable due their
chemical shifts being very similar and the broadness of the peaks.
At a mixing time of 400 ms, several intra-residue connectivities were observed. For
[U –15N, 13C]-L668, intra-residue cross peaks were observed between C↵–C , C↵–
C 1/2, C↵–C , C↵–CO, C –C 1/2, C –C , C –CO, C –CO and C 1/2–CO. For
G665, the only intra-residue C↵–CO cross peak was observed on both sides of the
diagonal. However, it is observed in 3 di↵erent environments: one major species
C↵1–CO1 and two minor species C↵2–CO2 &C ↵3–CO3.
Several peaks which can be attributed to inter-helical magnetisation transfer are
also observed:
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L668C –G665CO
L668C –G665C↵2
L668C –G665C↵3
L668C –G665CO.
These are highlighted in green in Figure 3.17. In the aliphatic region, both of
the minor environments of glycine form L668C –G665C↵ inter-helical cross peaks.
Interestingly, cross peaks between the minor environments are also observed in the
spectrum which may indicate a slow conformational exchange (relative to NMR
timescales) yielding two separate peaks in the NMR spectrum. These are shown in
purple in Figure 3.17.
The major species is responsible for the inter-helical L668C –G665CO cross peak
on one side of the diagonal and L668C –G665CO cross peak on the other. Such
asymmetry can be ascribed to non-uniform CP signal enhancement as well as some
inherent features of DARR recoupling (Ohashi and Takegoshi, 2006).
The presence of these inter-helical cross peaks is of great significance. Firstly, it
shows that the sample preparation method has yielded a sample in which Neu*
is not only reconstituted with an ↵-helical conformation in DMPC/cholesterol lipo-
somes but also, crucially, that it dimerises in the hydrated lipid bilayer environment.
Furthermore, the results support model A for the dimerisation of Neu* as they in-
dicate that L668 and G665 are close in space. This in turn supports the hypothesis
that the A661XXXG665 motif stabilses the dimer.
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Figure 3.17: 2D spinning frequency ssNMR 13C–13C DARR correlation spectrum of [U –15N, 13C]-G665/L668 labelled Neu* in
DMPC/cholesterol liposomes at a mixing time of 400 ms. Spectrum was acquired at 600 MHz with 10 kHz MAS at -15  C. The com-
plete spectrum is shown on the left whereas the aliphatic region is expanded on the right. All inter-helical cross peaks are highlighted in green
whereas cross peaks which are thought to arise from putative conformational exchange are labelled in purple.
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Short (30 ms) mixing time
A short mixing time (30 ms) DARR experiment was also performed under the same
conditions as above. The assignment of intra-residue cross peaks obtained in the
long mixing time experiment were confirmed. Some of the cross peaks disappeared
because, at short mixing times, long range through-space couplings cannot be ob-
served. But more surprisingly, at least three inter-helical cross peaks are still clearly
observed (highlighted in green in Figure 3.18), though just on one side of the diag-
onal. This could indicate very short intermolecular distances as a result of strong
dimerisation. Furthermore, the cross peaks between the two minor environments of
glycine are again observed (highlighted in purple in Figure 3.18).
Figure 3.18: 2D MAS ssNMR 13C–13C DARR correlation spectrum of the aliphatic
region of [U –15N, 13C]-G665/L668 labelled Neu* in DMPC/cholesterol liposomes at
a mixing time of 30 ms. Spectrum was acquired at 600 MHz with 10 kHz spinning
frequency at -15  C.
3.8.5 2D DARR spectra to investigate model B
As above, after collecting an alanine CP spectrum for referencing/check and optimis-
ing CP on a [U –15N, 13C]-T662/I659 sample of Neu* in DMPC/cholesterol liposomes,
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2D MAS ssNMR DARR experiments were performed. As stated in section 3.3,
should model B be representative of the dimeric interface of the Neu* dimer, it is
expected that inter-helical polarisation transfer should be observed in the form of
cross-peaks in the DARR spectrum.
Long (400 ms) mixing time
A 2D 13C–13C DARR spectrum obtained using a 400 ms mixing time is shown in
Figure 3.19. Several cross peaks on either side of the diagonal are observed. As
above, the strong signals on the diagonal are due to either the labelled amino acids
in Neu* or from natural abundance 13C present in DMPC lipids. T662 C↵ & C 
were unresolvable due their chemical shifts being very similar and the broadness of
the peaks.
At a mixing time of 400 ms, several intra-residue connectivities are observed. For
I659, intra-residue cross peaks are observed between C↵–C , C↵–C 1, C↵–C 2, C↵–
C , C↵–CO, C –C 1, C –C 2, C –C , C –CO, C 1–C 2, C 1–C , C 2–CO and
C –CO. For T662, intra-residue cross peaks are observed between ↵ & C —C , C↵
& C –CO and C –CO.
No evidence of any inter-helical magnetisation transfer was observed and as such
the results here do not support model B which states that the I659XXXV663 motif in
Neu* stabilises the dimer. However, ‘splitting of the peaks’ is observed for a number
of peaks in I659 which may suggests a high degree of mobility of the peptides and
possibly conformational exchange between multiple states.
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Figure 3.19: 2D MAS ssNMR 13C–13C DARR correlation spectrum of the aliphatic
region of [U –15N, 13C]-T662/I659 labelled Neu* in DMPC/cholesterol liposomes at a
mixing time of 400 ms. All intra-residue T662 cross peaks are highlighted in purple
and intra-residue I659 cross peaks are highlighted in mustard. Spectrum was acquired
at 600 MHz with 10 kHz MAS at -15  C.
3.9 Summary and Conclusion
Work presented in this chapter sought to investigate the structure and stabilising
interactions of the Neu* dimer. The ssNMR data presented was obtained from the
Neu* protein TM dimer in a hydrated lipid bilayer containing 10% cholesterol. The
rigidity of the membrane can be controlled through the addition of cholesterol, also
providing it with a ‘native-like’ heterogeneity. A pair of peptides were designed to
investigate which of the models for the Neu* TM can be corroborated, one for model
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A and one for model B. Upon receipt from the manufacturer, these were purified
and reconstituted into DMPC liposomes.
Circular dichroism indicated that these adopt an ↵-helical secondary structure within
the membrane and this was confirmed through secondary chemical shift analysis of
the labelled nuclei in the peptides.
For each sample, conditions such as CP contact time and various experimental pa-
rameters were optimised. Following this, 2D MAS ssNMR 13C–13C DARR corre-
lation spectra were acquired to check for any inter-residue correlations which may
strengthen the hypothesis behind either model A or model B. For model A, inter-
helical correlations were observed at both long and short mixing times indicating
that the residues were extremely close in space to the hypothesised dimeric interface.
For model B, no such correlations were observed an no conclusions regarding spatial
proximity of the labelled residues could be drawn.
However, both models showed evidence of existence of multiple conformational states
and/or exchange between them. For model A, G665 was observed in 3 di↵erent envi-
ronments and 2 of those had cross-peaks between the nuclei in di↵erent states which
could be taken as evidence of exchange between them. For model B, various nuclei
in I659 exhibited ‘splitting of peaks’ which could once again be taken as evidence of
a high degree of mobility. Evidence of more than one stable conformation supports
the theory that TM dimers can exist in ‘active’ and ‘inactive’ states and switch
between the conformations (introduced in section 1.2).
Previous MAS ssNMR analyses performed on this set of peptides were performed
on a sample prepared using a di↵erent protocol involving freeze-drying the sample.
Also, the protein : cholesterol : DMPC ratio was 1 : 5 : 15 compared to 1 : 2 : 20
here (Ellis et al., unpublished data). Even though spectra with good signal to noise
were obtained in the previous study, no cross-helical correlations were observed. The
existence of those peaks in this study highlights the importance of cholesterol on con-
trolling the rigidity of the membrane and also rea rms the importance of avoiding
placing the peptides in conditions which may compromise their structure.
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Chapter 4
Cloning and Expression of
PDGF R transmembrane
domain
4.1 Introduction
Platelet-derived growth factor-  receptor (PDGF R) is a type III cell-surface re-
ceptor tyrosine kinase (RTK) that plays an essential role in cellular processes such
as mitogenesis, chemotaxis, angiogenesis and proliferation (Heldin and Westermark,
1999). PDGF R activation is induced when a ligand binds to the ectodomains
of the PDGF R dimer and subsequently results in the autophosphorylation of the
intracellular kinase domains (see section 1.2) for details).
Much of the work towards the high-resolution structural characterisation of PDGF R
has centred around the soluble domains which are amenable to crystallographic
studies (Shim et al., 2010; Yang et al., 2008). More recent in vivo and in vitro bio-
physical studies have demonstrated the ability of the transmembrane (TM) domain
to self-associate with the juxtamembrane (JM) regions playing an important role in
oligomerisation (Muhle-Goll et al., 2012; Oates et al., 2010).
The role of the TM domain in mediating the dimerisation and activation of the
receptor is of significant interest also because the smallest known oncoprotein, E5
from bovine papillomavirus type-1, is known to induce ligand-independent activa-
97
CHAPTER 4. CLONING AND EXPRESSION OF PDGF R
TRANSMEMBRANE DOMAIN
tion of the receptor through a mechanism which is not yet properly understood.
It is thought that the self-assembly of E5 into homodimers and its subsequent in-
teraction with the TM domain of PDGF R triggers constitutive activation of the
receptor.
It is known that E5 must exist as a dimer in order to bind and activate PDGF R
(Horwitz et al., 1988; Nilson et al., 1995). Mutagenesis and computational data
suggest that the dimerisation of E5 generates two identical faces, each of which
is able to bind a monomer of PDGF R (Petti et al., 1997; Surti et al., 1998).
The specific interactions between E5 and PDGF R which stabilise the complex
involve hydrogen-bonding between Q17 of E5 and T545 of PDGF R, and electrostatic
interactions between D33 of E5 and K531 of PDGF R (Talbert-Slagle and DiMaio,
2009). This is illustrated in Figure 4.1
Figure 4.1: Schematic of the E5/PDGF R complex. Adapted from (Talbert-Slagle
and DiMaio, 2009).
The aim in this study was to develop a protocol for the heterologous expression of the
transmembrane domain of PDGF R (PDGF R-TM) for structural analyses using
solid- and solution-state NMR. High yield production of the peptide would allow us
to obtain currently missing direct evidence of E5/PDGF R binding in membrane
98
CHAPTER 4. CLONING AND EXPRESSION OF PDGF R
TRANSMEMBRANE DOMAIN
mimetics through chemical shift perturbations in NMR spectra. Furthermore, the
e↵ect of E5 binding on juxtamembrane regions was also be investigated by inclusion
of those regions in the protein construct.
4.2 Initial Expression Trials
4.2.1 Choice of plasmid and cell lines
The triple resonance experiments conducted in this study required that an e cient
protocol be devised for expressing high yields of PDGF R-TM. This is primarily
because high costs of isotopic labels can render the study infeasible if good yields
are not obtained. A single NMR sample of 180 µL requires a protein concentration
of at least 0.3 mM for 3D analyses and it is of utmost importance to maximise yields
to make it economically feasible.
Previous work by Dr Joanne Oates to characterise the role of TM and JM domains in
oligomerisation of PDGF R involved the construction of plasmids where PDGF R-
TM with either 20, 30 or 40 residues on either side were cloned into a pET30a
vector (Novagen) for expression in E. coli (Oates et al., 2010). All of these vectors
contained a His-tag which allowed for purification using IMAC. These constructs
will henceforth be referred to as pET30a-PDGF R-TM-20, pET30a-PDGF R-TM-
30 and pET30a-PDGF R-TM-40 respectively. It was thought that these constructs
would form an ideal starting point for the expression of PDGF R-TM for NMR
analyses.
Cells were grown directly from glycerol stocks which had the constructs of inter-
est in 3 di↵erent types of E. coli cell lines: BL21(DE3)pLysS; C41; and C43.
BL21(DE3)pLysS cells allow protein expression of any gene that is under the control
of a T7 promoter and has a ribosome binding site. These cells also contain a pLysS
plasmid which carries the gene encoding T7 lysozyme which lowers ‘leaky’ expression
but does not interfere with the level of expression achieved following induction by iso-
propyl  -D-1-thiogalactopyranoside (IPTG). C41 cells are derived from BL21(DE3),
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and contain a mutation which prevents cell death associated with recombinant ex-
pression of some proteins which may be toxic to the cells. C43 cells are a derivative
of C41 which can express a di↵erent set of toxic proteins than C41.
The C41 and C43 cells did not grow in LB medium in the presence of antibiotics
even after several attempts. The transformed BL21(DE3)pLysS cells grew in the
presence of antibiotics. The plasmid was extracted and sent for sequencing to verify
that no mutations occurred in the sequence.
4.2.2 Expression of pET30a-PDGF R-TM-40
Prior to optimising conditions for expression in minimal media, the pET30a-PDGF R-
TM-40 plasmid was transformed into BL21(DE3)pLysS cells (see section 2.5.3) and
expressed in LB (see section 2.6.1) as per existing protocols (Oates et al., 2010) to
check for expression levels. Once the cells were harvested, a portion of the whole
cells (WC) were lysed and centrifuged. The resulting supernatant (S) and pellet
(P), along with the whole cells were analysed on an SDS-PAGE gel as well as a
western blot as detailed in sections 2.8.1 and 2.8.4. The expected molecular mass of
the expressed protein is 18.1 KDa and the gel (Figure 4.2a) revealed a thick band
at the position of the expected monomer in the whole cell as well as pellet fractions
(highlighted in red box in panel (a)). This suggested that the protein was being
expressed in inclusion bodies. Inclusion bodies are formed for 70% of recombinant
proteins over-expressed in E. coli (Yang et al., 2011). This is usually due to the lack
of eukaryotic chaperones and the saturation of E. coli post-translational machinery
(Singh et al., 2015).
The western blot (Figure 4.2b) corroborates that the bands observed are of PDGF R-
TM-40 as only proteins with a His-tag will show up on the blot. A dimer is also
observed at about 40 kDa. This is slightly more than the expected 36.2 kDa but
such anomalous migration has frequently been reported in literature for membrane
proteins, especially for higher order oligomers (Rath et al., 2009). In particu-
lar, slow migration of higher order oligomers of PDGF R-TM has been observed
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(a) SDS-PAGE (b) Western blot
Figure 4.2: Expression pET30a-PDGF R-TM-40 in LB. Panel (a) shows the SDS-
PAGE gel whereas B shows the anti-His western blot. Cells were grown at 37   for
4 hours after induction with 1 mM IPTG. Red box highlights the position of the
expected monomer PDGF R-TM-40 band. WC: whole cells, S: supernatant after
lysis and centrifugation of whole cells, P: pellet after lysis and centrifugation of
whole cells.
previously (Oates et al., 2010).
Once good expression levels were observed in rich medium, the PDGF R-TM-40
protein was expressed in M9 minimal media. The SDS-PAGE gel shown in Fig-
ure 4.3a reveals that even though the expression levels drop considerably in minimal
medium, clear bands corresponding to the protein were seen (highlighted in red box
in panel (a)). A anti-His western blot confirmed this and a dimer of the protein
was once again observed (Figure 4.3b). A lane of non-induced whole cells (N) was
run on both SDS-PAGE and western blots to ensure there was no ‘leaky’ expression
and that the cells weren’t natively producing a protein which was being bound by
anti-His antibody during western blotting.
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(a) SDS-PAGE (b) Western blot
Figure 4.3: Expression pET30a-PDGF R-TM-40 in M9 minimal media. Panel
(a) shows the SDS-PAGE gel whereas B shows the anti-His western blot. Cells were
grown at 37   for 4 hours after induction with 1 mM IPTG. Red box highlights
the position of the expected monomer PDGF R-TM-40 band. WC: whole cells, S:
supernatant after lysis and centrifugation of whole cells, P: pellet after lysis and
centrifugation of whole cells, N: non-induced whole cells.
4.2.3 Comparison of expressions with varying JM lengths
As mentioned previously, the juxtamembrane regions are known to play an impor-
tant role in the activation and oligomerisation of the PDGF R. It was observed by
Oates and coworkers (Oates et al., 2010) that the PDGF R-TM on its own forms
higher order oligomers in vitro which are not biologically relevant. It was further
observed that upon the addition of 40 juxtamembrane residues on either side, the
peptide existed exclusively as monomers and dimers.
Since the goal for this study was to prepare samples for NMR analyses, it was
preferred that the number of JM amino acids to be included in the sample be min-
imised so as to avoid spectral crowding. This is especially important in the case of
a membrane protein embedded in detergent micelles which can lead to broad peaks
in an NMR spectrum. Figure 4.4 shows a western blot of the expression levels of
pET30a-PDGF R-TM-40 (JM40), pET30a-PDGF R-TM-30 (JM30) and pET30a-
PDGF R-TM-20 (JM20) in M9 minimal medium. Whole cells (WC) as well as
pellets (P) after lysis and centrifugation of whole cells were analysed. Good expres-
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sion levels were observed for the smallest protein, PDGF R-TM with 20 resides on
either side of the TM. For these reasons, all further work was carried out using this
construct.
Figure 4.4: Expression levels of pET30a-PDGF R-TM with varying JM lengths
observed using an anti-His western blot. Cells were grown at 37   in M9 medium
for 4 hours after induction with 1 mM IPTG. WC: whole cells, P: pellet after lysis
and centrifugation of whole cells, M: protein ladder, JMX: PDGF R-TM with X
residues on either side.
4.3 Optimisation of Protein Yield
4.3.1 Glucose concentration
When preparing isotopically labelled protein for NMR analyses, it is of critical im-
portance that expensive labels be used most e ciently. Studies have shown that
protein yields can increase several fold by increasing the concentration of glucose in
M9 medium to up to 4 g/L. However, beyond that point, even though there is some
increase in protein yield, it is not economically feasible (Berthold et al., 2011; Marley
et al., 2001). Figure 4.5 shows that a significant improvement in expression levels was
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obtained after doubling the glucose concentration from 2 g/L to 4 g/L (highlighted
in red box). Hence 4 g/L of glucose was used in subsequent expressions.
Figure 4.5: Expression levels of pET30a-PDGF R-TM-20 with varying glucose
concentrations. Cells were grown at 37  C for 4 hours after induction with 1 mM
IPTG. Red box highlights the position of the expected monomer PDGF R-TM-
20 band. Lanes labelled with the concentration of glucose used in expressing the
protein, M: protein ladder
4.3.2 Addition of Basal Medium Eagle (BME) vitamins
Supplements to the M9 minimal medium such as vitamins have also been known
to enhance the growth and expression of E. coli cells (Jansson et al., 1996; Kain-
osho, 1997; Cai et al., 1998). For PDGF R-TM-20 expression, Basal Medium Eagle
(BME) vitamins (Sigma) were chosen and consist of vitamins such as thiamine, ri-
boflavin and folic acid to stimulate cell growth. Figure 4.6 shows an SDS-PAGE
gel which reveals that the addition of vitamins did not lead to any improvement in
expression levels.
4.3.3 Addition of iron (III) chloride
It has been reported by Berthold and coworkers (Berthold et al., 2011) that addition
of a trace metal element solution to media improves the yield of the expressed
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Figure 4.6: Expression levels of pET30a-PDGF R-TM-20 with and without the
addition of vitamins to the M9 minimal medium observed on an SDS-PAGE gel.
Cells were grown at 37   for 4 hours after induction with 1 mM IPTG. Red box high-
lights the position of the expected monomer PDGF R-TM-20 band. Lane marked
(-) represents the expression without vitamins and (+) represents the expression
with BME vitamins, M: protein ladder.
protein. The e↵ect of trace metal element solution has also been studied by Studier
(Studier, 2005), where they showed that the addition of 100 µL of 100 mM FeCl3 is
enough to get very close to the maximal yield that is obtained by adding a complete
trace metal element solution. However, as can be seen in Figure 4.7, no improvement
in expression level was observed upon the addition of iron (III) ions.
4.3.4 E↵ect of temperature variation
It has been reported in scientific literature that if the rate of transcription is cou-
pled with that of translation and that of post-translational events then that can
significantly increase protein yield (Berthold et al., 2011). In order to enable this to
happen, the rates of cellular metabolism can be a↵ected by switching to a weaker
promoter (such as T5 or arabinose) or by using E. coli strains which overcome the
toxicity associated with the overexpression of the T7 promoter. However, the sim-
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Figure 4.7: Expression levels of pET30a-PDGF R-TM-20 with and without the
addition of iron (III) to M9 minimal medium observed on an anti-His western blot.
Cells were grown at 37   for 4 hours after induction with 1 mM IPTG. WC: whole
cells, P: pellet after lysis and centrifugation of whole cells, M: protein ladder.
plest way of achieving optimal rates of cellular metabolism is to scan a range of
temperatures. Figure 4.8 shows an SDS-PAGE gel where pET30a-PDGF R-TM-20
was expressed at 37  C, 30  C, 22  C and 15  C for 4 hours, 6 hours, 12 hours and
18 hours respectively. After harvesting cells at each temperature, some of the whole
cells (WC) were lysed and centrifuged. The resulting supernatant (S) and pellet (P)
were also run on the gel. The pellet contains the inclusion bodies. It can be observed
by looking at the pellet lanes at each temperature that the highest expression level
(highlighted in a red box) is obtained at 37  C, and it decreases as the temperature
is reduced (very little protein being expressed at 15  C). It was decided to perform
all future expression of this protein at 37  C.
4.3.5 IPTG concentration
Upon addition of isopropyl  -D-1-thiogalactopyranoside (IPTG) to a bacterial cul-
ture, it initiates the transcription of the lac operon and hence induces recombinant
protein expression when the gene is under the control of the lac operator. The final
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Figure 4.8: Expression levels of pET30a-PDGF R-TM-20 at varying temperatures
as observed on an SDS-PAGE gel. Cells were grown at 37   for 4 hours after induction
with 1 mM IPTG. WC: whole cells, P: pellet after lysis and centrifugation of whole
cells, S: supernatant after lysis and centrifugation of whole cells, M: protein ladder.
concentration of IPTG used to induce lac repressor-regulated promoters can have
a significant e↵ect on the protein yield. With certain genes, slowly inducing tran-
scription (with low IPTG concentrations) may be required to reduce the e↵ects of
certain toxic genes (Green and Sambrook, 2012). Figure 4.9 shows an SDS-PAGE
gel where pET30a-PDGF R-TM-20 was expressed with IPTG concentrations of
0.1 mM, 0.5 mM, 1 mM and 1.5 mM. The bands corresponding to the molecular
weight of the protein have been highlighted in a red box. It was found that 1 mM
yielded the strongest protein band in the whole cell and pellet fractions and all
future expressions were performed with this IPTG concentration.
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Figure 4.9: Expression levels of pET30a-PDGF R-TM-20 at varying IPTG con-
centrations as observed on an SDS-PAGE gel. Cells were grown at 37   for 4 hours
after induction with 1 mM IPTG. WC: whole cells, P: pellet after lysis and centrifu-
gation of whole cells, S: supernatant after lysis and centrifugation of whole cells
4.3.6 Media switching
Slower cell growth rates are observed when expressing recombinant proteins in M9
minimal medium as compared to LB, because the former contains a minimal num-
ber nutrients required for cells to grow. This results in reduced expression levels
due to the cytotoxic e↵ects associated with the plasmid exerting selective pressure
(Baneyx, 1999). To minimise these e↵ects, many studies have adopted the approach
of transforming, inoculating and growing cells in rich medium and then subsequently
switching to M9 minimal medium prior to inducing expression (Marley et al., 2001;
Cai et al., 1998; Sivashanmugam et al., 2009). This method capitalises on the fast
doubling rates of E. coli cells in rich media and hence greatly improves the e ciency
with which high levels of recombinant protein can be obtained. This also removes
unlabelled metabolites that can hinder growth and expression. Bacterial culture is
gently pelleted once it reaches the mid-log phase, and then washed with minimal
media without isotopic labels. It is then allowed to equilibrate in the new media
(usually for one hour) before induction.
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(a) SDS-PAGE (b) Western blot
Figure 4.10: Expression levels of pET30a-PDGF R-TM-20 after concentrating
the bacterial suspension to varying degrees. Panel (a) shows the SDS-PAGE gel
whereas B shows the anti-His western blot. Cells were grown at 37   for 4 hours
after induction with 1 mM IPTG following concentration. ⇥1, ⇥2, ⇥4 and ⇥8
represent lanes where the the culture has been concentrated to 1, 2, 4 and 8 times
their original concentration, respectively. N: non-induced whole cell.
4.3.7 High-cell-density expression
Further to switching the media prior to induction, it has also been observed that
using minimal media with labelled isotopes to resuspend the cell pellet in a fraction
of the original volume of rich media can lead to significant improvement in pro-
tein yield (Sivashanmugam et al., 2009). Figure 4.10a shows an SDS-PAGE gel of
pET30a-PDGF R-TM-20 expression after concentrating the bacterial suspension to
varying degrees prior to induction: ⇥1, ⇥2, ⇥4 and ⇥8. Improvements in expres-
sion level were seen after doubling and quadrupling the concentration factor, but
once it was raised to ⇥8 the protein did not express as can be seen in the blot in
Figure 4.10b.
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4.4 TOPO cloning of pET151-PDGF R-TM-20
As is explained in detail in section 5.2.4, the pET30a-PDGF R-TM-20 construct
proved to be infeasible for the production of high yields of PDGF R-TM-20. This
was primarily due to two issues. Firstly, pET30a has an enterokinase cleavage site
to remove an N-terminal thrombin site, S-tag and His-tag. Low e ciency cleavage
meant cleaved protein could not be produced in a cost-e↵ective manner for NMR
structural studies. Secondly, the construct also encoded for a C-terminal His-tag
which could not be cleaved; this can be problematic as the His-tag is can potentially
lead to non-preferential interactions and promote aggregation (Hammarstro¨m et al.,
2002). In light of this, it was decided that a new construct be made in the lab with
a tobacco etch virus (TEV) protease cleavage site.
4.4.1 TOPO cloning
TOPO cloning is a molecular biology technique which relies on the inherent biological
activity of DNA topoisomerase I. PCR products are cloned such that they have
CACC added at the 5’ end. As illustrated in Figure 4.11, the overhang in the
cloning vector (GTGG) covalently reacts with the 5’ end of the PCR product by
annealing to the added bases and hence inserting the PCR product in the correct
orientation.
PCR products were generated for the PDGF R transmembrane domain and 20
juxtamembrane amino acids on either side (PDGF R-TM-20) as detailed in sec-
tion 2.3.3. These were analysed using agarose gel electrophoresis (secion 2.3.4)
as shown in Figure 4.12. The resulting PCR product was observed as a band at
⇠300 bp. The gene was then purified using a gel extraction kit (section 2.3.5).
The TOPO reaction was subsequently performed by mixing the pET151 vector
and the fresh PCR product as per manufacturer’s instructions (Life Technologies,
UK).
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Figure 4.11: TOPO cloning schematic. Adapted from (Life Technologies pET
Directional TOPO Manual, 2010).
Figure 4.12: PCR products from the amplification of PDGF R-TM-20 encoding
with CACC added at the 5’ for TOPO cloning.
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4.4.2 Colony PCR
Colony PCR is a useful and convenient high-throughput method for establishing
the presence or absence of insert DNA in plasmid constructs. Chemically compe-
tent cells are transformed using the TOPO cloning reaction directly as described in
section 2.5.3. Several colonies were subsequently observed on the plate and Colony
PCR (section 2.3.8) was performed on 28 of them. Figure 4.13 shows the products of
the Colony PCR after being run on an agarose gel. Six colonies where there is clear
indication of insert DNA being amplified (marked with red arrows in Figure 4.13)
are grown in LB, their plasmids extracted and sent for sequencing. It was found that
out of the six constructs sent, only one of them had the insert in the right way round.
The DNA from the correct construct was saved for all future transformations.
Figure 4.13: Colony PCR of the transformants after TOPO cloning. Colonies
where evidence if DNA amplification was seen are marked with red arrows
4.4.3 Expression checks for PDGF R-TM-20 and TEV protease
PDGF R-TM-20
After successfully cloning the pET151-PDGF R-TM-20 construct and verifying the
presence of the PDGF R-TM-20 gene, all tags and sites, the plasmid was trans-
formed into BL21(DE3)PLysS cells as previously described (section 2.5.3). The
protein was then expressed in minimal media using the conditions optimised for the
pET30a-PDGF R-TM-20 construct. A band was observed close to the predicted
molecular weight of 10.85 kDa on the gel (Figure 4.14a) and anti-His western blot
(Figure 4.14b) indicating that the protein was expressed (bands highlighted in red
box).
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(a) SDS-PAGE (b) Western blot
Figure 4.14: Expression check for pET151-PDGF R-TM-20. Panel (a) shows the
SDS-PAGE gel whereas B shows the anti-His western blot. Cells were grown at
37  C for 4 hours after induction with 1 mM IPTG. Red box highlights the position
of the expected monomer PDGF R-TM-20 band.WC: whole cells, P: pellet after
lysis and centrifugation of whole cells, S: supernatant after lysis and centrifugation
of whole cells, M: protein ladder.
TEV protease
The PDGF R-TM-20 protein produced after expression contains a His-tag which
is cleavable at a TEV cleavage site. The TEV protease genetic construct for the
in-house production of TEV protease was present in a pRK793 plasmid which had
been transformed into E. coli BL21(DE3)-RIL cells and was expressed as detailed
in section 2.7.1. Figures 4.15a & 4.15b show the gel and the anti-His Western blots
of the expression check, respectively. It can be seen (bands highlighted in red box)
that good expression levels are obtained and all the TEV protease expressed is in
the soluble fraction.
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(a) SDS-PAGE (b) Western blot
Figure 4.15: Expression check for TEV protease. Cells were grown at 15  C
overnight after induction with 0.11 mM IPTG. WC: whole cells, P: pellet after lysis
and centrifugation of whole cells, S: supernatant after lysis and centrifugation of
whole cells, M: protein ladder.
4.5 Plasmid Stability Test
Unlike pET30a which is kanamycin resistant, the pET151 vector is ampicillin re-
sistant and as such requires that plasmid maintenance be monitored closely. This
is because the resistance protein,  -lactamase, is secreted which could result in the
complete degradation of the of ampicillin present in the bacterial culture (Robinson,
2011). Plasmid maintenance during outgrowths was examined using the plasmid
stability test, outlined in section 2.6.5. The cells were plated as outlined in the
protocol on four di↵erent plates (Table 4.1).
Plate Cells that grow
LB All viable cells
LB + antibiotic Cells that still carry the plasmid
LB + IPTG (1 mM)
Cells that have lost the plasmid or mutants that have
lost the ability to express the target gene
LB + antibiotic +
IPTG (1 mM)
Mutants that retain the plasmid but have lost the
ability to express the target gene
Table 4.1: Plasmid stability test
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Following cell outgrowths using the existing protocol, the plasmid stability test was
performed and it was observed that a large number of colonies grew in the presence
of IPTG (Figure 4.16a). This suggests the cells have lost the protein production
plasmid, because in the presence of IPTG, cells dedicate all their resources to pro-
tein production rather than cell maintenance. Approximately 45 colonies were also
observed in the presence of IPTG as well as antibiotics. While plasmids are retained
in these colonies, they have lost their ability to express the protein.
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(a) Ampicillin
(b) Carbenecillin
Figure 4.16: Plasmid stability test
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In order to minimise plasmid loss, and hence maximise protein yield, there were
three main changes that were made to the pET151-PDGF R-TM-20 expression
protocol. First, carbenecillin was substituted for ampicillin. Both ampicillin and
carbenicillin form a part of the penicillin family and hence adopt the same mode of
action in inhibiting cell wall synthesis. Carbenicillin is a carboxypenicllin whereas
ampicillin is an aminopenicillin (Figures 4.17a & 4.17b). Carbenicillin is known to
have improved stability over ampicillin when used in growth media. It demonstrates
greater resistance to heat and exhibits less degradation at low pH over time making
it particularly useful for large-scale liquid culture growth.
(a) Ampicillin structure (b) Carbenicillin structure
Figure 4.17: Structures of ampicillin and carbenicillin.
Second,  -lactamase was removed from overnight inoculants.  -lactamase, which
is expressed from the bla gene in the plasmid, hydrolyses and inactivates ampi-
cillin. It is secreted by the bacteria and hence is present in the culture medium.
If overnight inoculants are directly added to the bacterial culture, a certain pro-
portion of ampicillin is immediately deactivated from the  -lactamase present in
the overnight inoculant. In order to avoid this, overnight inoculants were gently
centrifuged and the bacterial cells were resuspended in fresh medium.
Finally, cells were harvested/induced at a lower OD600 . It was also found that at an
OD600 > 0.5, cells are much more likely to lose their plasmid. Hence, when express-
ing in minimal media, the protocol was modified to harvest all cells at an OD600
between 0.4–0.5 before expressing using the high-cell-density expression method (sec-
tion 4.3.7). When expressing in rich medium, cells were induced at an OD600 of
0.5.
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The plasmid stability was performed again after incorporating these changes into
the protocol. It can be seen in Figure 4.16b that the number of colonies which
grow in the presence of IPTG only is greatly reduced. Furthermore, no colonies are
observed in the presence of IPTG as well as antibiotics. These observations confirm
that the changes made in the protocol have improved plasmid maintenance.
4.6 Mistic-tag to facilitate protein expression
Figure 4.18: NMR structure of
Mistic. Adapted from (Roosild
et al., 2005).
Mistic was first discovered as a membrane-
associated protein in Bacillus subtilis (Roosild
et al., 2005). When used as a fusion part-
ner, it has been shown to greatly improve ex-
pression level of integral membrane proteins
by overcoming toxicity issues associated with
overloading the protein translation machinery.
It does not possess a recognisable signal se-
quence and it is likely that it by-passes E. coli
translocon machinery and autonomously asso-
ciates with the bacterial membrane (Dvir and
Choe, 2009).
It was thought that in this study, this property
of Mistic could be exploited to express PDGF R-TM-20 in the bacterial membrane.
Additionally, the enhancement of expression that this may provide could allow suf-
ficient quantities to be obtained for NMR studies. This would not only simplify the
purification procedure, but would also allow the study of the structure and dynam-
ics of the PDGF R-TM-20 dimers in native bacterial membranes using solid-state
NMR.
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4.6.1 Amplification of the PDGF R-TM-20 gene
Firstly, the PDGF R-TM-20 gene was amplified from the pET30a-PDGF R-TM-20
plasmid using the forward and reverse oligonucleotides shown in section 2.3.1. These
were designed against the template PDGF R-TM-20 sequence with the forward
primer incorporating PspXI restriction site and the reverse primer incorporating
SalI restriction site. This allowed amplification of the PDGF R-TM-20 gene by
PCR (Figure 4.19) with restriction sites at either end. A TEV protease cleavage site
was also incorporated in the reverse primer so as to cleave the His and Mistic tags.
These were then double digested with PspXI and SalI restriction endonucleases to
provide sticky ends for ligation.
Figure 4.19: Amplification of PDGF R-TM-20 gene from the pET30a-PDGF R-
TM-20 plasmid.
4.6.2 Ligation
The Mistic gene was contained in a Gateway cloning pDEST17 vector provided by
Florent Bernaudat (Institut de Biologie Structurale Jean-Pierre Ebel, CEA, Greno-
ble, France) as used previously (Bernaudat et al., 2011a) . The plasmid was trans-
formed into One Shotr ccdB SurvivalTM2 T1R Chemically Competent Cells from
Life Technologies, UK. They were then propagated in a rich medium and the plasmid
was extracted and sent for sequencing to ensure plasmid integrity.
To generate compatible sticky ends for ligation, the plasmid was double digested
with PspXI and SalI restriction endonucleases. Figure 4.20 shows an agarose gel
119
CHAPTER 4. CLONING AND EXPRESSION OF PDGF R
TRANSMEMBRANE DOMAIN
with bands close to 5114 bp and 1570 bp representing the cut plasmid and cut
fragment respectively.
Figure 4.20: The pDEST17-Mistic plasmid double digested at the SalI and PspXI
restriction sites. Bands are seen close to expected values of 5114 bp and 1570 pb
representing the cut plasmid and cut fragment respectively.
The double digested PCR products and the pDEST17-Mistic plasmid were then
mixed and ligated as per the protocol detailed in section 2.3.7. The mixture was
then used to transform E. coli TOP10 cells (section 2.5.3). Positive transformants
were grown to extract DNA, which was sent for sequencing to verify the presence of
the insert and to ensure no mutations were present.
4.6.3 Expression of pDEST17-Mistic construct
The pDEST17-Mistic-PDGF R-TM-20 construct was transformed into C43 and
BL21(DE3)PLysS cells to check for expression levels and to also ensure that the
protein was being inserted into the membrane due to the Mistic tag. Following
transformation, Mistic-PDGF R-TM-20 was expressed in rich medium in the first
instance (as per existing protocol). Figures 4.21a & 4.21b show the SDS-PAGE gel
and anti-His western blot respectively for the expression check. Even though both
cells expressed the fusion construct, disappointingly, none of it was found in the
soluble fraction following lysis which contains the bacterial membranes; all of it had
gone into inclusion bodies. However, the expression level in BL21(DE3)PLysS cells
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showed significantly higher expression levels than C43 cell line.
(a) SDS-PAGE (b) Western Blot
Figure 4.21: Expression check for pDEST17-Mistic-PDGF R-TM-20. Panel (a)
shows the SDS-PAGE gel whereas B shows the anti-His western blot. Cells were
grown at 37   for 4 hours after induction with 1 mM IPTG. Red box highlights the
position of the expected monomer band. WC: whole cells, P: pellet after lysis and
centrifugation of whole cells, S: supernatant after lysis and centrifugation of whole
cells.
This test expression was performed at 37  C. It has been observed for both BL21(DE3)
and C43 cell lines that solubility of membrane proteins and expression level can be
greatly improved by expressing the protein at lower temperatures (Berthold et al.,
2011). In light of this, further expression trials were performed at 30  C and 15  C.
Figure 4.22 shows the western blot obtained following expression. Cells were induced
for 4 hours at 37  C, 8 hours at 30  C and 24 hours at 15  C. Even though overall
expression levels were improved by lowering the temperatures to 30  C, no protein
was observed in the fraction containing the bacterial membranes. No expression was
observed at 15  C.
It is unclear why the protein was being directed to inclusion bodies despite the Mistic
tag having an overall hydrophilic composition. It could be that Mistic was not folding
properly when fused with the peptide, or it could be that PDGF R-TM-20 is unable
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to bypass the E. coli translocon machinery when fused with Mistic. Due to time
constraints, further optimisations to troubleshoot this could not be performed.
Figure 4.22: Expression of pDEST17-Mistic-PDGF R-TM-20 at various tempera-
tures observed on an anti-His western blot. WC: whole cells, P: pellet after lysis and
centrifugation of whole cells, S: supernatant after lysis and centrifugation of whole
cells.
4.7 Summary and Conclusion
This chapter focussed on methods adopted and optimisations performed to maximise
the yield of PDGF R-TM-20 such that a functionally relevant sample of PDGF R-
TM-20 could eventually be prepared for solution- and solid-state NMR spectroscopy.
A plasmid construct pET30a-PDGF R-TM-20 which had previously been used in
the Dixon lab to produce PDGF R-TM-20 for biophysical analyses was chosen as a
starting point for this purpose.
A number of cell lines were tested and it was determined that the best cell line
for expressing PDGF R-TM-20 was BL21(DE3)PLysS. The expression was subse-
quently optimised by fine-tuning the glucose concentration, temperature and IPTG
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concentration. The e↵ect on protein expression due to the addition of BME vitamins
and iron (III) chloride was also assessed. Furthermore, to maximise protein yield,
high-cell-density method of expression was adopted and optimised.
However, due to problems in cleaving the His-tag from the pET30a-PDGF R-TM-
20 construct (section 5.2.4), a related pET vector which utilises the TOPO cloning
method for entry clone insertion was chosen to take the study forward. This method
simplifies and improves the cloning process by using a cloning vector that has been
“activated” with topoisomerase I in lieu of ligase and long ligation times. Since the
TOPO cloning vector chosen, pET151, is also a pET vector, it was hoped that similar
level of expression would be obtained using the optimisations that were performed
on the pET30a vector. This was indeed the case; however, since pET151 carries the
gene for AmpR in place of KanR, it was necessary to ensure plasmid stability as
ampicillin is much more susceptible to degradation than kanamycin. This was done
by doing plasmid stability tests and modifying the expression protocol to ensure
plasmid maintenance. Since the pET carries the TEV protease cleavage site, it was
also ensured that su cient quantities of TEV protease can be produced using the
in-house construct.
Another avenue which was explored to express PDGF R-TM-20 in bacterial mem-
branes was fuse it with a Mistic-tag which has been known to by-pass E. coli translo-
con machinery and directly associate with the inner bacterial membrane. This would
simplify the purification procedure and also grant the added potential of being able
to look at the structural properties of PDGF R-TM-20 in native membranes using
solid-state NMR. Traditional cloning procedures were followed to create a genetic
construct which expresses PDGF R-TM-20 fused with Mistic. However, the fusion
construct only expressed as inclusion bodies despite some optimisations to increase
the solubility of the protein.
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Chapter 5
PDGF R-TM-20 Purification,
Sample Preparation and
Characterisation
5.1 Introduction
In the previous chapter, protocols and strategies were outlined that were optimised to
obtain the maximum yields of PDGF R-TM-20 for NMR analyses. This chapter will
begin by detailing the methods adopted for the purification of the PDGF R-TM-20.
Particularly, there will be a focus on the problems encountered in cleaving the His-tag
from the protein and how they were overcome. Furthermore, the protocols devised
for the reconstitution of PDGF R-TM-20 into membrane mimetics for solution-
and solid-state NMR will be presented along with some preliminary biophysical
characterisation of the samples.
As explained in the previous chapter, there were two plasmid constructs used to ex-
press PDGF R-TM-20: pET30a-PDGF R-TM-20 and pET151-PDGF R-TM-20.
The former produced a protein which contained a proteolytic cleavage site for recom-
binant enterokinase (rEK) and the latter contained a TEV protease cleavage site.
These will henceforth be referred to as rEK-PDGF R-TM-20 and TEV-PDGF R-
TM-20 respectively.
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5.2 Purification and Cleavage of rEK-PDGF R-TM-20
5.2.1 The purification strategy
The protocol used previously in the lab for preparing PDGF R-TM-20 in deter-
gent micelles from inclusion bodies involved a series of purification steps to obtain
PDGF R-TM-20–His6. The expression region in pET30a-PDGF R-TM-20 encodes
for the following sequence:
His6–S-tag–thrombin–enterokinase–PDGF R-TM-20–His6 .
The purification protocol involved solubilising the rEK-PDGF R-TM-20 inclusion
bodies in Guanidine HCl and then performing IMAC followed by on-column refolding
of the protein using n-Dodecyl  -D-maltoside (DDM). The purified protein was then
cleaved using recombinant enterokinase yielding His6–S-tag–thrombin–enterokinase
and PDGF R-TM-20–His6. Pure PDGF R-TM-20–His6 was then obtained by pass-
ing the mixture through an S-tag column.
5.2.2 Purification of rEK-PDGF R-TM-20
The protein was first expressed in LB and trial purifications were carried out as
per the existing protocol with two exceptions. Firstly, the choice of detergent was
changed to n-Decyl  -D-maltoside (DM) as it has a ten-fold higher critical micelle
concentration (CMC) and hence could be more easily removed through dialysis for
reconstitution into lipid bilayers. Secondly, the denaturing agent was changed to
urea in lieu of Guanidine HCl as the latter precipitates in the presence of SDS and
leads to various artefacts on an SDS-PAGE gel making the monitoring of expensive
labelled proteins in solution di cult.
The protocol has been outlined in detail in section 2.6.2. Aliquots were taken at
each stage of the purification and run on an SDS-PAGE gel followed by a western
blot (Figures 5.1a & 5.1b respectively). Several observations were made during the
trial purifications. First, it was seen (Lane 5, Figure 5.1b) that upon leaving the
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(a) SDS-PAGE
(b) Western Blot
Figure 5.1: Purification of rEK-PDGF R-TM-20. Panel (a) shows the SDS-PAGE
gel whereas B shows the anti-His western blot. Lane 1: supernatant after lysis and
centrifugation, Lane 2: pellet after lysis and centrifugation, Lane 3: supernatant
after centrifuging again, Lane 4: supernatant after solubilisation of inclusion bodies
in urea and centrifugation, Lane 5: pellet after solubilisation of inclusion bodies in
urea and centrifugation, Lane 6: 1st flow-through with DM in bu↵er , Lane 7: 2nd
flow-through with DM in bu↵er, 8 = 3rd flow-through with DM in bu↵er + 10 mM
imidazole, Lane 9–12: flow-throughs with DM in bu↵er + 300 mM imidazole, Lane
13: MES wash, Lane 14: dH2O wash. The positions of monomer, dimer and trimer
are marked with *, ** and *** respectively.
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inclusion bodies in urea for ⇠2 hours as per protocol for GnHCl, not all of them were
solubilised. It was observed in subsequent purifications that leaving the inclusion
bodies in urea solution in an end-over-end mixer overnight completely solubilised
them. Using urea instead of GnHCl was particularly useful in ensuring that all of
the labelled proteins had been extracted through IMAC purification when employing
batch binding.
After purification through IMAC, several bands were observed on the SDS-PAGE gel
which do not correspond to the protein of interest and are indicative of non-specific
binding to the resin (Lanes 9–12, Figure 5.1a) . This was significantly reduced by
making three changes. Firstly, 10 mM imidazole was added to the solution during
binding to the resin. Secondly, the imidazole concentration was increased during the
wash stage from 10 mM to 25 mM. Thirdly, the wash volume was increased from
1 column volume to 10 column volumes. All of these changes showed no deleterious
e↵ects on protein yield.
The volume of elution bu↵er was increased due to residual protein bound to the
resin after passing three column volumes of elution bu↵er through it (Lane 13,
Figure 5.1b). Six column volumes ensured complete elution of the protein.
Bio-Beads could also be employed to remove detergent as the protein is reconstituted
into liposomes. The ideal detergent for this purpose is Triton X-100 and purification
was also carried out using Triton X-100 without any loss of protein yield. Indeed,
the protein exhibited greater long term stability in Triton X-100.
5.2.3 Protein quantification using BCA assay
Concentrations of both PDGF R-TM-20 and the TEV protease were calculated
using the BCA assay as detailed in section 2.8.6. Protein concentration was cal-
culated by determining the gradient of the standard curve (m) and applying the
formula:
Concentration x = A562m
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where A562 is the absorbance at 562 nm. Figure 5.2 shows a typical BCA assay
standard curve.
Figure 5.2: A typical BCA assay standard curve obtained by measuring the known
concentrations of BSA
5.2.4 Site-specific enzymatic cleavage of rEK-PDGF R-TM-20
As mentioned earlier, the pET30a plasmid expressed PDGF R-TM-20 with tags
cleavable by recombinant enterokinase (rEK). Initially, an enterokinase cleavage
capture kit was used to test for cleavage of rEK-PDGF R-TM-20 in Triton X-100
detergent. The cleavage of 20 µg, 50 µg and 100 µg of the protein was tested with
a single unit of enterokinase as per the manufacturer’s instructions. Aliquots were
taken out at 2, 4, 8 and 16 hours after starting the reaction.
An SDS-PAGE gel was run for each of the aliquots and is shown in Figure 5.3.
The theoretical masses for the uncleaved protein, cleaved protein and cleaved tag
are 13.86 kDa, 9.46 kDa and 4.40 kDa respectively. Complete cleavage was only
observed after 16 hours for 20 µg and 50 µg of protein. This would suggest that the
entire cleavage kit (50 units) can only cleave 2.5 mg of protein. To ensure that the
low cleavage e ciency was not due to the degradation of the protease, a new kit was
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Figure 5.3: rEK-PDGF R-TM-20 cleavage using enterokinase after 2, 4, 8 and
16 hours for 20 µg, 50 µg and 100 µg of the protein. U: Uncleaved rEK-PDGF R-
TM-20, P: cleaved PDGF R-TM-20, T: cleaved tag. Lane C represents the control
with no protease.
also tested. Figure 5.4a shows the anti-His western blot obtained after performing
the cleavage reaction on 50 µg and 100 µg of the protein with 1 unit of enterokinase
for 16 hours. Even though the cleaved protein is His-tagged, the cleaved protein
could not be observed on the blot. The same blot was developed with C-terminal
specific anti-His antibody and the cleaved protein could be observed on the blot
(Figure 5.4b). However, no improvement in cleavage e ciency was observed; 100 µg
of the protein could still not be cleaved with 1 unit of the enterokinase. Such low
cleavage e ciency renders this protocol of producing large quantities of PDGF R-
TM-20 for NMR studies infeasible.
In light of this, a new plasmid with a TEV cleavage site was introduced. This choice
was based on the fact that TEV was currently being produced in the lab in large
quantities in an economical manner. This also allowed the non-cleavable C-terminal
His-tag to be removed for simplicity of purification.
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(a) rEK cleavage using anti-
His antibody
(b) rEK cleavage using
C-terminal specific anti-His
antibody
Figure 5.4: rEK-PDGF R-TM-20 cleavage using enterokinase after 16 hours at
room temperature for 50 µg and 100 µg of the protein. Lane C represents the control
with no protease.
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5.3 Purification and Cleavage of TEV-PDGF R-TM-20
5.3.1 The purification strategy
The protocol used for the purification of TEV-PDGF R-TM-20 was exactly the
same as that used for rEK-PDGF R-TM-20, detailed in section 5.2.2. The expres-
sion region in pET151-PDGF R-TM-20 encodes for the following sequence:
His6–V5-tag–TEV–PDGF R-TM-20.
The strategy was to add TEV protease to the purified protein in a 1 : 1 ratio
and, after cleavage, remove the cleaved tag plus the His-tagged TEV protease using
IMAC.
5.3.2 Purification of TEV-PDGF R-TM-20
Purification after expression of TEV-PDGF R-TM-20 was performed as described
in section 2.6.2. Aliquots were collected at each stage of the purification and run on
an SDS-PAGE gel (Figure 5.5). A clear thick band can be seen in the elution lanes
close to the expected molecular weight of 10.85 kDa.
5.3.3 Purification of TEV protease
TEV protease was purified as detailed in section 2.7.2. Aliquots were taken from the
washing steps as well as the elution steps and run on an SDS-PAGE gel and western
blotted (Figures 5.6a & 5.6b). Pure TEV indicated by an (*) can be observed
in the elution lanes 2 & 3 along with a dimer species indicated by an (**). This
construct of TEV employs a maltose-binding-protein (MBP) fusion partner which
self-cleaves post-expression. The monomer and dimer bands for this can also be
observed, indicated with (+) and (++) respectively.
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Figure 5.5: Purification of TEV-PDGF R-TM-20. Lane 1: supernatant after lysis
and centrifugation, Lane 2: supernatant after inclusion body wash, Lane 3: after
filter sterilisation, Lane 4: protein remaining in solution after first batch-binding,
Lane 5: wash and on-column refolding using Triton X-100, Lane 6: 25 mM imidazole
wash, Lane 7: elution using 300 mM imidazole, Lane 8: protein remaining in solution
after first second batch binding step, Lane 9: wash and on-column refolding using
Triton X-100, Lane 10: 25 mM imidazole wash, Lane 11: elution using 300 mM
imidazole, Lane 12: MES wash. Position of the TEV-PDGF R-TM-20 band is
marked with a red arrow.
(a) SDS-PAGE (b) Western Blot
Figure 5.6: Purification of TEV. Panel (a) shows the SDS-PAGE gel whereas B
shows the anti-His western blot. Lane 1: wash elution (1st batch), Lane 2: Protein
elution (1st batch), Lane 3: wash elution (2nd batch), Lane 4: protein elution (2nd
batch). Lane 5: MES wash. TEV protease monomer and dimer indicated by * and
** respectively. Cleaved MBP fusion partner monomer and dimer indicated by +
and ++ respectively.
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5.3.4 Site-specific enzymatic tag-cleavage of TEV-PDGF R-TM-20
using MBP-TEV
After both TEV-PDGF R-TM-20 and TEV protease were purified, they were mixed
together in a 1 : 1 protein to protease molar ratio to perform the cleavage reaction
at room temperature overnight. Aliquots were collected and run on an SDS-PAGE
gel (Figure 5.7). It was observed that after leaving the mixture overnight at room
temperature, cleavage of the tag had occurred. The TEV-PDGF R-TM-20 band
close to the expected molecular weight value of 10.85 kDa (indicated with U in
Figure 5.7) had largely disappeared and a new band near the theoretical molecular
weight value of 7.83 kDa for the cleaved protein appeared (indicated with C in
Figure 5.7). A second IMAC step was performed to remove the tags and obtain
pure PDGF R-TM-20. The TEV protease and the cleaved tag from TEV-PDGF R-
TM-20 were removed completely. However, the cleaved MBP fusion partner was not
removed after the second IMAC step.
Figure 5.7: Proteolytic cleavage of TEV-PDGF R-TM-20. Lane 1: purified un-
cleaved TEV-PDGF R-TM-20. Lane 2: TEV protease solution, Lane 3: post-
cleavage reaction, Lane 4: After final IMAC. U: uncleaved TEV-PDGF R-TM-20,
C: cleaved TEV-PDGF R-TM-20
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Separation of TEV protease from MBP using gel-filtration chromatogra-
phy
Since MBP could not be removed from the cleavage reaction, an attempt was made
to remove the MBP from the TEV protease purified solution using gel-filtraton
chromatography as this method had been employed previously by others (Tropea
et al., 2009). Absorbance at 280 nm and 220 nm was monitored in the chromatogram,
and aliquots were taken from the fractions which were thought to contain the TEV
protein. These were then run on an SDS-PAGE gel and can be seen in Figure 5.8.
Unfortunately, MBP was co-eluting with TEV protease throughout the separation
and could not be separated.
Figure 5.8: Gel-filtration profile of the TEV/MBP mixture
Cleavage attempts using TEV protease from other sources
In light of the above, it was decided to obtain TEV protease from another source
and test the cleavage e ciency, in the first instance. One batch of TEV protease
was obtained from Dr David Roper’s group at the University of Warwick and the
other was a commercially available TEV protease purchased from Sigma Aldrich,
UK. Cleavage reactions were initiated with 1 : 1, 1 : 2, 1 : 5 and 1 : 10 TEV
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protease to TEV-PDGF R-TM-20 ratios. Aliquots were taken after 16 hours and
run on an SDS-PAGE gel (Figure 5.9). Unfortunately, the commercially available
TEV protease did not cleave at all. The TEV protease from Dr David Roper’s only
showed signs of cleavage when added in a 1 : 1 ratio.
Figure 5.9: Proteolytic cleavage of TEV-PDGF R-TM-20. Lane 1: purified un-
cleaved TEV-PDGF R-TM-20. Lanes 2–5: TEV from Dr David Roper’s lab with
TEV protease to TEV-PDGF R-TM-20 ratios of 1 : 1, 1 : 2, 1 : 5 and 1 : 10, Labes
6–9: TEV from Sigma Aldrich with TEV protease to TEV-PDGF R-TM-20 ratios
of 1 : 1, 1 : 2, 1 : 5 and 1 : 10. U: uncleaved TEV-PDGF R-TM-20, C: cleaved
TEV-PDGF R-TM-20
Purification of MBP/TEV mixture using amylose resin
MBP has been used as a fusion protein in expressing proteins for decades and purifi-
cation of these proteins has often exploited the MBP’s a nity for amylose (di Guana
et al., 1988; Maina et al., 1988). It was proposed that MBP-TEV mixture could be
passed through an amylose column allowing the MBP to preferentially bind to the
amylose resin and hence removing it from the solution. Aliquots were collected and
an SDS-PAGE gel was run (Figure 5.10). Unfortunately, not only did all of the
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MBP bind to the amylose resin, but all of the TEV also bound irreversibly to the
resin and hence could not be separated from the MBP using this method.
Figure 5.10: TEV protease purification from MBP using amylose resin. Lane 1:
untreated TEV/MBP mixture, Lane 2: after passing through amylose resin. Lane
3: elution with 50 mM maltose.
Removal of MBP using centrifugal concentrators
It was also proposed that the large di↵erence in molecular weight could be ex-
ploited to separate PDGF R-TM-20 from MBP following the cleavage reaction.
This could be performed using centrifugal concentrators with a molecular weight
cut-o↵ of 50 kDa, bearing in mind that MBP is ⇠42.5 kDa and the PDGF R-TM-
20/Triton X-100 micelle is > 90 kDa. Two separate concentrators were used, one
with a PES membrane and the other with a cellulose membrane. Aliquots were
collected before and after conecntration and run on an SDS-PAGE gel followed by a
western blot as shown in Figures 5.11a & 5.11b. It was observed that separation did
not occur using centrifugal concentrators with either of the membranes (Lanes 8 and
10). Furthermore, after centrifugation, at higher concentrations, the cleaved protein
ran through the gel a bit more slowly than expected and the protein band (indi-
cated by an asterisk (*)) was observed at a higher molecular weight. No proteins
were observed in the filtrate.
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(a) SDS-PAGE (b) Western Blot
Figure 5.11: TEV protease purification using centrifugal concentrators. Panel (a)
shows the SDS-PAGE gel whereas B shows the anti-His western blot. Lane 1: puri-
fied uncleaved TEV-PDGF R-TM-20, Lane 2: purified MBP-TEV, Lane 3: before
cleavage, Lane 4: after cleavage, Lane 5: post-cleavage IMAC (first elute), Lane
6: post-cleavage IMAC (second elute), Lane 7: MES wash, Lane 8: after concen-
trating (PES membrane), Lane 9: filtrate, Lane 10: after concentrating (cellulose
membrane), Lane 11: filtrate.
5.3.5 Site-specific enzymatic tag-cleavage of TEV-PDGF R-TM-20
using GFP-TEV
Since TEV protease exhibits poor solubility when expressed in bacteria, the MBP
tag has traditionally been employed to increase the solubility and expression level of
TEV protease in E. coli. More recently, however, it has been found that even higher
levels of TEV protease can be expressed if it is tagged with green fluorescent protein
(GFP) (Wu et al., 2010). Additionally, the TEV protease is fully active with the
GFP tag bound and there is no need to cleave it from the TEV protease, as opposed
to MBP-TEV protease which self-cleaves in vivo after expression.
The expression construct for GFP-TEV protease was obtained from Dr Kelley More-
men at the University of Georgia, USA. This construct was expressed at high levels
and cleavage was tested. Aliquots were collected at each stage of the cleavage and
run on an SDS-PAGE gel (Figure 5.12a). A anti-His western blot (Figure 5.12b) was
also performed to monitor cleavage after adding an excess of GFP-TEV to TEV-
PDGF R-TM-20. It can be seen in the western blot that complete cleavage occurred
overnight at room temperature (Lane 3). After a second round of IMAC, the cleaved
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tag and GFP-TEV were removed to yield purified PDGF R-TM-20.
(a) SDS-PAGE (b) Western Blot
Figure 5.12: TEV-PDGF R-TM-20 cleavage using GFP-TEV. Panel (a) shows
the SDS-PAGE gel whereas B shows the anti-His western blot. Lane 1: purified un-
cleaved TEV-PDGF R-TM-20, Lane 2: purified GFP-TEV, Lane 3: after overnight
cleavage, Lane 4: after second IMAC, Lane 5: 20 mM Imidazole wash #1, Lane
6: 20 mM Imidazole wash #2, Lane 7: 40 mM Imidazole wash, Lane 8: MES
wash #1, Lane 9: MES wash #1. U: uncleaved TEV-PDGF R-TM-20, C: cleaved
TEV-PDGF R-TM-20, T: cleaved tag.
In order to maximise the use of GFP-TEV protease, a range of di↵erent protein to
protease ratios were tested. An aliquot was taken from each of the reactions and
run on an SDS-PAGE gel (Figure 5.13). It was found that at protein to protease
ratio of 1 : 10 (Lane 5)was optimal for cleavage.
The tag and the TEV protease were removed from the solution using IMAC. The re-
sulting PDGF R-TM-20 in Triton X-100 solution was concentrated tenfold through
a centrifugal concentrator and run on a gel, as the protein band after cleavage is
very broad and di cult to visualise. After centrifugation, five clear bands were
observed in positions corresponding to higher order oligomers of PDGF R-TM-20
(Figure 5.13, Lane 8). To confirm this, the bands in the gel were sent for mass spec-
trometry analysis as detailed in section 2.8.5. Mass spectrometry analysis revealed
that each of the bands represented various oligomeric states of PDGF R-TM-20
(Figure 5.14). Even though SDS-PAGE shows the presence of higher order oligomers
at these high concentration, it has been shown that PDGF R-TM exists primarily
as dimers in detergent micelles as well as lipid vesicles. (Muhle-Goll et al., 2012).
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Figure 5.13: GFP-TEV protease cleavage observed on an SDS-PAGE gel to ensure
cleavage optimisation. Lane 1: purified uncleaved TEV-PDGF R-TM-20, Lanes 2–
7: GFP-TEV cleavage reactions at a protease to protein ratios of 2 : 1, 1 : 1,
1 : 2, 1 : 10, 1 : 30 and 1 : 60 respectively, Lane 8: concentration of cleaved
PDGF R-TM-20, Lane 9: Filtrate after centrifugal concentration. U: uncleaved
TEV-PDGF R-TM-20, C: cleaved TEV-PDGF R-TM-20
.
The methods and sample protocols developed here were used to prepare samples for
biophysical characterisation.
Figure 5.14: Mass spectrometry analysis of PDGF R-TM-20 oligomers.
5.4 Sample Preparation for Solid-State NMR
5.4.1 Choice of lipids
It has been observed previously that the PDGF  receptor is localised to lipid rafts
(Pike, 2005) which are cholesterol-rich, highly ordered regions in the membrane with
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a high proportion of saturated fatty acyl chains. It has further been hypothesised
that the thickness of the membrane controls the ability of the PDGF R-TM domain
to dimerise, and that the activation of the receptor may require its relocation to
membrane-thick regions in the form of lipid rafts (Muhle-Goll et al., 2012).
For reconstitution of PDGF R-TM-20 into liposomes, three di↵erent lipids (with
di↵erent chain lengths and saturation) were used to check how well they would
pellet with ultracentrifugation: DMPC (C14:0), POPC (C16:0/C18:1) and DEPC
(C22:1 (cis)). Knowing this property was important to assess whether they could be
centrifuged into a solid-state NMR rotor. Figure 5.15 shows proteoliposome pellets
in 1.5 mL ultracentrifuge tubes which have been spun at 267,000 ⇥ g for 45 minutes.
DMPC and POPC liposomes formed dense pellets while DEPC liposomes did not
pellet. DEPC lipids have the longest chains out of the three lipids, and hence would
be useful in mimicking thick lipid rafts, but the PDGF R-TM in POPC lipids has
also been shown to have a tilt angle of 20   consistent with the dimeric species
obtained in DPC micelles (Muhle-Goll et al., 2012). Hence POPC lipids were used
for reconstituting PDGF R-TM-20 into liposomes for CD and NMR analyses.
Figure 5.15: Ultracentrifugation of various liposomes.
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5.4.2 Reconstitution of PDGF R-TM-20 into lipid vesicles
After PDGF R-TM-20 was purified and cleaved as per the aforementioned proto-
col, the detergent was removed and the protein reconstituted into liposomes using
Bio-BeadsTMSM-2 Resin as described in section 2.10.2. The equilibrium and kinetic
aspects of reconstitution through the use of Bio-BeadsTMhas been extensively stud-
ied (Holloway, 1973; Le´vy et al., 1990) and its e ciency in removing Triton X-100
has been established (Allen et al., 1980). Furthermore, removal of detergent using
Bio-Beads also allowed us to control the size of the liposomes formed, since their size
is strongly dependent on the rate of detergent removal (Le´vy et al., 1990).
To ensure that all detergent was removed following treatment with Bio-Beads, 1H
NMR spectra were acquired by solution-state NMR before and after detergent re-
moval. Particular attention was paid to characteristic peaks of Triton X-100 such
as the two aromatic peaks near 7 ppm (Figure 5.16a). Peaks arising from the bu↵er
were also considered by acquiring 1H NMR spectra of the bu↵er on its own and
in the presence of detergent-solubilised lipids. As the detergent is removed and li-
posomes are formed, the turbidity of the solution increases and was monitored to
check the rate of liposome formation. The 1H NMR spectrum of the final suspension
after the removal of the beads revealed the absence of Triton X-100 detergent peaks
(Figure 5.16b).
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(a) 1H NMR spectrum of Triton X-100 micelles in water
(b) 1H NMR spectrum after the removal of Triton X-100
Figure 5.16: Removal of Triton X-100 monitored using 1H NMR spectra on a
500 MHz spectrometer at room temperature. Panel (a) shows the spectrum before
removal and (b) shows the spectrum after removal.
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5.4.3 Circular Dichroism (CD) spectroscopy
The secondary structure of PDGF R-TM-20 was measured using CD experiments.
CD is a commonly used biophysical technique for the determination of secondary
structure of proteins and peptides and detects the di↵erential absorption of circularly
polarised light. Certain spectral signatures readily indicate an ↵-helical fold, and
fitting software can be used to determine the relative percentages of ↵-helix,  -sheet
and random-coil in the sample.
Purification was performed in a 20 mM HEPES bu↵er, but this bu↵er led to scat-
tering at wavelengths below 200 nm. A literature search revealed that sodium phos-
phate, Tris and sodium acetate do not produce scattering (Kelly et al., 2005). In
light of this, the protein samples were exchanged to 20 mM sodium phosphate bu↵er,
pH 7.5 using a PD10 column. CD measurements were then carried out as detailed
in section 2.11.
Initial CD characterisation of PDGF R-TM-20 was performed in Triton X-100 and
can be seen in Figure 5.17a. Visual inspection reveals the presence of bands at
210 nm and 222 nm indicative of predominant ↵-helical structure. Bands at these
wavelengths are also observed when PDGF R-TM-20 is embedded in a POPC bi-
layer, as can be seen in Figure 5.17b.
The CD data were also analysed using a fitting software (DichroWeb, CDSSTR)
(Whitmore and Wallace, 2004) which confirms a predominantly ↵-helical fold for
PDGF R-TM-20 in both Triton X-100 detergent and POPC bilayers. Table 5.1
shows the percentage distribution of secondary structure features obtained from
DichroWeb using the K2D algorithm with reference set 4 (190-240 nm), where 74.9%
of the protein is predicted to be in an ↵-helical conformation in Triton X-100 and
68.4% of the protein is predicted to be in an ↵-helical conformation in POPC bilayers.
These results indicate that the protein is well-folded within POPC bilayers and
suitable for further analysis through solid-state NMR.
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Membrane mimetic ↵-helix (%)  -sheet (%) Turns (%) Unordered (%)
Triton X-100 74.9 0 9.4 14.6
POPC 68.4 0 13.9 17.7
Table 5.1: Secondary structure percentage distribution for PDGF R-TM-20 in
membrane mimetics according to DichroWeb.
(a) CD spectrum for PDGF R-TM-20 in Triton X-100
(b) CD spectrum for PDGF R-TM-20 in POPC liposomes
Figure 5.17: CD for spectra for PDGF R-TM-20 in membrane mimetics. For both
measurements, ⇠0.25 mg/mL of the peptide in a bu↵er containing 20 mM sodium
phosphate, 20 mM NaCl at pH 7.4) was used.
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5.4.4 Labelling strategy and initial NMR results
A recently developed labelling strategy that relies only on the use of [1-13C]glucose
and [2-13C]glucose (Loquet et al., 2010) has been used to successfully acquire a high-
resolution NMR structure of type III secretion system needles in bacteria which had
previously not been amenable to structural studies at the atomic level (Loquet et al.,
2012; Demers et al., 2014). This sparse-labelling scheme greatly improves spectral
resolution and many of the cross-peaks can be assigned to long-range distance re-
straints.
With this strategy in mind, a sample of PDGF R-TM-20 was expressed with [1-
13C]glucose as the sole carbon source during expression. The protein was reconsti-
tuted into POPC liposomes (see section 2.10.2 for details) and then pelleted into
an MAS ssNMR rotor for analysis using 13C–13C correlation experiments. The ex-
perimental parameters and set up for solid-state NMR experiments were optimised
as for the Neu* peptide (section 3.7). After collecting an alanine CP spectrum for
controls and optimising CP on [1-13C] PDGF R-TM-20 in POPC liposomes, 2D
MAS ssNMR DARR experiments were performed.
A 2D 13C–13C DARR spectrum obtained using a 150 ms mixing time is shown in
Figure 5.18. The strong signals on the diagonal are due to either the labelled amino
acids in PDGF R-TM-20 or from natural abundance 13C present in POPC lipids.
A limited number of cross-peaks are also observed on either side of the diagonal,
in both the aliphatic and carbonyl regions of the spectrum. However, these peaks
were significantly fewer in number than expected. Furthermore, the signal to noise
ratio was so low that the experiment had to be performed for 6 days in order for
signals to be observable above the noise. This poor S/N could be due to ine cient
reconstitution of the protein into membrane bilayers or dynamics and conformational
exchange within the bilayer on an intermediate timescale.
Unfortunately, it was not possible to obtain any distance restraints using this spec-
trum, and the low signal to noise ratio made further experiments infeasible. Trou-
bleshooting needs to be performed before proceeding further; however, this could
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not be done due to the limited timeframe of this project.
Figure 5.18: 2D 13C–13C DARR correlation spectrum of PDGF R-TM-20 in
POPC liposomes, acquired over 6 days with a mixing time of 150 ms. Spectra
were recorded at 500 MHz spectrometer with 8.5 kHz MAS at 10  C with 552 scans.
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5.5 Sample Preparation for Solution-State NMR
While solid-state NMR is an invaluable technique in terms of probing the struc-
ture and dynamics of membrane proteins in bilayers, more traditional solution-state
NMR methods can still yield crucial structural and mechanistic insights into mem-
brane protein function and interactions, bypassing the di culties that stymie ssNMR
analyses. As was explained in section 4.1, PDGF R interacts with E5 from bovine
papillomavirus but the molecular details of this interaction are poorly understood.
Studying this interaction in detergent micelles would yield the first direct evidence
that E5 binds to the TM of PDGF R and shed new light on the binding interface. In
the first instance, it was decided to continue investigations with the His-tag attached
to the protein construct as that would significantly reduce sample preparation time
and ease further investigations.
5.5.1 Purification of PDGF R-TM-20
In pursuit of information relating to E5/PDGF R-TM interaction, a protocol for the
purification of PDGF R-TM-20 was developed to prepare samples in detergent mi-
celles (or mixed micelles) for solution-state NMR analysis. This has been explained
in detail in section 2.6.3 and involved purifying the protein in a chaotropic agent
such as urea, followed by dialysis and an additional HPLC purification step.
SDS-PAGE gels suggested that the protein was largely pure post-dialysis (Fig-
ure 5.19), however, initial NMR screening revealed poor solution behaviour leading
to broad NMR peaks in the 1H–15N HSQC spectrum (Figure 5.20a). An additional
HPLC step lead to reduction of noise and improved NMR peak shape and intensity
(Figure 5.20b). Furthermore, it was found that the protein powder obtained af-
ter HPLC dissolved more readily circumventing dissolution issues encountered when
dissolving the protein powder directly after dialysis.
HPLC purification was performed as detailed in section 2.6.3 with a semi-preparative
C4 reverse-phase HPLC column. The chromatographic profile shown in Figure 5.21
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Figure 5.19: SDS-PAGE gel of PDGF R-TM-20 before and after HPLC purifica-
tion. Lane 1: before HPLC purification, Lane 2: after HPLC purification.
(a) HSQC before HPLC (b) HSQC after HPLC
Figure 5.20: 1H–15N HSQC spectra before and after the introduction of an ad-
ditional HPLC step in the purification process. Data was acquired at 37  C on a
750 MHz spectrometer. PDGF R-TM-20 was dissolved in a 20 mM sodium phos-
phate bu↵er with 100 mM DPC detergent at pH 6.8.
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was obtained, measuring absorbance at 280 nm.
Figure 5.21: HPLC chromatogram for the purification of PDGF R-TM-20. Peak
containing the protein is marked with an asterisk (*).
Mass spectrometry was performed on HPLC fractions obtained corresponding to
major peaks in the chromatogram. The peak at 35 minutes (marked with (*)) was
found to contain PDGF R-TM-20. Figure 5.22a shows the mass spectrum of 15N
labelled PDGF R-TM-20 with various charge states and Figure 5.22b shows the
corresponding deconvoluted spectrum with a peak for PDGF R-TM-20 at a mass
of 11038.68 Dam which agrees well with the expected mass of 11037.78 Da.
All subsequent NMR samples were prepared by directly dissolving PDGF R-TM-20
into the detergent bu↵er solution up to the required concentration. The concentra-
tions were measured using Beer-Lambert law.
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(a) Mass spectrum of PDGF R-TM-20
(b) Deconvoluted mass spectrum of PDGF R-TM-20
Figure 5.22: Assessment of purified PDGF R-TM-20 through ESI-MS. Pooled
fractions from the HPLC purification were checked for the existence of the protein
and it’s purity. The top panel (a) shows the mass spectrum with multiple charge
states of the protein. The bottom panel (b) shows the deconvoluted spectrum with
a major peak corresponding to the theoretical mass of PDGF R-TM-20 protein.
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5.5.2 Purification of E5
A peptide corresponding to the TM domain of E5:
KKKFLGLVAAMQLLLLLFLLLFFLVYWDHK
was ordered from a commercial manufacturer, and provided in a crude form con-
taining truncated products and protecting groups from the solid-phase synthesis. It
was purified using reverse-phase HPLC (RP- HPLC) as detailed in section 2.6.3 and
then analysed by mass spectrometry.
Elution fractions corresponding to major peaks in the HPLC chromatogram (Fig-
ure 5.23) were collected and pooled. The peak at around 46.3 minutes (marked
with (*)) was found to contain E5. This was deduced from the mass spectrometry
data (Figures 5.24a & 5.24b) which revealed a peak at 3662.2 Da in the deconvoluted
spectrum, which is in good agreement with the theoretical mass of 3664.60 Da.
Figure 5.23: HPLC chromatogram for the purification of E5
The pure E5 peptide was stored in TFE. The concentration was measured using ab-
sorbance at 280 nm and Beer-Lambert Law. E5 was then titrated into the PDGF R
sample by first drying it under a stream on nitrogen such that a thin film was
formed. This film was then dissolved in a solution containing PDGF R-TM-20 in
DPC/DPPC mixed micelles.
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(a) Mass spectrum of E5
(b) Deconvoluted mass spectrum of E5
Figure 5.24: Assessment of purified E5 through ESI-MS. Pooled fractions from the
HPLC purification were checked for the existence of the peptide and it’s purity. The
top panel (a) shows the mass spectrum with multiple charge states of the protein.
The bottom panel (b) shows a major peak corresponding to E5.
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5.6 Summary and Conclusion
This chapter began by detailing the modifications that were carried out to purify
PDGF R-TM-20 which was expressed using an existing plasmid construct with
an (rEK) enterokinase cleavage site. This was important because even though a
protocol existed in the Dixon lab for the purification of unlabelled PDGF R-TM-20,
it needed to be ensured that yields were maximised when the protein was expressed
in expensive labelled media. The changes involved switching the chaotropic agent
to urea, changing the volumes of elution and wash bu↵ers and the concentration of
imidazole in them. Also, the choice of detergent was changed to Triton X-100 as it
could easily be removed using Bio-Beads for reconstitution into lipid bilayers.
It was subsequently observed that despite optimising the cleavage conditions, it
would not be economically feasible to use rEK for cleavage for the quantities of
protein required for NMR. Additionally, the construct contained an uncleavable C-
terminal His-tag whose removal would require genetic manipulation. In light of these
di culties, a new construct was created using TOPO cloning with a His-tag cleavable
using TEV protease. The construct was created exactly as per requirements and
TEV protease was chosen because protocols existed in the lab to produce it in large
quantities in an economically e cient manner.
However, it soon became apparent that the self-cleaving MBP which is produced
when expressing TEV protease cannot be removed from the sample using any of the
purification methods that were tried (section 5.3.4). A GFP-tagged TEV protease
was then acquired which resolved this issue and samples could finally be made for
NMR analyses.
A protocol for the reconstitution of PDGF R-TM-20 into liposomes using Bio-Beads
was adopted which monitored the removal of detergent using solution-state NMR.
Insertion and secondary structure classification was studied using CD which revealed
a highly helical structure of the protein within Triton X-100 detergent and POPC
liposomes.
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Two-dimensional 13C–13C DARR correlation spectra were acquired of the liposomes
after inserting PDGF R-TM-20 labelled with [1-13C]glucose. Peaks were observed
in the aliphatic as well as carbonyl regions of the spectrum. However, not only
was the signal to noise ratio very low, but the number of peaks were significantly
lower than expected such that meaningful distance restraints could not be obtained.
This necessitated a re-examination of several aspects of the sample preparation
process. It may be that instead of spontaneously inserted into the membrane upon
detergent removal, a certain percentage of the protein is aggregating. Approaches
to circumvent this could involve changing the bilayer composition, or the length
of the juxtamembrane region. A more traditional uniform labelling scheme could
also be adopted. Due to time-constraints, this problem could not be immediately
addressed.
The last section of this chapter dealt with the sample preparation methods for the
investigation of E5/PDGF R-TM interactions using solution-state NMR. A dou-
ble purification method involving IMAC and HPLC were adopted to obtain pure
PDGF R-TM-20 for analyses. The following chapter will address in detail the
solution-state NMR experimental optimisations performed and the results obtained
from these studies.
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Chapter 6
A Solution-State NMR study of
E5/PDGF R Transmembrane
Interactions
6.1 Introduction
Solid-state NMR is a very powerful technique that can be employed to investigate
structural properties and interactions in a lipid bilayer, however, current data ac-
quisition methods render it far less sensitive than its solution counterpart. Where
cutting-edge methods are being developed for structural assignments of proteins in
ssNMR, assignment methods using 3D NMR are well-established in the solution
state. In light of this, it was decided to investigate E5/PDGF R interactions using
solution-state NMR as a complementary method.
Solution-state NMR requires fast tumbling on the NMR timescale in order to average
anisotropic NMR interactions (e.g. CSA), therefore large biomolecules or complexes
> 50 kDa pose significant di culty in yielding adequate resolution and signal to
noise ratio. As such, liposomes do not constitute a suitable membrane-mimetic for
studying membrane embedded proteins using solution-state NMR. Detergents, on
the other hand, have been used to study membrane proteins in vitro for the past
40 years (Helenius and Simons, 1975; Tanford and Reynolds, 1976) and most NMR
structures of membrane proteins have been solved in detergent solutions (Kang and
Li, 2011; Warschawski, 2013).
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This chapter will introduce NMR experiments performed on uniformly 15N labelled
PDGF R-TM-20 in detergent micelles and establish a suitable system for acquiring
more complex 3D experiments. A set of resonances was hypothesised to belong to the
TM region of PDGF R-TM-20 through Hydrogen–deuterium exchange experiments.
PDGF R-TM-20/E5 interactions were explored by titrating E5 into the PDGF R-
TM-20 mixed micelle solution and the implications of the results obtained will be
described.
6.2 The Heteronuclear Single Quantum Coherence
(HSQC) Experiment
First described in 1980 (Bodenhausen and Ruben, 1980), the HSQC experiment has
found its place as one the most important, and most frequently used, experiments in
solution-state biomolecular NMR. It is usually the first heteronuclear experiment to
be performed on proteins, and the spectrum acquired forms a ‘fingerprint’ because
there is a peak for each NH residue in the protein backbone (apart from prolines).
The HSQC spectrum allows us to assess whether higher dimensional experiments
are feasible, and whether experiments exploiting the use of expensive carbon labels
are economically viable. In the case of large proteins or complexes, the need for
deuteration can also be evaluated.
The HSQC experiment is initiated by transferring magnetisation from the proton to
an attached 15N (or 13C) nucleus via INEPT (Insensitive Nuclei Enhanced by Polar-
isation Transfer). The magnetisation is subsequently transferred back to the proton
after a certain delay (termed t1) for detection. A 2D HSQC spectrum is produced
by collecting a series of experiments with an increasing t1 delay (see section 1.5.6
for details).
This experiment was heavily used in this work to optimise PDGF R-TM-20 sample
quality. Projections of other 3D experiments are also compared with the HSQC
spectrum to ensure no sample degradation had occurred. Additionally, the e↵ect of
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deuterium exchange and chemical shift perturbations upon the addition of E5 ligand
were monitored using the HSQC experiment.
All experiments were conducted on a 700 MHz spectrometer as detailed in sec-
tion 2.14.
6.3 Optimisation of HSQC experiments
6.3.1 Analysis of [U –15N]-PDGF R-TM-20 in trifluoroethanol (TFE)
Prior to performing detailed analyses in detergent solutions, a 1H–15N HSQC spec-
trum was acquired for PDGF R-TM-20 solubilised in deuterated TFE (TFE-d3)
(Figure 6.1). Since TFE promotes secondary structure formation (Roccatano et al.,
2002) while destabilising intermolecular helix–helix interactions and hence disrupting
oligomerisation (Luo and Baldwin, 1997), the homogenous population, high signal
to noise and narrow linewidths allowed us to get an idea of dispersion and confirm
incorporation of 15N labels.
A total of 112 peaks (including side-chain peaks) were expected in the PDGF R-
TM-20 HSQC spectrum, and a total of 110 were observed (Figure 6.1). Based on
their unique position in the spectrum, we identified all 6 Gly residues (expected from
sequence) in the PDGF R-TM-20 spectrum (highlighted in a blue box in Figure 6.1).
Similar observations were made regarding the side-chain peaks of Trp, Arg, Asn and
Gln and are summarised in Table 6.1.
Category Peaks expected Peaks observed
Gly backbone 6 6
Gln and Asn side-chain 6 6
Trp side-chain 3 3
Arg side-chain 2 2
Table 6.1: List of identifiable peaks in an HSQC spectrum of PDGF R-TM-20 in
TFE-d3 by amino acid type.
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Figure 6.1: A 1H–15N HSQC spectrum of U –15N-PDGF R-TM-20 dissolved in
TFE-d3 on a 700 MHz spectrometer. Blue box identifies peaks which are present
in a region characteristic of Gly peaks. Similarly, red box anticipates Asn and Gln
side-chain peaks, green box anticipates Trp peaks and purple box anticipates Arg
peaks.
6.3.2 Detergent screen
Although detergent micelles are the most commonly used solubilising agents for so-
lution NMR studies, there are no generally applicable rules which dictate the choice
of detergent (Poget and Girvin, 2007). Nonetheless, the choice of detergent is crucial
as a determining factor of spectral quality (Krueger-Koplin et al., 2004). A total of 4
detergents were tested to determine which would yield the expected 112 peaks in the
HSQC spectrum (Figure 6.2). It was immediately clear that the detergent micelles
which o↵ered the best spectral resolution were those formed by the zwitterionic
detergent n-dodecylphosphocholine (DPC). The lysophos-detergents 1-myristoyl-2-
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hydroxy-sn-glycero-3-[phospho-rac-(1-glycerol)] (LMPG) and 1-palmitoyl-2-hydroxy-
sn-glycero-3-[phospho-rac-(1-glycerol)] (LPPG) along with the anionic detergent
sodium dodecyl sulfate (SDS) did not yield adequate signal to noise ratio. Sub-
sequent NMR spectra were hence collected by solubilising the protein in DPC, as
the spectrum acquired even without further optimisation was deemed of su cient
quality (by checking the number of peaks and linewidths) for monitoring of chemi-
cal shift perturbations upon the addition of E5 ligand, which would provide useful
information on binding. It is estimated the size of the protein/micelle complex is
about 30 kDa.
6.3.3 Temperature
Slow molecular reorientation or tumbling can lead to increased linewidths and spec-
tral overlap via fast relaxation of transverse magnetisation (short T2). A simple
strategy to minimise this e↵ect in the large membrane protein/micelle complexes is
acquire data at elevated temperatures.
Typically, temperatures above 30  C are preferred for NMR spectroscopy of mem-
brane proteins (Ferna´ndez and Wu¨thrich, 2003). A temperature range of 25–45  C
was tested, with measurements collected at 25  C and then at 4  C increments be-
tween 37  C and 45  C. These spectra can be seen in Figure 6.3, and suggest that
there is a dramatic improvement in spectral quality when increasing temperature
from 25  C to 37  C. It continues to improve gradually up to 45  C when several
new peaks start to appear (highlighted with red arrows). The protein was stable at
a temperature of 45  C for at least a week, hence all subsequent experiments were
performed at 45  C.
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(a) LMPG (b) LPPG
(c) SDS (d) DPC
Figure 6.2: 1H–15N HSQC spectra of [U –15N]-PDGF R-TM-20 solubilised in dif-
ferent detergent micelles. LMPG (a) and LPPG (b) were used at a concentration of
50 mM whereas SDS and DPC are used at a concentration of 100 mM. All experi-
ments are conducted on 0.1 mM of protein at 310 K in a 50 mM sodium phosphate
bu↵er with 20 mM NaCl and pH 6.0.
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(a) 25  C (b) 37  C
(c) 41  C (d) 45  C
Figure 6.3: 1H–15N HSQC spectra of [U –15N]-PDGF R-TM-20 at various tem-
peratures. All experiments are conducted on 0.1 mM of protein in a 50 mM sodium
phosphate bu↵er with 20 mM NaCl and pH 6.0.
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6.3.4 The transverse relaxation optimised spectroscopy (TROSY)
e↵ect
TROSY-based NMR (Pervushin et al., 1997) methods have been utilised for a num-
ber of years to successfully overcome the 30–40 kDa protein size limit encountered
when using traditional NMR pulse sequences. Application of TROSY-based methods
has allowed acquisition of assignable spectra of proteins with a size of about 150 kDa
(Salzmann et al., 2000; Tugarinov et al., 2005). It has also been observed that im-
provements in 1H–15N correlation spectra are also observed using the TROSY-e↵ect,
even in the absence of deuteration (Kim et al., 2009).
Experiments using traditional HSQC and TROSY pulse programmes were performed
on the same [U –15N]-PDGF R-TM-20 sample in DPC detergent (Figure 6.7a & 6.4b).
However, no significant improvements were observed in the TROSY spectrum in
terms of the number of backbone peaks or linewidths.
(a) 2D-[1H,15N]-HSQC (b) 2D-[1H,15N]-TROSY
Figure 6.4: 1H–15N correlation spectra with and without the TROSY-e↵ect.
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6.3.5 Addition of DPPC
Recently, it was reported that the addition of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC) to detergents has provided a more native-like lipid environment around the
protein without significant loss in signal to noise (Ortega-Roldan et al., 2015; Brady
et al., 2015). In light of these observations, it was decided to add DPPC to DPC
micelles at a q of 0.1, where q = [lipid][detergent] . The chemical structures of DPC and
DPPC are shown in Figures 6.5a & 6.5b respectively.
(a) DPC
(b) DPPC
Figure 6.5: Chemical structures of (a) DPC and (b) DPPC.
It can be seen through a comparison of Figures 6.6a & 6.6b that a large number of
resonances remain unperturbed upon addition of DPPC. This is not surprising be-
cause the lipids would be expected to preferentially solvate the transmembrane helix
and any chemical shift changes that are seen would be expected around the lipid–
bu↵er–protein interface where the phosphocholine headgroup of DPC is replaced by
the phosphatidylcholine headgroup of DPPC. Only minor changes (if any) are ex-
pected in the central regions of the transmembrane domain because the acyl chains
of the lipid and the detergent are chemically similar. Similarly, since the chemi-
cal environment around the soluble juxtamembrane regions remains unaltered, few
changes in chemical shifts would be expected.
Adding DPPC to the detergent solution yielded three important benefits. First, it
was observed that peak widths throughout the spectrum were reduced leading to
greater resolution. This is likely due to the lipids granting the protein a greater con-
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formational stability. This is particularly evident in the case of Trp side-chain peaks.
When solubilised in DPC, two of the three Trp side-chain peaks exhibited ‘splitting’
where two peaks were observed for a single amide due to slow chemical exchange
between two conformational states on the NMR timescale (Figure 6.7a).
Additionally, more peaks that can be attributed to residues in the TM domain
were observed after the addition of DPPC. This was deduced after conducting D2O
exchange experiments with and without the addition of DPPC as explained in sec-
tion 6.4.
Finally, in DPC, the maximum concentration of PDGF R-TM-20 that could be
solubilised before the chemical shifts started to change was around 0.3 mM. Upon
the addition of DPPC, the protein had a far greater conformational stability, and
no major changes in chemical shifts were observed. This was particularly important
as in order to do backbone assignments 3-dimensional NMR experiments need to be
performed which require very high signal to noise ratios which can be aided using a
high concentration of protein.
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(a) DPC
(b) DPC/DPPC, q = 0.1
Figure 6.6: 1H–15N HSQC spectra of [U –15N]-PDGF R-TM-20 with and without
the addition of DPPC. All experiments are conducted on 0.1 mM of protein at 37  C
in a 50 mM sodium phosphate bu↵er with 20 mM NaCl and pH 6.0. DPC was added
to a concentration of 100 mM while DPPC was added to a concentration of 10 mM.
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(a) Trp side-chain peaks in DPC (b) Trp side-chain peaks in DPC/DPPC,
q = 0.1
Figure 6.7: Trp side-chain peaks with and without the addition of DPPC.
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6.3.6 pH
The rate of exchange between amide protons and solvent protons is pH-dependent.
Although certain pulse sequences have been developed to minimise the deleterious
e↵ects of fast amide protein exchange with water (Zerbe, 2003), minimisation of the
exchange rate can significantly increase sensitivity.
Four di↵erent values of pH between 4.6 and 6.8 were investigated and resulting
spectra are presented in Figure 6.8. pH 4.6 yielded the best spectrum, however
the protein demonstrated reduced stability at this pH. This has been observed for
micellar systems previously for pH values below 6.0 (Chadwick et al., 2015) and
is likely due to the pH being close to the isoelectric point (pI) at which the net
charge on the protein is close to zero and the attractive forces between the proteins
dominate leading to aggregation. No significant di↵erences were observed in the
spectra collected at pH 5.0 and pH 6.0. However, when increasing the pH to 6.8,
several peaks disappeared from the spectrum; for example, 3 peaks at the top of the
spectrum in a region which is characteristic to Gly peaks, can no longer be observed.
In light of these findings, a pH of 6.0 was chosen for further studies.
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(a) pH 4.6 (b) pH 5.0
(c) pH 6.0 (d) pH 6.8
Figure 6.8: 1H–15N HSQC spectra of [U –15N]-PDGF R-TM-20 in DPC/DPPC
at various pHs. All experiments are conducted on 0.1 mM of protein at 45  C in a
50 mM sodium phosphate bu↵er with 20 mM NaCl.
6.4 Hydrogen–Deuterium Exchange Experiments
To investigate which resonances observed in the HSQC spectrum belonged to the
TM region of the PDGF R-TM-20 protein, the NMR sample was lyophilised and
resuspended in 100% D2O. This was performed for NMR samples in presence and
absence of DPPC, under optimised conditions. Peaks arising from solvent-exposed
protons will disappear as the protons are exchanged with deuterium. However,
amide protons from transmembrane residues embedded in the (mixed) micelle are
protected and will take considerably longer to exchange.
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It can be seen in Figures 6.9a that only 15 peaks remain after H/D exchange in a
sample prepared in DPC micelles. If DPPC is added at a q = 0.1, then 19 distinct
peaks are observed after H/D exchange (Figure 6.9b). This is most likely because
DPPC preferentially solvates the region around the transmembrane domain of the
protein and it has two 16-carbon acyl chains (Figure 6.5b), compared to the single
shorter 12-carbon acyl chain of DPC (Figure 6.5a).
The above would allow more residues to be embedded within the hydrophobic mixed
micellar environment.
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(a) DPC
(b) DPC/DPPC, q = 0.1
Figure 6.9: 1H–15N HSQC spectra of [U –15N]-PDGF R-TM-20 in (a) DPC or (b)
DPC/DPPC before (black) and after (red) lyophilising the sample and resuspending
in 100% D2O. All experiments are conducted on 0.1 mM of protein at 45  C in a
50 mM sodium phosphate bu↵er with 20 mM NaCl at pH 6.0.
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6.5 E5 Titrations
As has been detailed in section 4.1, strong evidence exists to suggest that the bovine
papillomavirus E5 protein binds to the PDGF R-TM to form a complex. How-
ever, no studies exist to corroborate which residues are implicated in stabilising this
complex. The aim here was to identify which amino acids in PDGF R-TM play a
critical role in E5 binding and to determine the e↵ect this has on the juxtamembrane
regions.
Once sample conditions had been optimised as detailed in the previous section, E5
was titrated into the PDGF R-TM mixed micelle solution in a step-wise manner.
Chemical shifts are very sensitive to the electronic environment and hence even
small changes in 1H and 15N shifts upon the titration of a ligand can be used to
map a binding interface. It was anticipated that a varying degree of chemical shift
perturbation would be observed which would establish which amino acids lie close
to the binding interface (e.g. T545 and K531) and exhibit clear signs of a change in
chemical environment.
The chemical shift perturbations observed upon titrating E5 to PDGF R-TM-20
can be seen in Figure 6.10. After obtaining a 1H–15N HSQC spectrum of PDGF R-
TM-20, E5 was gradually added at PDGF R-TM-20 to E5 molar ratios of 1 : 1,
1 : 3, 1 : 5, 1 : 7, 1 : 9; no further changes in chemical shifts were observed once this
ratio reached 1 : 11, indicative of saturation.
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Figure 6.10: 1H–15N HSQC spectra of U –15N-PDGF R-TM-20 in DPC/DPPC upon the successive addition of E5.
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Upon the addition of E5, a variety of phenomena were observed. There were peaks
which did not exhibit any significant shift (Figure 6.11a), while a widely varying
degree of shifts were observed for others (Figure 6.11b & c).
Figure 6.11: Examples of chemical shift perturbations upon the additions of E5.
Some peaks did not show any significant shift (a), while a widely varying degree of
shifts was observed for many others (b) and (c).
There were also peaks which disappeared upon the addition of E5, as well as the
appearance of new peaks. This can be explained if the residue is involved in very
strong binding to the ligand, leading to a slow rate of exchange. It has been ex-
plained previously (Williamson, 2013) that if the protein–ligand interaction is in the
fast exchange regime then the chemical shifts change continuously as the binding
partner is added to the protein. Conversely, the interaction could be in a slow ex-
change regime if peaks reduce in intensity and eventually disappear while new peaks
may appear and grow in intensity simultaneously. In such a situation, the binding
is so strong that it can safely be assumed that throughout the duration of the ex-
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periment any one protein molecule is either free or in complex and chemical shifts
for both are observed simultaneously. This has been illustrated diagrammatically in
Figures 6.12a & 6.12b.
(a) Fast exchange (b) Slow exchange
Figure 6.12: The e↵ect of exchange rate on NMR peak shapes. (a) Fast exchange:
a gradual transition from unbound (red) to bound (brown) is seen. Slow exchange:
the peak representing the unbound state (red) reduces in intensity as the peak from
bound state (brown) increases in intensity. Figure adapted from (Williamson, 2013).
As an example, this phenomenon can be seen in a region of the spectrum highlighted
in Figure 6.13. There are 3 peaks (encompassed in a blue box) which completely
disappear upon the addition of E5 without any change in their chemical shift. Con-
comitantly, however, at least 3 new peaks emerge in an adjacent area of the spectrum
(encompassed in a green box). Even though it could not immediately be established
that the new peaks belong to the residues which have disappeared in the blue box,
this observation does lend strong credence to the hypothesis that strong binding
events are occurring.
Interestingly, according to the H/D exchange data presented in section 6.4, each of
the 3 peaks which disappear upon the addition E5 is suggested to lie within the
mixed micelle (and would thus lie in the transmembrane domain). Upon further
inspection, it can be noted that 12 of the 19 peaks which putatively lie within in the
mixed micelle unambiguously exhibit this property where they gradually disappear
from the spectrum without much change in chemical shift. Furthermore, for all
peaks that are thought to lie outside of the mixed micelle and that do not exhibit
any significant change in chemical shift, their intensity is reduced only by a small
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factor (if at all). This can be attributed to the the increased size of the mixed
micelle.
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6.6 Backbone Assignment Using triple resonance (CHN)
3D NMR
In order to extract amino acid specific information from the NMR titrations de-
scribed above, it was necessary to attempt to assign each of the peaks in the 1H–15N
HSQC spectrum. All of the triple resonance 3D NMR experiments conducted for
this purpose have been introduced in section 1.5.7 and the experimental set up is
detailed in section 2.14.3. The optimisations described in section 6.3 are particularly
important because higher dimensional experiments have lower sensitivity, so a peak
with low signal to noise may not show up at all in a 3D experiment.
Additionally, some 3D experiments are even less sensitive than others. HNCO is
the most sensitive triple resonance experiment, and the relative sensitivities of other
standard experiments used in this study are given in Table 6.2. The least sensitive
experiments, such as CBCANH, may not allow the observation of weaker peaks in
the HSQC spectrum. On the other hand, although HNCO is the most sensitive 3D
experiment, the dispersion of CO nuclei is very small, ⇠174–177 ppm.
Experiment Nuclei observed Relative S/N (%)
HNCO Hi Ni COi 1 100
HNCA Hi Ni C↵i C↵i 1 50/15
HNCOCA Hi Ni C↵i 1 71
HNCACO Hi Ni COi COi 1 13/4
CBCACONH Hi Ni C↵i 1 C i 1 13/9 ↵/ 
CBCANH, HNCACB Hi Ni C↵i C i C↵i 1 C i 1
4/1.7 ↵/  (i)
1.3/0.5 ↵/  (i  1)
Table 6.2: Relative sensitivity of backbone assignment experiments compared to
the HNCO experiment. Adapted from (Sattler et al., 1999).
Where the complementary pairs of 3D heteronuclear experiments HNCO/HNCACO
and HNCA/HNCOCA are useful in determination of backbone connectivities in
amino acids of a peptide chain, the CBCACONH/CBCANH pair additionally pro-
vide useful information about amino acid type. There are 4 amino acids which give
very distinct shifts and hence are easily identifiable. Gly is unique in that it is the
only amino acid which gives a C↵ but no C  signal. Furthermore, it is the only
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amino acid which has an average C↵ chemical shift of below 50 ppm. Ala is also
uniquely placed in the spectra, with a C  peak which is usually below 20 ppm.
Ser/Thr are the only amino acids which always show a C  peak at greater than
55 ppm, with Thr C  usually higher than 65 ppm.
6.6.1 An example of sequential backbone assignment
In order to demonstrate how sequential assignment was performed after the col-
lection of appropriate 3D data, the N-terminal stretch of 5 amino acids VSSDG is
shown in Figure 6.14. Due to the higher signal to noise, the HNCO/HNCACO and
HNCA/HNCOCA datasets were simultaneously used to determine backbone connec-
tivities as shown Figure 6.14a & b respectively. In the case of the HNCO/HNCACO
pair, the HNCACO shows two peaks: one of which belongs to the COi (current
residue) and the other COi 1 (preceding residue). The HNCO, on the other hand,
only shows the COi 1 peaks, which allowed us to di↵erentiate the peaks in HN-
CACO. Once COi and COi 1 have been identified, the preceding residue can be
located in the spectrum by looking for a residue that has a COi correlation at the
chemical shift of COi 1 correlation of this residue. This procedure is then iteratively
continued. An analogous procedure is followed for the HNCA/HNCOCA pair.
While the HNCO/HNCACO pair helps trace connectivities through CO nuclei and
HNCO/HNCACO does so through C↵ nuclei, the CBCACONH/CBCANH can pro-
vide additional confirmation of these connectivities by tracing C  nuclei. As ex-
plained earlier, the C ’s can also be used to deduce amino acid type. In the exam-
ple shown in Figure 6.14, Gly can easily be identified using its distinctive C↵ shift.
Similarly, it can be identified that there are two consecutive Ser or Thr residues.
The link X–S/T–S/T–X–G is then compared to the sequence and only one unique
match was found, so the backbone assignment VSSDG was made for this group of
peaks.
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Figure 6.14: An example of sequential backbone assignment. The spectra in (a) and (b) are used for sequential assignment whereas (c)
additionally provides valuable information on amino acid type.
179
CHAPTER 6. A SOLUTION-STATE NMR STUDY OF E5/PDGF R
TRANSMEMBRANE INTERACTIONS
6.6.2 Backbone assignment results
Using the above strategy, a total of 29 out of the 90 non-proline residues were
assigned. The low signal to noise in other regions of the spectra inhibited further
assignment. The results are shown in Figure 6.15. Any residues which were in the tag
region attached to the protein are highlighted in blue. Four of the residues, 481Ser–
482Met–483Gly–484Gly could be assigned to two sets of peaks, likely because they
are in two di↵erent conformational states, possibly induced by the flexible glycines.
Each of these is su xed with an A or a B, where B forms a part of a continuous 14
amino acid assigned stretch. Unfortunately, no residues within the transmembrane
domain could be assigned. However, 7 residues of the C-terminal juxtamembrane
region and 16 residues of the N-terminal juxtamembrane region were assigned. The
sequence is given below:
N-HHHHHHGKPIPNPLLGLDSTENLYFQG IDPLWNSMGGDSQEVTVVPHSLPFKVVVISAILALVVLTVIS
LIILIMLWQKKPRYEIRWKVIESVSSDG-C
In the sequence above, the italicised region represents the tag, and all assigned
residues are underlined.
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Figure 6.15: Backbone assignment of 29 residues. Assignments in blue are of
residues which belong to the tag region of the expressed PDGF R-TM-20 construct.
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6.6.3 E↵ect of E5 on the juxtamembrane residues
Since greater than 50% of the juxtamembrane residues werre assigned, some useful
information could be extrapolated. Firstly, many of the chemical shift perturbations
such as those for 495Ser and 494His (Figure 6.16a & 6.16b respectively) are nonlinear
which is indicative of a conformational change (Williamson, 2013). This is in line
with some of the existing models of ligand binding to RTKs which predict a large
conformational change in the juxtamembrane regions upon ligand binding.
(a) 495Ser (b) 494His
Figure 6.16: Non-linear chemical shift perturbations of (a) 495Ser and (b) 494His.
Unlike the peaks from residues proposed to lie within the micelle, the juxtamembrane
peaks exhibit fast exchange and their perturbations can be followed in the NMR
spectrum. In order to investigate the e↵ects of the PDGF R-TM/E5 interactions
on the juxtamembrane residues which have been assigned, the following formula was
used to calculate chemical shift perturbations (Williamson, 2013):
  =
q
1
2 [ 
2
H + 0.14 ·  2N ]
where  H and  N are the chemical shift di↵erences in 1H and 15N dimensions re-
spectively. The results from the calculations have been illustrated in the bar graph
shown on Figure 6.17.
Even though the largest shifts upon the addition of a ligand tend to be local
(Williamson, 2013), when E5 is added to PDGF R-TM-20, some very large per-
182
CHAPTER 6. A SOLUTION-STATE NMR STUDY OF E5/PDGF R
TRANSMEMBRANE INTERACTIONS
Figure 6.17: Chemical shift perturbations of PDGF R juxtamembrane regions.
turbations are seen in the juxtamembrane domains. This is particularly evident in
the last 7 residues in the C-terminus. This, however, is not unexpected as studies
have shown that receptor tyrosine kinase juxtamembrane domains undergo dramatic
rearrangement upon activation (Matsushita et al., 2013). Unfortunately, not enough
peaks could be assigned to quantitatively assess the significance of these perturba-
tions.
6.7 Summary and Conclusion
This chapter explained all the experiments that were carried out to investigate
PDGF R-TM/E5 interactions and the conclusions that were drawn from them.
Firstly, the HSQC experiment was used to make the best possible choice of detergent
and pulse sequence, and to optimise experimental conditions such as temperature
and pH.
The addition of DPPC lipids yielded significant improvements to the spectrum. The
number of peaks increased and narrower linewidths were also obtained; but most
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importantly, it allowed higher concentrations to be reached without significant shifts
in the spectrum, indicative of greater conformational stability. Hydrogen–deuterium
exchange experiments also revealed that after adding DPPC, more peaks which can
be attributed to the TM domain can be seen.
After the sample conditions had been optimised, E5 peptide was titrated into the
sample to investigate its e↵ects. A large variation in how much the chemical shifts
were perturbed: some peaks remained at their given chemical shifts, whereas some
moved significantly. It was possible follow the transitions when the rate of exchange
was fast. There were several peaks which appeared to be exhibiting a slow rate of
exchange given that they disappeared upon the addition of E5 without showing any
chemical shift perturbations. Several new peaks were also observed, indicative of
strong binding. It was additionally observed that all of the peaks which exhibited
this behaviour were those which H/D experiments suggested lie within the mixed
micelle.
Backbone assignment was attempted using 3D NMR experiments. It was possible to
assign 29 out of the 90 non-proline residues. Even though no transmembrane domain
peaks could be assigned, it was possible to do so for over half of the juxtamembrane
peaks. Large shifts were observed on both sides of the transmembrane domain
which was in line with receptor tyrosine kinase activation model which suggests a
dramatic rearrangement of the juxtamembrane region upon activation of the receptor
(Matsushita et al., 2013).
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Probing the structure of membrane proteins and the dynamics associated with var-
ious biological processes taking place within the bilayer environment is a major
challenge in structural biology. This is attested by the fact that less than 3% of
all entries in the Protein Data Bank (PDB) fall under the classification of mem-
brane proteins. However, due their great potential as pharmaceutical targets, an
increasing amount of resources are being expended to overcome the di culties in
the biophysical analyses of membrane proteins. This has borne some fruits in that
the number of membrane protein structures determined increases several fold each
year. Nonetheless, they are still disproportionately low compared to water soluble
proteins.
There are several di culties that are associated with membrane protein production
and analysis due to their high hydrophobicity and requirement for reconstitution
into membrane mimetics (section 1.3) if they are to be studied in vitro. The first
major challenge is to express membrane proteins in su cient quantities. Several of
the commonly used prokaryotic expression organisms such as E. coli do not possess
the cellular machinery to cope with post-translational processes associated with
membrane protein folding during heterologous expression. Great strides have been
made towards overcoming these problems which include: (1) the development of
strains which are more tolerant to toxic membrane proteins like C41, C43 (Miroux
and Walker, 1996b) or Lemo21 (Wagner et al., 2008); (2) tags to improve expression
levels such as GFP (Drew et al., 2006) and Mistic (Roosild et al., 2005); (3) hosts like
Lactococcus lactis for which inclusion body formation has so far not been observed
(Kunji et al., 2003); (4) optimisations of eukaryotic expression systems such as insect
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(Trometer and Falson, 2010) and yeast (Sreekrishna et al., 1997) cell strains; (5)
preparative scale expression of membrane proteins in cell-free systems (Jermutus
et al., 1998; Schwarz et al., 2007).
Once protocols have been developed to produce membrane proteins in adequate
quantities, there is still the need to reconstitute them into membrane mimetics while
minimising the compromise on structural integrity. Several such systems have been
developed (see section 1.3) to address this challenge and the reasons which govern
the specific choice of mimetic are manifold, the most crucial being its compatibility
with the analytical technique employed. Sample optimisation (e.g. detergent screens)
usually needs to be performed which can be laboriously time-consuming. However,
techniques such as NMR are now being used to access structural information for
proteins in vivo which represents an exciting development in a field with great
potential (Gold et al., 2014; Renault et al., 2012).
The aim of this study was to establish methods for the production of, and/or use
cutting edge techniques to retrieve structural information for, the transmembrane
(TM) domains of receptor tyrosine kinases (RTKs) Neu and PDGF R. As evidenced
through biophysical studies conducted on the RTK-TMs, these regions play an es-
sential role in receptor signalling and do not merely tether the receptor to the mem-
brane. They do so in two di↵erent ways; firstly, they confer a thermodynamic
stability to the TM dimers which is essential for signalling, secondly, depending on
how the dimers are structurally oriented, they can maintain an active or inactive
state.
Despite the medical significance of RTKs as highlighted in section 1.2, no high-
resolution structures of full length RTKs are available. However, several structural
studies have been performed on isolated non-TM domains of the receptors and-high
resolution crystal structures of the intra- and extra-cellular regions, with and without
ligands have been obtained. To the contrary, there are only two high resolution
structures for RTK-TM dimers, namely, ErbB2 (Bocharov et al., 2008c) and EphA1
(Bocharov et al., 2008a). However, the role of the respective RTK-TMs in receptor
signalling with respect to the conformational state in the structures is still unclear.
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Furthermore, a synergistic structural understanding of how extracellular events such
as ligand binding induce catalytic activity in the cytoplasm is still lacking.
Both of the aforementioned structures were obtained through solution-state NMR
and there have been no successful attempts at crystallising RTK-TM dimers for
structure determination. While it is hoped that high-resolution structural infor-
mation of these systems will emerge following the ongoing developments in X-ray
crystallography (Garman, 2014) and Cryo-electron microscopy (Goldie et al., 2014),
NMR spectroscopy is uniquely placed to address the limitations of these techniques.
The ability to study and understand conformational change of RTK-TM in acti-
vation of the receptor is central to developing a model of how signalling occurs.
Using solution- and solid-state NMR, such conformational dynamics can be closely
monitored.
Bearing the above in mind, the structure and dimeric interface of oncogenic Neu
(Neu*) RTK-TM was investigated using solid-state NMR. This a↵orded an oppor-
tunity to carry out analyses in ‘native-like’ bilayers. Work conducted was based on
two di↵erent models for the stabilising interactions in the Neu* homodimer. The first
hypothesised A661XXXG665 motif stabilises the dimer (Smith et al., 2002b) whereas
the second implicated I659XXXV663 as the stabilising interface (Beevers and Kukol,
2006; Beevers et al., 2010).
Two di↵erent samples were prepared to investigate this. For each sample, a pair of
peptides, each of which was labelled at a single amino acid in the sequence, were
reconstituted into DMPC/cholesterol liposomes. Solid-state NMR DARR experi-
ments were performed to look for inter-helical correlations. The spectra obtained
provided evidence to support A661XXXG665 motif as the stabilising interface due to
inter-helical correlations obtained even at short mixing times. No such correlations
could be observed for the other model. However, two additional conformations were
observed when studying the A661XXXG665 motif; cross-correlation between two of
these conformational states could suggest conformational exchange between them.
High degree of mobility of the peptide was also observed when looking at the pro-
posed I659XXXV663 interface. This could indicate more than one stabilising motif,
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with one being more dominant than the others. This would fit in nicely with the
rotation-coupled activation model for the Neu RTK (Bell et al., 2000) where Neu
exists as dimers and activation of the receptor requires rotational positioning of the
dimer such that one conformation is preferred over the other.
There are several avenues through which the work performed on the Neu peptide
can be taken forward. Firstly, experiments with several more mixing times could be
performed as per the methods outlined in this study. The peak intensities could then
be collated and build-up curves (normalised intensity vs mixing time) drawn. The
build up curves for the intra-residue and inter-residue peaks can then be compared
to get a quantitative estimate for the distance between specific atoms at the dimer
interface. Secondly, the method of studying singly labelled peptides can be extended
further. In this study, where one sample showed cross-molecular correlations even
at really low mixing times, the other showed no such correlations even at high
mixing times. An approach could be adopted where labels could be incorporated
into adjacent residues to the current ones and observe what e↵ect that has. However,
it would need to be ensured that experiments are feasible in terms of time and
money. Thirdly, incorporation of 19F nuclei into the aromatic ring of phenylalanine
could be used to obtain inter-helical correlations over a longer range (10–20 A˚) with
very little background (Hong and Schmidt-Rohr, 2013). Fourthly, the cholesterol to
lipid ratio could be further modified and a complete characterisation of the e↵ect of
this ratio on the dimeric state at various temperatures could be obtained. Fifthly,
a completely new approach of uniform labelling in bacteria could be employed to
obtain the complete structure of the oncogenic Neu dimer.
A substantial portion of the work presented in the preceding chapters focusses on
the production, purification and structural analysis of PDGF R RTK-TM. Prob-
lems associated with the cleavage of tags in an existing protein construct led to
TOPO-cloning being used to create a new construct for the heterologous expression
of TEV protease cleavable PDGF R-TM plus 20 residues on either side. A series of
expression optimisations were performed to ensure maximum yield for NMR studies.
Additionally, plasmid stability was closely monitored and ‘high-density’ expression
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methods were employed to ensure maximum protein yields. Once expression con-
ditions had been fully optimised, two detailed protocols for the purification and
reconstitution of PDGF R-TM-20 were devised, one each for solid- and solution-
state NMR analysis. For solid-state NMR, purification was performed in Triton
X-100 detergent and the protein was reconstituted in liposomes using BioBeads.
For solution-state NMR, IMAC purification was done in a chaotropic agent such
as Guanidine HCl or Urea, another purification step involving HPLC followed and
the final sample was prepared by directly dissolving the protein in detergent solu-
tion.
No immediate conclusions could be drawn from the preliminary data obtained through
solid-state NMR spectroscopy and further analysis was precluded due to time con-
straints, however, several interesting observations came to light in solution-state
NMR studies of PDGF R-TM-20. A detailed screening of various conditions was
performed to get the best possible HSQC spectrum (see section 6.2). What was
particularly noteworthy was that addition of DPPC lipids to the sample led to nar-
rower linewidths, more peaks and higher concentrations were achieved without any
change in chemical shifts. Hydrogen–deuterium exchange experiments revealed a set
of peaks suggesting that they are associated with residues embedded within the mi-
celles. E5 was also titrated into the sample and a variety of changes were observed.
While some peaks remained largely in their original position, others moved consid-
erably, while yet others disappeared altogether. The disappearance of some peaks
and the appearance of new peaks suggested strong binding events. Interestingly,
the peaks exhibiting this phenomenon were the ones which hydrogen–deuterium ex-
change experiments suggested would lie within the TM domain. Even though no
transmembrane domain peaks could assigned, a section of the juxtamembrane re-
gions was assigned on both sides of the TM. During E5 titrations all of these peaks
exhibited significant shifts which is in line with the hypothesis that the juxtamem-
brane regions are substantially rearranged following activation (Matsushita et al.,
2013).
Amongst the endeavours which could immediately be undertaken to take the study
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of PDGF R-TM forward is to complete the backbone assignment. This could be
done by deuterating the sample and maximising the benefits of the TROSY e↵ect in
obtaining 3D spectra for assignment. Once this is done, assignment of all new peaks
after the addition of E5 could also be done to show direct evidence of E5 bind-
ing to PDGF R-TM. This can be followed by side-chain assignment culminating
in the complete structure of E5/PDGF R-TM complex. In the longer term, lipid-
juxtamembrane should also be investigated. Other membrane mimetics (section 1.3)
such as bicelles are also promising candidates to be considered for high-resolution
structure determination. Eventually, the length the juxtamembrane region being
considered could be increased to get a holistic understanding of how signal trans-
duction occurs across the membrane. More generally, a cross-disciplinary approach
could be adopted to study RTK-TMs; for example, bicelles represent a unique sys-
tem in that they can be crystallised and analysed by solution- and solid-state NMR.
Moreover, methods for crystallising membrane proteins could be adopted to pre-
pare RTK samples for solid-state NMR as they would provide greater local order
and have the potential of providing high-resolution structures as has already been
demonstrated (Shahid et al., 2012b).
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